var title_f28_38_29280="Thin blood smear 2B with answer";
var content_f28_38_29280=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F72894&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F72894&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Blood smear of falciparum malaria",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 368px; height: 292px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Giemsa- stained thin smear of blood showing the characteristic banana-shaped gametocyte of Plasmodium falciparum (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Stephen B Calderwood, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_38_29280=[""].join("\n");
var outline_f28_38_29280=null;
var title_f28_38_29281="iCycleBeads";
var content_f28_38_29281=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F83607&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F83607&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    iCycleBeads software application",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 350px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    After the&nbsp;woman enters the start date of her most recent period into her private account, the web app shows her where she is in her cycle and whether she is on a day when pregnancy is&nbsp;possible (fertile day)&nbsp;or&nbsp;unlikely (non-fertile day)&nbsp;according to the Standard Days Method of family planning. The information is provided both on a color coded calendar and on a virtual representation of CycleBeads&reg;. She can also receive alerts telling her the day is a fertile&nbsp;or non-fetile day and&nbsp;reminding her&nbsp;when she is about to get her next period.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; 2002-2012 Cycle Technologies. Photo reproduced with permission.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_38_29281=[""].join("\n");
var outline_f28_38_29281=null;
var title_f28_38_29282="Ventral suspension";
var content_f28_38_29282=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F65156&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F65156&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 507px\">",
"   <div class=\"ttl\">",
"    Infant ventral suspension",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 487px; height: 619px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Ventral suspension measures the strength of the infant's trunk and neck. The infant is held in a suspended prone position in the air by placing a hand under the chest. A normal term infant will keep his/her head in the horizontal plane momentarily with flexion of both the upper and lower extremities. An infant with decreased muscle tone will appear limp with extended limbs and a drooping head, as shown in the inset.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_38_29282=[""].join("\n");
var outline_f28_38_29282=null;
var title_f28_38_29283="Pubertal events girls";
var content_f28_38_29283=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F52047&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F52047&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Sequence of puberty in girls",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 418px; height: 498px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Sequence of events in girls with average timing of pubertal development in the United States. Black girls tend to reach a milestone at a younger age (left-hand side of the bracket) than white girls (right-hand side of the bracket). The median length of time between the onset of puberty (breast tanner stage 2) and menarche is 2.6 years, and the 95th percentile is 4.5 years.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Biro FM, Huang B, Lucky AW, et al. Pubertal correlates in black and white US girls. J Pediatr 2006; 148:234, and from: Tanner JM, Davies PS. J Pediatr 1985; 107:317.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_38_29283=[""].join("\n");
var outline_f28_38_29283=null;
var title_f28_38_29284="Sporo asteroid body";
var content_f28_38_29284=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F73691&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F73691&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Sporotrichosis - asteroid body",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 339px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFTAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDxa5uZ7+4kldi7sela3hSwuZLyNJoH2lxnK9qztBjabWrdFHGc19R+GdLtX02ETQx79o+bFeN7SNBqTWiPsszzCdOXsaau2mbXhOGC20RQgG7b+VeT/GhLO+4ZAtwvRu9evx2hX7nAx0FcR458N/2lC7bcuOhA61hVlPEVPaNnj5V7PCTSl8z5rhtTJeRg8gMK+n/CKE6LbHodg4ryK38Kmyvw9yMRg5YmvXPB2o2l9afZ7KdJPLGODyKr2kZe42etmrhVaq0lddzoL2IT2ZiZgHIIBr5j8Z289n4hnt7hiV3ZU57V9MvKFPlyocjiuE8f+A11uB7yzO25QE49aShFNsjL8XChbn6nm/w88TTaHq8cUsh+yykKw7CvU/GayzwxvCAYpFyCK8ChtphdmJ1bej7SPevqbwXo/wBv8KWYnGSigYPJrSngVX95mma1qOGrRnHaX6Hzh4sivCVjlVtoOQMUvg/w7dXurRMUIjUgmvoHxD4QtLmRfMTLKewp2k+FDa2krW0YVypI+tdEaFOit7mUs554+zireZ4X8S7cQap5KOWWNB36V5+hIPzevevVdW0l7i/uo9RVlmySCa84ubKYXMsTxlQp4OOtY8ns1ZntUqkJRjGL1/M6TwnrF/prj7HMQucsvavpvwjq/wDamhW1xkbmXD47V8y+C9Hu764EUEbEMcFsV9FeDdLfQ9Lis5DnJyc9q8+vT5Pf7nl5tKlVStbm8jqmCqparFs6EHmqd0R5IKnpVSOYr8yg/TNEMS1sfPewc4my8EcnzD9Kp322OMGNeCMGnR3iCNWPQ9RVPWr6KO1ZlPAGeKbxPPuiaVCfPaxUaeESlZSBx19KvRSRPbqIpPb615LrniBvtG5Jgozgg966zwXqq3VuysQSuDTUEndM9OvgnCnztM9G0yNI4DsABLZPvXI/GHwwfEPhqR7aPddwjIH94eldRY3KM2xeuKvhsjBr2MHjIr3XqeBNTpy5ouz6HxU3g2+hmjDWkpyeRt719G/Bvwx/ZOkmSZSpfnaw5zXctpVi0hc20e7OenerqbY12oAqjsK9FToRi+RWHXxVfE2VVJJCmNQWKjGetY2raesgJFa/mZ4FYGv3MtqrN1BHHNePi8VH/l2XhqblUSRhzqlk2BgDvXmHjbVnt57m4hUymFC4QdTitvVNRmkupGuJCgz3PFcJq16ZppGBDZO3iuKddysup9VgsFd67GV8J9FK6lca7qalbqdswL6BuS1eqeKtU+x6ZGqsSTWB4E0xpwQy7f7oHpXe6z4Za9stiqMhQMHuauLnOTctjGusPhakY3uup5KusXE9yqRZwxxmvTvBVjdXLR78laq6T4LjhuFaVBlOvFejeG7WOD5Yl2gd8da6MNKCqWe5z5liqcqdqKL0OneSoXjgdB3NOFii/MyjOK0GGTnNcv488Sx+HtMaVxlscD1NduKrcjtFanz9CjKtJQXU1JLuC1TJIXA5rFi8QWpuzGJAWPYHmvn7xF8S9T1ZmiTEIz/Ce1WvhVqdxc+IHa4dpQeMk15E6kpRdz6SOS+zjzyPbPF+px2OmGeTkda830T4iQvqAguQIwThTnpW58XtUW28MrGF/eOf0r5wN4wutxzkHqK5Y4dVVdHbgsJSdJuovQ+zdNzdwJLGSRjPFT3MSKMk/MeteefBPxmmqWv9mz8TRLznuPWvSrmMzBwg+U96yVZx916NHiYig6VVxexzni/U4tG8NXd6WVQiHYT3NfJt5qZvZ5nlbzJHJZia+jfi5pV1qWgwxwhvKi+cp/er5xl0W4a5IEDgE4+71ruw0eamnI9TK1GEnONn0sygyrjJJTNXdL0i5vp41hVnVzjcRXofgr4XXWpSRz6hGUthyAepr1238D2cdtawWqLGkLZJHet5VOVWubYjM4xnywW3U4fwZ4Ft7WBZrlAZT3Ir0jS9Nit0AhQBV5zWhHaoGRABtXvXl/xQ+IZsHfStDZRIvEs3ofQVwtyk7I8yMJYqdluz0+N45HIZlz7Gn7QoIGCK+cPC/j6+s9RSO8naSFjyT1r2bQPEtrqCjypdxPUGlGtUovlmisVlUqfvLU6d2bI4+UVGGDMSRirC4aEEcg0gRQuWxgnmujnTVzz1Bp2KctkkuWY8Y6VzuoeE7W/uVkmjVlU5AIrY1/V7fR7N7i6kVIkHU9T9K88g+KVvPfiFVZIicbmqKlWdJXib0MBLE6w6GD4D8FNb3kc9wwY9s17dp0SwxiEnGBxXkFp4thsLBDdECTsB1rE1r4l3rDbaMY/RieazqVKlWaSWh6VLLp1pyqt/M+lLdjHtL81xXxE8WW3h0FpR5jOPlQVx/wAMfiTd6jdJYawFk3cLIvUfWrHx58PTXVva39updUGGx3HrWlShNOPZmODp0vrLpVN1/SPNfF/jmbWrVoorc25zkkHrXO6Brd3ol5Be2VwyyBvm54b2IrPvDtQowYMvbvUelKZpMKpZCeRiuinSjGOh9HVhTivY9Gj6r8KeIYfEWkx3ijDhfnX0Nc74t8fR6VI9tCu+QdQO1Vfg7olzBYXLFz5Lj5RXnvjfSL611m7NwjbGc4bHauethpTqW6eR52XU8NKrKE3exd0vWtHu55prq2Edxv8AM68GvU/h58TdMkuvsEqGBSdqtnj8a+aWWWLJORz3qWwuTBN5iMVPrmt1zxWkmdGMyzDYhXUdX17eh9z6hBDdQCRMHIyGHeqtnE5XCMB61yPwk1z+3fB8aPLuubf5WB647V0ou5bWcBkJU9a5Z4iVKr7+p8bCk1zQjujK8TeC4NTPnQ4WXv71yl78L4phvlAJHpxmvVI7hWQMDxUctwApPUV6FXMIygrLX0HTxeJguRSOR8PeGLXSIkeCJVP05roII0kyzjlTmlzjkAlSe9PdSYG8vjvXntSqy5mW5u1rnPeJNWgsQ4LfL1FYdv4lhe0eWNt20Zx61yfxeluLdiFyA3cVxHh/WTDbyQyyYzVLD8qdz6bC4GMqKkjqdX+JFzbXjpGuIyfumup0fxBBr+jnedspGODXh+r3MMtzjGDnrXpHgY2zWKxx53+1SqcafwnRjMLGKi4qzMfxzZi1tnmbICnAPrXO+GvHF3o9yCqiSPuprrfjBLHHZ2dpuxIx3sPavIWZRIwGaqEVWT5jvTboKMtj6m8CeMLbWZICmQZOMHsa9MByK+W/g5fxw3rxyOFCkMuT39q+nrCUT2scqnIYVOFvTrcnQ+NzmjGE1OGxNTJGwDnipTjFVLt08tgWA7V7mLkqdLRniQXMyu85jmPdcVh+Iy87Kmflb7ua0Q6+WQ8gJ7c1lXcizEKpyVOa+W0vuexhadp81tjzPxpo115ckm/avY+lcNY2bi7UJ84B5969P+IM0jQeUoySeRmuO8MRGW82YGc4rvpTUmrI+pw/O6TlzbHqPw30vy0V2XcW5Oe1ehzWsUgAA2/Sud8FQtFFtI+UDrXVcV6VGnzOzPjMwqS9u7MzpLCLfnkcYp1pEsJKr0FWJehGce9V4Y9rkhiSeua56yUKqSZzKblHVl7NeY/Gqxku9Ec45A4NemoR61xHxPtrubTj9nGQQQK7sRzNqUS8E0qqu7HyHdb0mKj7+ea634c6vHpOsq0pwvc1mapp72963nAh88g1Qt7SRZXlJIX2rzqsLxcWfosZKcE27pnqnxF8Sadqenlt+WUfL9a8VZt8zbDxnIFamokyRqjZIHamWlmZpFEURJJxwKKMXGPc5Z040E4KStvueyfAfRWSQ6nMcbhsUD09a9u1G+igtyEOD9a8/wDhbYfYtGjRARxnn1qH4gay9iuFbbXN7CU5NtHiSpfWKqbdzfuNYgnmFs7BgTz34q5HoukSMjGGP5eeg5NeReEJ7nUNYEhYlM5JzXZat430TQD5MzmSYdcHoazjCdFuzdvIuvgFJ2itT0gRRiMJAoUAccUsFu+Dt/OuQ8LePdK1fakEqiRv4Sa9C0yVJoyVOQP1q6M4VHyvc8rFUquFWq0OY1RxBZzxhgsjKQDXyb46ia31qZY5BJuYnjmvevinqt1FePFCcRnI9K+ddTRpr2VpGO4Mc813Km6UmnsevleGk3GqpWbW3kZ8fmtNGcYI71618MbS7kuojhhF1JrzjRrN7i/hhQFyzgcdTX1B4Y0L7FbwbYwgCgVjWak7M9HHV1Rpcu7kdDFEDAoHAA5PrUdyu2BpSflXn61YMTEAE4T+dUNdlMWnOFPY9u1c0JN1EmfNVElG6PC/i5rst64gBKwoePrXlu5wdwJ3ZyDXY+K5VvdVmWRyAWxz0FTwaBYS2RZWZpcYUiut1Ywdj6Gi4YSin37HPeIJsalOFJK5+WsmeKV4VbaT7gV0mq6e0V7uaM8nnI5rr/DWj25tDJdqgBHG4dK6KUKcIXm7WN8bi1Qgo73Of+GNlNNrEMiZCqeTivpS6uIptKWK5AbC9DzXn3hmy0q2mH2Zo1ftiu1uIP8ARyQ4Y47VliK1N8qi9EfLP2lTEOtONm9DyfxX4Z02S5MqxMGY/wAPSqng/wAN2dvqXAGScjcOK6bVriW3L7kGPeqWlolzcB1JR/bjNVTld3TPanGrKjrqj2Dw/BDFZCOFEQgZwtRanolvqcTpcwK+R1xVTw2JDGuWO4DBrp7OCXexB+U881XsZczlFnz06jpPszyDxF8Lbe6t5Da5jmGSF7H2riG+EupLjYvy55r6jmjXZhlUmmQ7DkFAPwrT20KbtKN2U80xUoWUtjy/4V+F73w3M7ysVSRcFfWvQLm6QQsXAOO9aFxt8okjiuR1aQRb2QnaeorzsVatK60Fh068nOpuacWpRqAqtkVa+1q8YAGQRzXDJeIJFbJye1dFo9z5sD7xn0rDkaOqvhYxXMjSu52CLsHA9aWGcPEQTjIqofMkzv4FQSzJEV5OKuM+QiNFNcq3MvxZ4bTWLQxyDdkcHuK8H8Y+HJ9BlLITgHrivpCbVVWEbTujri/HcVnrGnMjKA5HFXTxbl7kkepga9alK8tj5zMjySZIJP0r074fRkumCVYdKfpPgmGWUAr8vrXaaL4Tk0xvMhG7I79q393oz0q2NjUjZo4z4zaNcyyWeoR5dAmxwO1eV3MTx4TYQzdOK9s1231ibUNgj8y3LYK9qmu/C8N5bQxS2gikzw2ORVxp3V0ZxzCNP93e9/wR5J4aima9gSAESFwBj619j6DC9vpVrFJy3lgk15f4Y8BW9jdpdEKzKcgV6xZuEgVXYZHrWTqQg9Txs8xCrKMYbIlc7Rk9KyNRjjky6khs1l+L/GFjo8XEqtIOdoPWuJ0j4qWt7qS29zA0ccj7FfPc1brufmjjwuX1+X2yVjsfskh3Ek+1WobCGMA7TknmtyxtlZRIACGGRViS0UqwUAFuaUsDOceeKM6uPbfKedeINGWTzAxyD931rI0bw4LWbeg613GviGzjZ7ghY1GSSa5XTfE+lTz+VDdxM65wM4rmptU3aR7uEnWq0eaCuSXvxC0rwxdmznZpJxwyoM4rofDPjzStfn+z28my4xnY3Ga+bPEIC+KL6S6zl5GYfnW34AtLi58R2P2HdvEocsOwHrW04SWqk7m2JynDzoOtLR2ve59OTE44H1pqkDvyaPNCpl+GHaq6MrMXY4xXI6jvzPc+RUNC8j+lQatCLmydCuSORSQMS7K3Y8e9SXjsluzKM9q6qeIqVY8sSVHlmjxTxFoFi+qM91H064Fcb4kGmQKqxJsUda9N8dSPBGXUY4rwDxLeST3b5J2jvRKnU5rtn3GWYaE0qjew5Zrb7SvyAgN3FeteAbPTr+a3ZrdF9cCvFNMjaWQMeRjJrrNM8TXGjmIwj5Y+T71LjJSvBnZmGEp4mK5UkfSHiHVNO8OaOWRUXA6Dqa+evFHiKXxJqyqq7EZtqis7W/Ft94i3ec5VOyg1v/CfQP7W1lHmXiJs0Qc4+9J6nBSwtPA0OeWrexu6Np8miaZNOUx8hOT3rxbWZ57u9lln5LMTyelfY3iPw1DJo0qDByhGK+SPGWn3GmalLCqEJuODXcoJrmj8ziwePhXm4T7aeZS8PX0ljqNtNBIVIkAIBr7I8Fams+j2z4ySgzXxbpyYuFd1xs5Ar6R+D+tvPZmKQcRjOa4cQlGamjqx+E9rhW30IvjTG7xO1onU8kV4tY6ct+7w/MJj3x1r6o1fRYtUs8Srnec/Sue07wHY2d3vhRWbdk5Fdyca0FK+qPMwONhRo+xmtupxvwn8BmOQX9yqsQflBH617E8fkgJ3x0p9vZNa2u2JdmOgFQX0qW1vJcXLbVRSTmvOrwbdjCriXXnzN6DSy9wTjtWdrSrNZSALkkGvKtV+Lzw3Nylhbq43bULHoK6XwL42j8SD7HcJi6I5Ucisk3SackdVTAVVT9oldbnlXiXw5dNfOyJhS2c1lPdXWnAR42KOua+j7vQfNbc8Yx6EVwvjHwTHeRPIBscdK9eOHp1oc1x0M4hKcYVY3RF4ssIILYPJEvmr7da821G/vJ5fLjBEecYFbvj/AMR3UV89u68DvWH4a1+2F8qXsIZSevpXmQjKa5po9WjTeHp+0kubsdJ4JsLwXYaUOB1wc16vc3cVjpRmlJGwZNHhxIXtIpYI1aNhgcVn/EqLyfDd26DqvYVz1ZWdlocCn9Zqpu3yPK/Eni6O7umVD8uetdX4Og+22yzLjOeteH3jESgHOTXsnwS1lJ4TY3WNyHIJ7ivawqjCLUzrzZOhTXs9lueyeHbdogDJ0HtXTxSrjgDHtWFBLEqkRudw6g+lR3WrQwIHDexrGrXUXdHyzoTry03N+4mjVBuIwfSo42Xft3cHofWuLudbtijl7pB7ZrNfxdYRKpS9ywPHNcUq3NK9zojldXl0R6XPGTEcc8YrlNas2IIXo3WtHwzr8GrQnbKrMOoBp+qusZbjI967ZTpxSkjmoxqUajpyWpxDaa0bgsCdp7CtyxRVVCjbMjofWp7eQTSncBlf1FTQQI0pDLgZ6V59WqpOyPTqVFazWxYWGQoGOMVj+IXENuHRTuHUDvXTTbYI1X+E8DNYmsWRu4yFOT2pw5W7HNhaqc057HKQa7aI/k3KFCe/arV9BaXMJMJBYjIOelcxqtuYbvZOnQ9cV1ui2MElmGZj8w4q2o09bnuVqcYxU47EXhPy5jJEwAlU8e9dTeWcwsmMYxxXkXirX08O6g0cTETdtvFNg+LJWxeK6DZKEBh2NZybnsiFga87ThsdHNqf2C/KtOjNn7pIro9Nvlv3CSoPWvmG71K4vLp52mYvI5IbNe2/CjV3v9PC3SFpovkZ8dR2NVGlKmrnZjMLThT5urPSbuNoLZ3t+CBnA71yvjzxJPpPhRbiMlJ5G2c9q61H88hUzzxXI/HHTYf+EQj/AHiLLHJvCnqw71nCKqy948XDThGtCFRXdz521XWLq7meS4mkkLHkk1Y8PvJd6hbQ5+ZpVwfxrn7i4TztjZAHtXa/DzR7i+1KK5gUtGjA8DpXq4fDuTSSPosbi6VOjJKS10PrbQN50i38z74XBrQ254rhNO8WLZ3EdpOpACgcmu6tpUmiSWM5VhkGvUw81ODptWsfn2Lw1SjLnktHsz50+OXiee81R9PspCLa3bbIVP3mryCOR3uQsTFCOdwOMV6R8XNJk0nxFqG/lZJC65HUHnNeb2vmS3I+QgMcV5VbDexm4n6FlE6LwcOXRHoOjWdlrtjaXOpsUa3yskn96vQvCF1pemzKulwgMernrivMNah+w6XBbxsygruYDuaoeHdbuNMn3MzMoPrXJV55e7fQyqYWOIT6/l9x9Rw6lHcJkJk46+9To6TQHjaRXl/hXxvb3bpF1Y/pXosNxGbVnDAbhxXJKHLufNYrBexlaKL9k/mO27grxj1rSEaum1hxXlWv+NotGlfDBnXtmtfwP8QLfX5fJPyy+ma68HVVDdbnPicrrxj7RLQzviJAxjmQLkAcV4Ff6Tcz3RCRkljjpX1d4h0Z75GYAMTXIweFAtyHZF+mK9erSjKCkjvyzM1RptN6nn+gfD/y9IMtwuHZc/SuWv8Aw7cFpFWF8bsLxX0mulf6IgP3ehAqs/htFQtsQ4Oc1zKrGGktjJ5rOM3JO7emp434F+HbXDF72Lj+FTXs/gjwvZ6HAzJGBMTzWppdvFbL8mM44rQVxk1l9ZhUlZaI87E4qrU0lJhcok67JG+X0rxT4yeC2lTz7GHdnngc4r16dZDOgJ4LZq5dLFJblZgp4wM1tl8vZzl7RaM5uadGUKlN6o+LItDuoZvKWF3kY7QMd6+hfhn4d/sTRokusfaJTvf+groH8OWkl95yIgYHOcVYcR2gZmfJqcTThKdqex9HUzOpiKSpvQ1JLoxBVC8HqaYlygfPyge9cdfeJN92sQH7teSfWobvWFmYCJuMetcVWnKEuVaHLDBKSTfU9Be8jSCSV3UIoyTXzx8UvH0+pXM9nYSMlumVO0/ertPGuq3KeGJvsrHeVwcV86X0r+dggkk5atYQ5o3Z6OWYGnGc5T6afeVQ0hlAXkk9K7X4c66nh7V/tEy72cbT/s1y+kxT3V0Y4o9zkfkKuOiWMh84gv6A5p1YKpFxZ78YRtyt6dj6x8P67FqluksRDKwzjrTPE9xahCWQKQvIrgvgvJHLp4ETl2zlh/d9q7jxRZC40u7lLBdqGuXAr33Tv5HyOY0aWHm5NaI+bvHOpwau4kjXa3fFcdDiKZGBO4VYedicnkZqzZacb7Hk8PXZCPIuU+xq06cYW7Ht/wAKdea7sFtW6qODXZeJLeS90q4gIzlCOe9ea/DbSbzTSrkYU8k16jLdZQpLwSOtcOJpWkfKUqi9rLl2ufK3iKxlt7p4ihWRGIwa6r4UGW31pWdG2Y5Ir0fV/D9re3LvNCrgnrt5q/onhu3scyWyAE9OK9Cjfl1O/GYmFem4yerOgvtRCW4ZG2joSa8v8X+KGiuGjhkO30zW38Q9YfTbEQsBvboRXkRhudTucRhnZjXL7F1JvsdGWYenGn7WpoiS/wBdnnJxIwJ9DWet3cSKRufH1rqIvAuoRWrXE6YYDIFcnetMsjoi7ApxWippaJHpe3pT0h9yPVvg9fSWt3iaYgHjBNe6zPHcRBjhgRzXyP4W1C4s9UgBckMwB5r6e0eVTYxNv+Vl5yazxSk4Jo+XzCivrD6M0liiBzHjjFWliR5F253D9aqxIinejjAFcn4j+JGnaBdG35kn6kKM4rgcbW6s5I4apWdqSud3Okhj2yAlT0PpSyWLNEPLbLVxfhP4j2GuzNCxEch4AY12tndqrZZ1KeoNbU1r7xz18PiMPpJWOcvNNjlMguIwxP5ioVgW1eCPkR5/Sup1CFZCJ4Du9QK57xEkk1i7wJtdQeMVrCjKrLkO7D4tzS5tj59+MbxnxTO8b5VsY9q4AhmK+W249Ctdbr+lXdzqc0k6yGTeevOa1/CPgxr3UFM8bLCOSRxmvUpYSaVmezXx1PD0d79rbnJaZpF27CPyJCjfMhAr6I+DHh6ez06WW8TajkYyMV2Gg+FtPt9Oi2xLkD5cr0rWn8mztiqOqhRnA4rhxdVQTjDdnz2JzKrioqjHRJ/MnW0iEiunABrxz9omR21DTbcMQjRk9a7e58SKsojDfu85zmvP/i7FJ4isoLu1cNLaA5UdSprHCRk1eR25dhauHxEatbb/ADPB7lUW5KgAjOCa+mP2fLK0fw9K5iXzFOCfWvnG3RGuCmDvJ6H1r6n+CmnNp3hUeYpWSVtx47V6MarpxbRtxA4ezj3ucL47uGHiq6gjwiRtw2a9j8ENIfDNmZm3MVznOeK8W+JkES32qqjE3gk3Y7kHpWj8FtU1G31CGxvbmSWGZCERz9zvgV2UZ8iutTnzKn7XCRS0sk/wO4+KXgk+KoYJbUqtzFwwP8QrzjQ/hrdx6xE95CFtoTk8da9+301iG4PQ1pipqUU0eHhcdWw0XTi/dfQ8i8TeGbUlrhkG0LjkdK8T8QJHbXjRwHKg19SeLdGN3pkwtSRKwxXzP4u0C8sLxjMrbSeteIoSc9z67J8XSnq9zQ8A3dtDqCiYheh5r0PxH4ngtrRltZ1Lhema8LEkltKhQkFetJc3slwSCxyeuTVTg5PU9mWEp1J8xa1HVJb6+lkkctuPHNdT8LXlXxRA8W7aB82K89XcJOle4/A+1trtHbyx5ycE03ypanLmFRQw7Vtj3eOYvZKx6kVn3EkYPDDNS3kkdpAN7FVC9xXmfiDxXYWmpDddKqqecmoeIcYWTPj8DgvbybWx6TNep5KxowHSqIvTIWjMh2jp715fqHj+0WDNtKrn0BrIj+ICrIoQsDnnIrCcXUVz1IZPJJ2R7dFKIkHlktjrV20l3Jljz3rkfCOsrqsIdSCtdMIg85w5GeawinB6Hk4qh7OTjIvsy5BbHHSs7Vbk8COn3KFRuLcLXKap4gjilaMuikHqSOa7FiJ7sWCwjqzTjrY0VvJUDnGcdcdKydW1CFLZpphwB0zS2+pxXp2rIoiH3tp615x8RdXljd0hJEI4pUqsua6PajhFKfI1Zs5vxH4wLX8iWwOAcDFN8Na7c3V4VfJHfNcppyG51MExs4LeleveGPC4W1EywbWc8kiuydRVH7x2zdPCwjFWOj0TTjq1v5UoyjDpiuT8f/DpNO09ri2gJZjknFev+GrVLOJCU56V0V5bQ6jamK6QMh7VpgpwhK0ldM+cx+OrU6l6Lt+p8VLZz2m5YmYMxxlfSmQaZNJISY5JD7DrX1qnw90EOWa3yTzWhZeE9EsW329km71YZrrqUKCTkmzr/wBZptJKn97POfgto0+laFLc3kLQmVsqp64rr9cxdabMkRGXHNW9XuhBFJHtCgHoMDFcv/bUEMwQOGPpXgym6FTnh3M582N5nLS6PmGW3eNwpQkV3vgHTlkuIsx8Z59hXYXHgW3kufMUEAHOK6vQ/DdtaRLlVU12NS5eY9fGZpTrw5Irc39IsoIkVdgxipLyCOGbBRWib9KaqiCL/WrjHGaqRzO0pEkoZa89znKp7zPIp01FXA2aM2I+npUzWzQRk/lVi2QLKuT8vb3qXVCyxMV5XHautVdEribi5WR4Z8T5pLvU0g+9t9q6n4b+Fkay+0TR5zyOKpaxo0l5rBlaNmyfTtXsPhK1itrGNUTsMg9q66C5IPuzozLFtYeNKm/UzotDd7eRNmUPTNeS+NfhpcC4kurEfeOWTHWvowEDpxUNxDHMpDqDmto00tZLQ8fD5hVoS5oux8x+GfAt2upwvdRYUHvXuK2UVtpyQwkbgtbSaVb5IOBzxgdKbeaco2+USMVUowxVP2cNLFrFyniPbVZNsw7WGVY24OSMde9fM/jqC6tPF2ox3IIcvuXPoa+tLG0ZJRuBKHrmuJ+KfgW019Y7m3xFfIDtcD7w9DXkzpfV5++exg8yjCvZ7PsfMMdzLBIksLmNwecGvS/CPje+sXQzTNIhGGRjnNcP4j8NXmjXJN5GyKThT2OKy4J5Y3BBP0rSUIyPpEqde8prR7f5n1V4Y8cWOoxeXny5OhQ9/pXUwmO5yikMrjIBrwT4b6Yb9Ir1JGKg4Zf7pr3TSY8W6FuHQ4rnm5Upcx8vmWGpUZOVJlS48I2lxIZHjUH+daGm6FbWZGFUY9BWmjnA3N16U+u36zWqR0Z4LnLqx67UXaowKwPEVos0DkSlSR071vgZFUtYjtmtStxIsZP3STisalOT96RphajhVTR4jqsU+9lTIOeATWSJbyO4EZDFWGD9K7/VPD5ulkaGUFlOQynrVXTdAmU7pF3gcZNXB6LQ+q9q4wvzmLpHgO0+0RXz8szBwuK9h0dVgUbflQAACs+CwC2cQA+dOcVpRDcAEOARyK4cViJOdkeBiJxmnrds4v4ieCJdY1L+1dPb96UCyxjvjvTfBfgq7stYt7+7xFHCMhc8k136EqBzmnljjivVw2OtH3o3Zzyxld0vYc3u/wBaFhmphznimgk08dK9BwWJWuhw7DSN4wx4rz/x9pCiFpJIhJGAT0r0QAVT1q0F3YvGecjpXJLA+y996nXhMTKjUVtmfJ2s6cPMd1i2KegxWXdaJNb2YuiyiJjjNeyeJfCk/mjcg29q8f8AE/mtqb2KSMIIzyoNYVISiz7zD1+eMVTd7mbZiBS3O4gd69l+CFvcrfPcpERARgnHBrxywtCYJHDqMHABr6O+BWqLdeH/ACJUXzIWMe4DGa5q01Fa6mWcVJ08K7RO28S3EJtnVwThecdq+SfGpzrt624na5Cg19eeIrbzbKRkXLY7V80eMPDN3f6tM0Fu/mZ64rvwuDdWm3E+dyvF0qEk2+j3PN45WTDDIOemasw6gGcqAR6mtC+8Majb5L28nA5G2qltod0jlJYJEZuQCpqKmHlDSasz6SGMhKyotWZ9C/CuPytMiKNuVscivWIkXClVywHJrzH4P6TNbaDAbgMoUc7q9DOsWsUnlIylh1rgVGUpXkfLZk/bVP3SuZvjdruPQLhrRSs2DgjtXybq19fG6me4llL7jncTk19kG/tbyF4nI+YYIrwD4heDppdXkFpa7omOQVr1KGFp1KbS3RplWNeEqOFVWT6nBeFvFF3pV4pYlraQ7WBNel6vpa63piXNsNylcjHeuGt/A2o3d3FbeUYlJ+Zj0Ar3fQdHTTNGhtQATGoAPrXn4im6E1c9ytjaNVXpO55j4f8ADj200ZaHaQckYr2TTYvKs49yjp0xUJggjwzhfWlm1ECE+T5aIByWNedOp7SR51ecquiRrWlwOQCMVr2vK5zuNee2uo2ssh2X0UhzyqsOK6zS9WtfKJMqgDvmnQxHs52k9DzsZgpxjdI3u9R3UjRx5UZPaqkesWDvtS5jLemanM0c44IxX0lPHYacWr6nkSo1IP3lY4bxHFcfvC3BbJrwXxHcana6y5UOV3fKBX1JqGmx3ac8muM1Hw3ZS3BZ4lJHOSKilSo1LzkjvoY+dGSSVzds7aIuMJkUaqIba2Z3GFx09K1YYxDZ7zgNjmvLviXr8kNrJDG4yfevNxGJa9yB1ZfhHiankJqfirSYwyPOykdTniuctvG9p9rMUbloycZzXkWq3ryO5Zue+azYrsIAdzbs0o4dyV2fTVMDSorlufVujambmFVyGQ/dNdGsZkgw+TxwRXk/wo1H/iXCSc5Reu412F18V9A0+4FtKWdlOCY1zis5Ukp8vU+fq0pylLkV7HS2FoWmKtFuXscc10tvEIUCrWV4V8RaZ4hgMmnShiByCMGtqTC17EaDhBSnoeHVqOUnETNIx4qB5ADw2DVS/wBQW2jYjkiuatjYRi0EKUptKJSl1GRb5otwBB6Vp2U/mbQ/JzXm+ua2ovGmBwR1rb8L+Ior2ROcnOCtLK566o9DF4WUIJo77jGKrXFokuCAMirAIIBHQ0ufWvYr0IV42keTGTg7o8z+MHhOXVvCcjWkQkmt280KBzgdcV80tZXcNxtNu3JxgjkV9yDBHPSsa78K6LdTGaSwiEhOSVGOa5I5fFLc9jCZ5WwseS1zzf4N+H7i10GWWSPCSsDg+td1HDcwzMNj7WreitktYVitkVI14CigEnqOlcVeipTtJWOV42pNuUrO+v3la3iYKN/UdKsEERkjqBxUigelPCg/Suilgla9zklUu7s8g8XeP77TdRW3swA+4jDDivM/GfxBu9c1eGO7ZoYYRtwjEZPc1638SvCS3BeeAbWILKcdDXz1quiSfa3WfIm3YwK0eBdlyH0+CxGE5edRtJHpvw08R3Fvr62ksrT2sv8AeOSK97tIYHtwURdp9q8D+HnhuS1WG9mypA+XPavWtC1QxuY5Hzzz6GprYdU7I8/GzeKnKdLRHTlQDgAVXMAViy5BPpVhZFcZU5FNbk1w1MPTktTylJoZGhx83NTBQBTN2KTzO2ea3pVcNhlZ7id5EwoB96qtMqAkv0qvHqETHGcHOKl53BNWQ1Rk1dGoKeMHg9KpmXGOetTJLxjvXdRzOhWdjNwaC+sLe/jCzLyOhHavmH4neGJtF8TXhA+WZtyt2xX1JG+axvFHhrT/ABHbiO+j+dfuuOoruUKdaFpbPqdWCx9XBVY1I6pdD5EtdPubeXa6lvMOFUc5r6W+F2hpoOgQtKCsso3MuOcmpdK+HOm6ffJcvIZihyoYdK7RUVQAFHAwK8bFYL3uWDPTzDOnjIKmlaK+8fE4kGcZHuKibTrFpPMa2j35znFSr8oxSGQZ6130GsLTUZS1PBau7ogudH065GJbSIn1ArHuPCNhNeCd1TC9BtroQ2e9Ix460sXiJOndMKS9m/d0OX8azxaB4ZnmtxtI+UAV8+3/AI5u4ZxJBKpk6Yr6K8aaT/bGhXEAyTsOBXybrmhXWm3jwywyfewPl615MJOUOY+tyGdKpGVOb1O+0f4iuwHncyHrjpXS6L41stW1JYJgyqvBbPU15PovhHVbi3a7Ns8cI5GR1q54e0y9XVo4oon3lsGtbTULpnqSw+Eqt2/4Y+pdP0zTp7ZJYcMcdaNQt0iXcAAFqbwtafZNHgjKkPtG4n1qTxHaGTTJ2QlXC9RUxwtSvFS3Pi/beyrOKelzx7xn4uWyuHUOmF4AB5ryTxH4vv78mMTulv8A3VOM/WovGQuE1i6SQs2GIzXIOzuzYY8HHNZLCKEmmj7KnShGnFpXbNzR9Uu4LlZIpGQZznNa+s+MLyVDBBdSRn+IK2K5izeTIBGB/Oq9+jG5fYmGz96j2MHUu0LHWUYdfU19N1y9s7uOeO6m3hs8sTmvqf4fa8dT0K3ndcOyjOeua+U9E0y5vbmGJEMkjsAABX1v4E0QaVotpCVG9UG4+9YVqCnUjynHmDpxw1p/JdTqrdy6/KMfWue1+SSOVjsx7V1KY4ArkPGt3sRtuPlHJr6LD4aLp8jPkYVOWopIo+K/EVrpkDPPIFVRXhXjnxXbakrfZeWPUmtn41LdxXkaHd5DV5QbW5kD/unCdM4r52jRdT35H3+Bo0aEItbspXjPJ8zkD3otLKS6kUJyc9qnW1kYJG3XPevQPhtpdvJrMcNzGQSevavWoUZVNImOYV40ffnsFzY32i+FFZHlAf7xHGK5a2tJiVkXLM4yS3XNfZFt4W02XR/sl3Cs0Ui4IIrCtPhboFpc+YiyMnZGOcV20sDS5m5Ox8+s+VKCUYXt/Vzyj4N6hcWGtxQ3CHDtjcBxivoa7yq5AJ+lZ1voWkaZtaK2RSvRiOat/b7ZjtEi5HapzCtRnD2UHqjxl7StVlW5dyjcSNx8uQay9Rw0W0g5PatuS4iLhSVxWZr1xDbRpKoyAecV8lWgj08M3zpcp5b410m7ltv9G5Y+lWvh1ot1Z7Wum+YHODXR6tqthJBuLjjnA61hTa4scSvATkdfSu7D1XSWh7NWnKvTUWj2GA/uVGQcCn15Vp/xDhtnRLlwBnBIbNegWGu22oWoltpAw9R2ro9vNJt7Hz1fAVaLV1uaxfYCTwBVMapCZvLLAfjXnPxG8aSaZH5Fq2ZW7g9K8sg8dXsN4puJWkBPOavDYypJ76Ho4XIZ1qfPLQ+pwQ4yvIpSox0ryvwh4+inMcbtuOOQTniu/wBQ1iFdBu76Bs+VGWx17V6UqrUHLc8mtgqlKoqbRNd6ja2pZZJVDgfdzWdB4o055NonU4618+3vi28E0jvId0xPJrE/4SC4tp/kdi7Nlge9cCVRO7lY+mpcO0uS8pNs+tv9H1KzI+V42HB9K4DUvh9ZzaobjaDg5xWJ8L/F7XLpCAfmIDIf517AShzkDmvXo4hxXLfU+bxmFeEqcj1TOB1aybT9MxBH8i8cda80vdW1C1nyu7aTjpX0FdQxyRlWUFTXGaroVgkrtJEGBzjNebjanJL3tz1crx1OHuShcXwJqN3eWQMykqOrV1bAlgQcViaHELS38qNQqEYGKuGVrVz5jlhjrXhVsQmtDixUVUrScFYsrOPMZMcjmuf1DWFF0QDtYcCqmqar5c/mROAtcnqN6bm4ZxnIHauJy59z1cvyp1HzTWljcvddKq4DEk9OaxotfeNxvasm4JdfvkYqn5OeGyeetHKmfTUctoxhZo7+w1uWcp8+BXY6VMWh5bJPQ147bXBhIUHArr9E16RUEajp1JpRbg7rc8TNMpfLekj0GO4QNtJAb0qwr7jxWDptylx80uNw6VsQkKPrX0OW4+dSSpTeh8lXo+zdupMx4pAKWgV7zgr3MAxwc1g6nd/ZmaUGtydvLgd/QV4n481vUvt5SE4izilPCqtFt9DpwjTnZnp2l66l0fLA+YDk+la0ZMo3bgy+1eIeE9WuWu3Dbs/xYr1DTdZCRKjY6V4eJwsoO0noejiMIt6W50hmjQYY8GuS1qz06aV2aBS4OQWFWb/VVji4A3E8GuR1yW+uIXe13Z9BV0MHKS0ZFCjCl79Q6TSmtJx5RKcfw1fttMtI5vNEMa45yBXnXg+C+W6eW8Ygf3a6661uzs4yJ7oKx4AJ6VhOlLD3i2dMo+2lek9zsItTt1IjVssOwq1LcQzwtG7A7h0ryj+3Ynm/0edW5zwa63Qr6O5hHmnJ9Sa2w+JlD4XoctfLeWPMjB8U+AtO1V3ldVVj6V4F4u8G3Olai6RIWgJ+UgV9bGCPYPLcH1zWLqmlW082ZYlfHOccVrWxKmnzF4LFzozWrt2vofLmheHru7u0VYGKg8kivWdI8B2t5Cnn2qBx1JFd/BZQRy7YLZQf72K14kESYEYH0FeTKpKUnyo9HHYv6ykpWOc8P+EtM0dw0MS+YO+K7GFd0TIrYUjbn0rIknDZEaEGp7S+2jbLxj1rTD15Rn7x5talKUdDa06E21qsTSGRl/iNc54vhV7afocg81s/bBs+U8HisDX5wlu+cNkV7mGxDb5TgWHerZr+IfCem6/beVeR89j6VhQ/DexhsJrclZFkBH3ea6e38Q6XNN5K38HnDgpvGRWqjhhlSCD0IrlVWMl7NaJidWvTkm27xPl3xH4Eu9A1Vop42a0kb93MBkD612Pwz8OSrq4NwivGMEOK9su7a3u4ylzEkq+jDNQW9na2Q/0WFI/oK9KlXjh4X6nTi8xqYul7OXUu+YFUKOg4pN5PeqczkLndioTK8bYBBB6EmvInmbbascUaN1ocZ8Sdfl0tMhsLXhl38RtWF40sLhI1PA9a9q+JGjTa1o9yI+ZlUldvevl64tpYriSGVHSRWIKkYINcVNc8m2fc5bSovCqNtep798P/AB0viXZBebUuV7r3rZ8caqun2wjkLbcZ3V5P8J9GuxrC3KxlE9cV7H4g0lb/AE6RL1Ogzuqq8IppvqcdOMade26PDtW1+S7nxBIVGe1SRahcpblTJuzWbqT2em6tJHD+9VW611nhmOz1zMSptb0IraPK46Hu1JwpJSaVjiLtpN5MgPJzkV6N8LNQvY5GjDMbcjnNWpvAKPdx+cxEZ9K7iw8LRWultHpxKkrjmnKUeRpbs8XH4uNZKmlZdzyL4gXyS6pIY3J2kjOa4iaWMnDAljXdeJ/CGo2ty7yRMyu2dwrL0bwpPdXy+YrsB1GKihTskj34YmlTorlkmij4duJorhWhDAhhX0H4c1m3s9EmGpqPKkj5Dd+Oa5bw14IX7WsgjAQdQRyD610fxH0aO28Po8SszRDn3ruvywsmeFjMTQxdVUZPdnifiMx3FxP/AGdCWtVclCB8yisiG2/tCaFICzXBOOnQ1t6bem21VWGAg4ZcdRVm9uray1RLuwiCszZO3oPwq48rVpM9GrKrSSVON7f1qe2/DDwoNE0VJr5Ue6k+bpyortWbBrjvhx4gGqWTRTOzSDGMiuzIyelck6NSdTRnwmMlN1pe0d2MLnZ7VVkt4Zc70BzVt1GOmKqPCN4YMw9gayx8K0Er6mNNro7EYhWFDt5x0rE1W/KvggYHBGK1brfGSRkiua1WbeX3AYxxXz0nd3PUwVLnneWpzmrzI7NsJGe3pWbBFyTuIx3PFXJ1BZzjBFZ2oyFLcRpnzHqo6s+3oRtFQiMnuYQ2yBd79CTSI107YVRgdsVpaBoQnCMw4xyfeuy0zSLdomAQbl+U16lHCNq7M8TmVDDaLU86a5iDbJ12Me4q3A7W5GxsjqK0fGnh1IYXmDEHPSuc0SV5o2gfmRDxz2rmxNB0jpo1aeJo+0hsd3oU8kzKSxAyK7qykEiD/Z4z615fp8zQuCMiu70C6YxgSfdbgfWuelJ06ikfI5zhrPnWx0aEMOKbJPHHuyw4psXyk1m6rkBv7rfpX2VHFqdNc2jPnaVJTnykV7rcGxkLgdiM1xesW9jfvhpEUt2qK4v9MN+bcXcJkzyN3erD6OzBZVGVzkGsqcqrbUZHv/UKVJJ2I9L0m2sd7RDgjrWjZw9GwSOtTQWsqgIBkGtyPS3NqpfG72rlxlWorcw6k6VDrucnGs11qBQ42Ka7S10yEWvCrkjmsZ9ORGZlJyT2rb01WjibMnXoK5amYSjZLY48TZxvBnMeIW+w2kn2eIBiOoFeM+Ior/UJG2EnB596+g9SitLmExyuua46bTNN0wyyyurZ5GayhiFPfc9PL8SqMXJx1PKtH0vUYF3ksD/dHNes+ELe6MEfnqVz69a89134gW9rqLR2sClUOMr0rrPA/jqHWZRCo2yVo1ytWR0YnEVsTTvNWXoerRWu2IZbBI5pGh7DB/pUKXTLDk/MccYqdPNkRTwuevrisKlRy0Pl5KcW3JiQ2ioc9TSyQI3GMVaVcAY5oYe1d8cNGMb9TB1ZN3uYN3GYmJXGcVnwzAyfvY8kn0roLi2y7OuMnsaoXVqygPkYFcsqHvXTPRoV4tcsiQBBHlVxisHVVeclGUBfWtWcPJBgNjArntRlktlI354rvpJ8vNFm9GkpPU+Y5tRnjvXuS8iz7ySwJBHNfQvwg8dte2CWl5JvZBjLHmvM/HPgoxX8tzYSAI7EsjevtWd4XeTQZGO4Fz19qxo1VKB62YYKOMUfZx96+/569T64iuIZlDI68+9MlYEHa1eE6T46uWZYyyEZxnOK9N0bURf2qEOSx96MROXs7nh4jK5YeWrN52Tb8zk+1V7u+s7aDN1IFUDkk4qNg6NkfdA5Jr5/+K/iSa71qS0glZYIeGUHGTXjRlKcuWJ15bln1ypy30R6lf8Ai6yt5G+yTRyr0K55rCcaJq8r3D20LTk5zgZr55uL9vOzFI6sPQ81s6LrF4ZUAmww/WvShQmla57ssDCDcYan0XoUUNpIhhgEfsK2deR7zS7iOMESOh2kCsX4dTSXmnI9wQzgZz3rvbcRSLgqMiscXFwkoydz56riVTmpqOqPkrUdBv01KSI2s2/eedp5r0j4X+Eb+G/F3eRNEgGPm717U2mWplLmJc9TwKgNrMjfuQdnpUPFWVorU3xOdVMVT9lokUn08SShMcdq07ayMSAZGcUy7u4dOtzPeMFVRzk1mWni/SL9tlreJ5oOMHvWEJy2PPl9YrxvFNo0LnTVuRieJHHSiLQ7aMZCIr+oFW7eWR4tzEEHpipA5I54rshiuVcrOZ1qsfdTG2lpFbPujHNP1Wyi1GwmtplBEikfSnqc08OFI3EfjXTTqLls+pzOUnLmvqeHeKfAM2kESwxmWM5OQOleVavFcx6iFVGUL6dK+y5oYriMpKAykdK5DUvA2h3FyZHVF3ds967JwsuVM+mwHEC5eXEXv3RxnwM86VJJHBG3INevtxWZ4f0iy0e2MNnGi56lTnNabDIrrwj0PAzCvCvXc4KyK8zYqszEdFzVuQcVAVxXl5nSqzndPQxptJFK88wwOMgDHFcVrKuASc5HU13rorKQ1cz4giUhlTDH2NfNzTi9T2MsrKFRKxxCtnPJ5PPFU9VH7y3kA4U84qzdebbTFcfe4xU0UKXVsYm4Y9D6GnB2Z9tGShap0N/wxOV2hl+XrmtDVPFNrol9ucARsMEY71y1hfXWnuIZo/lBwHPQ1jeNo5NRiWRACUPQGvosNXi4bnl1cujXr8017rOh1PxDD4iuRAqkQn7v+1WPplkE1u5KD90uBmsTwzaXRmTa4JzgKDXp9tpAsbMBhmVuWNcGPq8yt1N8RKll8FSg99Ev1MpFVHztGc10un3AVUaMZI6Z7Vh3cBBJBwfSrWmOUA38noBXlM8nFJVqfMdlYzNMhLV598ZtavtOs7aO2V1t5M+YV6n2ru9NXdCrBiOckCp9V0qz1azMF9CJI2/MfSvYy9tq72R8/Tqxw9dTtex8npdw3gd/J8qRckY6/WnW3jrWliitm1CVYoQSMdSPevbrv4RWUkkklleeXuBGHXJ/OvLvGHwx1Lw4GuTH59qT8zLzivXcozS5Hdn1OGzTC4iaT0duvc3/AAt44v1jjluJFnt+Mk8NXs/h/VbbWtPV7SYMCOR3FfLlhfwxxCOGMAKeQa734W3mqHxMkdsMQS5LKOlc2Is4c0d0PNMsU4OWiaV0/wDM9zGnIH3Bz7iuU+JGuxeF9NWZWw79BXaoHCgOQT7VxPxY8KyeIdEMlvlpoedo7isKOHWIly8p8lQr8tWLqPS589av4w1O8uDO13NEScqA+Kz9S8TX0lltlvJJGI6E03V9CuYbkgxOccZIrHv9PljcIVGcdMdK1VDkeqPv5wouH7tLyKRuZHbLE/N3rpfB+rS6VfLJCec8+9cntdX2YP1xxWpp7+WVJ4pVYJqwUI+292R9VeGPEB1LTI5U+ZwOcdq6SDUdijeQ2f0rx74XavZLZeQ1yqyN/CTzW940vLu0sC9gxUEfe615kKTnOy6Hg4/BQhUakj0e41+2txlyCO/NJaeIrG7P7qRc5x1r5b1bXdaHM87bO2Tyag0jxTe2c6uZjgHJBPFenOpJU0okUchhUTbPqye7ErHy+nbFDRNLDljXA+DPFkWqaeGDAOOuTXVQaklwRHuCnvzXmyqzUuZnDVwMqT5Y9C5Db4bk5BrI8T2SC2JXqa30jYR7hIpUdOaZPbrdwEEbj0r08JiYxa5tjm9pJO6ZxfivRRdRuQw46AV5pLonl3R8wAr3zXv2q2UEkLtjnHrXinioPbX74JEYOetccJRhNRR9HluKeIhyroUl0aB+AVQ9sV3vgiCSAKisWUdDXG2L29yF3As4PY16X4ct4hbIygqR1HerxHNytvYMwSppKSN8ysx2bc+orx74q+C4pXfUdP8A3cxyXXs1ezIseQyNn1zWH4ht47qJoVdfm4wTXm0bxlocOV4l0aytt1Pj65gdLiRZEIYHBNSWkwi+YkjB4r3PWPhqk7tJGyl25NZg+FyJCS4fcfQV6zrxS1PelWhvB79zoPg/r6zLFAWLNjHvXtMLIseTgDrXlPw78L/2MxZkwwPDV6eyxPFhzkkdq4679o1Y+Rx8V7TTYo3+qLbyMytwPU1HZayZPm3YU+tcr4z3WULSplgucA14prXjDU2mZlnZAp4CnFZ06bbsj2cLk9PEUeZfees/GbXDFoojSUbmb1xkV4KNUuIboSRSsuD2OKXXPEV5qyRi9LOIxgHPSs6zYtOiMuVznPqK7aVG3zPYw9OnhKHs7n0p8HfEt3q1oLa7ZpNo4Y+lelndu5HFeW/CZEsbdHVD8wwa9UJ3AMOhrDG0oxkrbnxWYcvtnKC0Ym4IpLHAFcjrPjK2sYphMuQMgH3rq7iHzrd1U4cjg18+/EjRNWtJ5C5ZomOQy9PxpxTVrnZkmEw2KqONd+hl6v8AFLVnup1tZWjRSduDWWPibrkjgTy+YPUcEVyV/p91FmXaT/eAqksb5LAYOeldcLR1TPrKmGpX5eXb8j2Hwv8AEm8N0ivMxXPQ9a918NayNWs1c434ycV8caSXtdRhnbhNwzmvqn4dpEtorxkEOo/lXVSrqLV3qfM5zhYxTajZnbNUZXsKkJHrTG4r2GozWp8wQSJwc9KwNVtlhBbHB/Wugkqpc2yzDLckdK+OzOio1LQWh2YeryO7PMdbRnk3IhGKqWzlCCMhj6V2etWR3sAn5VylyBBuBTk9PavNTPt8Fio1qSika9oEuUEbqHB65Fc14qW3lnNnYK6uv+sYnpW7o1wyPzwR0rnbxpodSnZcF5GJya2oN8xtgqbjiJa6JaLoU9Ba00y6EdxJIHPOQ3euutNcdLlYZpfOtn4DHkg+9eb67aSNOLhNwZhg/WrWkzSRWLeapDFlC5PWuyvHmhqenicFTxMeaW/9bHpWpMUJCtwas6GySEbyK5/ULomOMZwQoz+VaWjB2RPLOD/OvNkfN1sO44fVnoVoihAE4Wrh4AFZWkLMIv3hGO1aIzkZr6DLmvYv3d9LnxtaNptXuSLx9K8W+LfxDJjuNI05Nyjh36/WvXtWMy6Vdtb/AOt8s7fyr5P8R2tx9suFVWM2SWzWtPDOL5ke1keHp1ajqVPs2OTeWWO56lS5zxX018FtHit9NS+Zi00qDBI6V8+WWj3Ny8IjjMs0hwFHJzX1n4D0iTR/Ctja3P8Ar1QF89j6VlVjJ7HrZ5inRoukpfF08jfHJqVP0qPHFCTKoJZgAOpNdeFrQpW59LnxLTlsZereFdH1bm5tFV853R8VyGu/CzQjbvLbJILkjgs2a0fFPje2tCbaybfN/Eaw7LxZLqEiK8saAdt3JqauMk52TuexhcJiVBS5nFdrs8Q8S+DrvS7yUeQ7xZOGArj7iIxz+WARjrx0r7HOlPqkAZFhbPUHFed+NfhVKFlvrGJWkblkUcCnCi6usT18NniptUcQ7W6ngNm88MyvA7KVOcg17P4Hv77WtGk+1qJREdvJ5NcUfCmoWm5TYymVjgKq16f4H0WXw74elluRi4m+Yof4a460LSS63PWxdei6L5Xd/eeX/EJfJm8to/LOelcAXO7afXiut8ZXkl7qs7ySZyxx9KwrLT5LmVVjQsT6Vq2o7m9GjKFFXZs+HNQu7ZClrIUz15rutN1OeFFkmvN0npnk1z/h3whqN5MgjiZU7sRXbN8PrsqpLrle4rmdH2srIxr4nCrST+aN218UyRWyNcn5fQVZ0X4gWUl95JlHXGK5DUrabT9LeCYZZM8kda8imvpLXUTJCfmDZqo4eVOHI1ZnkqjSrVJWfun2RqAEcXEgwa8Z+Kts9tB9oj5V+DivTNZklniBt23Z9K8/8eQXNzozGWF8IetY4i3Mmu4snXsakbvc5D4dahE+oCKY5Y9M+te86XYgRI+7gjtXy5pJmtNYiZUZTuGOPevqvwxC9xpMEkgJJUGumq3KkaZ7alPmT3I9YuI7CBiXA49a8N8W+MGS+cW5f5T1z/KvVviBps8tk7xFgV5wDXzdryyreOjEhgeQRXDQppyuzvyTDUpUHO92z0Twb44nub6OKdiwJxya9ytTFfWqOjrnGcV8oeFbW5F9HPBxsPWvc/DviRIo1S43BiMdK9Gth4OknbU8rMaLddqDOrvLlLRmZ2UKOuKi03WrW6uAiTD8DmsvxVNbzaOzxkMXGOtcF4KaS2v5Ow3Z5rippQbv0KWFjOjzdT1rxBpUOoWb/vlwVwM14N4l8BX0MztbIXhJPNfQmlxw3lpubhhzg96wvFVyLGEssWW/SiVRc14iy3GVKE3Ri7tHy1qeny2FwYLhDvB+7UulxGS6QEBcn8hWx4/ne71IyqFVu+KxtOikLp8+GJ6iuuMna59M25xfOraH0x8PrOIWEQjcEgdq73awTaTkjoa8s+GFrdC1UpIzAdcivU4iTGN33sVxVnzztLqfA5hZT93YVMgD1rJ8RxxSWxFzbpIuM81quXC/JjPvUGtpv0qcrjeF4NSrctl0OXDy5asW+54fqGpaQdUaM6ciIpwWxxWi/gfRNdiE9uURW7xmvO/E17PDfSp7nNdN8ONVUny/M2knld3euqDtG591icHUhTVSlLodda/BzSxGjPcSO2cgMeK7/wAP6CNIhRA27YMDFX9HBNorMQSVFW+c1msSqklGR8TicRVlKSk7htJpWBwOaeOlMlkWNWZjgCvooqnCG+5wat2EKZFRlMc1BbanbXLlEcbvfvVraTxmsK1OFVe6rstxlB2loYGueY+VVdoA+961yGqWUoQSuvGeBXo1zCske1xkVz+q22W8sKSMenFfJYmhKhP3j2suxvs2kjzlbmSG55GOelV9YeR2Sa3wcdVrc1jSnGWRef51zEjyRZVwc5rOEuqPuMJKnXtUhuUL2W5lIMkZYAYAFWtHs5mZJr0bI05VPemG4IbAx9TVlbolcA7m/St5VJSVj0JqXLyxViW7u2eQkA4Jxiuj8PTybV3ZxWFptm80ih/u5yTXdaPZImAQBgcGuaTvseHmtelTpezsbemXcnAwfxraW4+7kjJ6VTsolCBlIzRf5EeVHPQV2YSpVp/C9D4Soo1J2SsT3WrW1pIsU7AM3bNY994R0LWJXmaFQ0g528Vx3jXRNRvZo5baWRWU54NbHga21WB1F4XKDqTX1EJy9nzp9C1S9kuaDafc6Hw74L0XQpDLaWwabPDvzj6Voazr9jpSMbqYKR271e3kIxGMgcZ6V4B8Y9SMWqz24bDFicg1wSqSnFtGuX4X6/X5a0mztT8XtEtr9orppNpOAQOlal14t03WNNmk0qZJkI5CHDD618i3ExN3KztkjoSa2PCurXVlq1u9i7IzsA47Ee9c86LSuj2YZbRU+ba3Q7PxRqRhuZnhJBH61wJ1W5F0X85w2eoNexeJvCsl9pRuEKl2XeAvPFePXOmuk+1kIZTitKdNctz2KU4VEo0+h6n8I/Gl9Hq0dpc3EkkD8cnOK+lIZhLErBsgivk/4c6PK+pIyI27PYV9N6Dby29momYliOlKNNqV09z5/iGhSi4yjoyPXbVY4muLeIGUdeK8r8U3168Uql/LBHb0r2eePzo2QkjIrzbxHoAnnkAcsy5+lKdOSfM0cOWV4X5KuqPn/U9Pmaclu5zXdfDbSkjuN9xEHJ6EiuhtvB0l1NuljAQHvXa+H9ASwRUVR/hRJe002PpMRmUYUnBGvaxqlp+6twPcDFZep3UsI+U4NdbFGnlhQwFVNQ0q2uVO9gTivRo0aco76nx88U1Nu2h4n8Qrx1093aQDjoO9eJO/nXLS+vtX014m8Ex6mGQkFK43/hVCRSBgxKg9DzXRUwjlFWZ1YHMYUJtzPW9PXEK7sMoGARVu8sre+tmhljBjI6Vl6LdRmyTOckc9627ZUkUNvzjtXzM03Npl1JOL5o6WOOtfAOmpqInByqnIU12jajBp1nt3BFQYqxDGrq3Cj0NeP/GHUrnTojFHJhX9K3TlFpLqdFBSzKryVXsdXqHi62u5GiLoR0yTXiPjqJP7Wd027T6Hg1ykmoXEQ3iRyevWoLzWZ7+REKjKjlq2dK8lKJ9LhsOsBNJbM3dI1J7eZURRtz2Nem+H5P7QaPZjI61wfw/0iPVbnbN8vqRXvOheDo9Ps1eMFuMj1raUpKnrsceMxWGhUbvqczrUM1vZSDdkHotcr4dgvDqI3cAt6V6pe6PO/wAuzOe2KkstEWIh/J2t7DFeXCpZ+8YSxlNU7J7mroUTm3XcduBXn/xT1WW3fyITgkZye9em2Vq0aZDEdsVx3jvw+NTt33JlgODiqjZyODLq9NYvnnsfN2qLNdTPI3Oe+a0vB+myXN6A6HCnOas6rod1YyP+7cAHHI4NbHg+/ksJN2xWfpgivQdqauz6vFKNek3SZ774Ftkt9NCoO3piukIxXM+FNZVrONZEClhmukdiVDRkYIzXn4ipFy50fnuLpzjVfMV764FrFvbGPeqq6rA1i/mldhByQa8x+Kfie6tpGtiSsWOccV5I3ie/KPFHcyCM8feoowc9T6DB8POrRjUk9XqWviPd2i+ILhrKTfGxJIHrXN6XqosL2Ob94MEHIqnLueWR5lZ2Y53ZqCQvJcJsHyjtiu2NNJcp9EpVKdHkbPpjwZ8VdFvXt7W4We2ZgEDyD5c/WvTzJGy7g42EZDA8EV8Y6W0r3UcJACetfQvhPWpY/ACiRTI8TFAxPUVzTwn24ny2Y5Qozi6b3dn6nfHVLdXKbxx6nrXDePPEF1a6eSrYLNwoPQV5B4x8YXwupIYJGQg/eB5FcVfaxf6hKBPezu46bnOBW1JS+0zpp5OsNNStf1PbfBmtXVzfGKcOMn5CK9rt1byEMn39ozXjXwMuLbUcQ3zh72Ablz/EK9savcw0NNXc8bOsRCrW5Yx5bbkL4x71UnKhSTj8qtSg1A0e4YYAivMzOnKq+VR2PMp2Wpj3NirxNJIc8Vy2oaJFKNxA+bpXftEMYKgr6VDJZxMCCoB7e1fPSw1SF9D08LmE6DumeR3PhpsOQTxUNrocyNkg4zXpl1YkEooGGPpT00pVALDgDtWTcloe8uIaih7zOa0+yURjK4I9K6bS7UtEBICu3pTrK0VHZiMLngEVqFScbTtx6U6cHJniYzGOq7EZtlXBjYoRUpQOAG5Ip4BNJsxyO9elClK3Mloea5N7sY1v5jAsc456VbUBVwAAKhTPep8ZFezg4OUHZGc5N6McoBBHTjFfNXxz0u6t9bkndWMTfdI6V9KoMHrWP4o8N2niC18u6jV8dM0ToztsdmXYuOFq80tmj4c8v5GYs24nvW34es5mlXyY2ZmI6Dmvc7j4MKNQ3RjMbHOOoFdn4b+HNppWx2RS698c1lUjLldz3aWaYahJTTvoQeG9BvP+EftZJT+8EYyp9Khu/h9pV6zzl9knVlx3r0ZI1iiVT91elQyi3Equ+35uK5qcuXqeN/aNVzbg7XfQ4/w9oUWhti2td2f4yK7S3LbBuGD6VJwQNvTtSjg1rh6V6ynJ6HLiMS6+slqOI4qpcWUcykBVVvXFXM5pCQvJPFe7ONOWrORNrYoQWXlqVkCsPahYFVzlSKvSHCHBGR61XRtwzXmYqlGnotmbKpOWrZXlgwpKsRVdYDJjMmPpVwSb8jtVWbzA4WAYHvXLTnJu0TaLezLAtVWP5cM3rRDbo2NygUiJIUyx5pfOWM8k13SrKnHUz5b+Zk2VlbJGEUAVLEgtZGA5HpUyGJo/MV1dCMgg0yILK3IOB3rwasZOpbqd3NzJtPQuW9yp48s+nSvPfi34YXWbItGGWQcjFeiwoyAFTn8KmngiuU2yrmu6lTVlzPYzw+K+rVeeOx8W6rod1pzGGaJmPQEVmwaXcfalxbzYPopr6/vfBlldXXmPCGz7VctvCmnwDIhjOOmVrqjGG9z162eXglG11seM/C7wrqEMwmaORVbnaRXu2n288KIJWJA7Vas7eO1j2xqB9KdPdQ26GSdwiAck1y1pwm0k7I8OriKlebb1bFcY52kn6VWklXGGbBzwK5DW/ijoljM0ETNI/TcvSubg+KekyXyrKrgA/eNYywan8MjppZbiHHmlBo9NcGNSFbnrVNZJZt0bDIPGTXJn4oeFprj7Ol9iT6HH510+kSRahCLizmWSLrkGs5YedP3nsKNoJ8+5iaxottdxtFcx85zkd6878R+H30y5D2qfKehx0r2m7g3tGHB2k1m6ppsd/EEYjevQAVi6smevgs0lTau9DgfCeoywyoLs5A7npXoh8UWFvYl3ePIHTcK8o+IBfStOKIvlsOAy968au9Uui26S5kPtmtKMPaq7R3YnALF2qytY9w8fiDxNY/aLEq8gPzLXj82kzWs7LLbygA+nFVNP8R6nYyhrebCZ+7616L4L8X/btQitr20jk38dK3pU5U3bodMMXUwdPlcbxj+RgeHrBZL6PfZG4gbh1I6V6RJ8HNL1CH7Rp91NaTsuQjfMK9SsNEszaxvHZxR7gDwBWnBAYG4YbQMAYxTqYnlVmjxMfnEa1nSupI8e0H4N3cV0DqF9Cbc9di/Ma9G1Twza2fhZ7PT48CJMgf3jXSI+ehqQkMCD0PBr0KKhVou7PGqZliZ1Y1JyvY+NfFej3iXzyLC5554rJGkXBQyvbTp7lDzX2Pd+F9Ku3DzWynHPtWDrniTwxoSrBMiPtO3CgHFcrpTh0Po3nn1myoU231PP/gP4cuY9VOoyq6W8UZVS2RkmvdXrJ8N63pOs2obSpY+OsYABH4VrvivXwacYWkfLY6rOtXlOorPsRMM1HtqUim4rqcE9zmuR7aQrntUhIFR78cVxVoUFpIpXI2X8qf5fFBINGeK4Y4ejzNvUq7KzR/vdzdB0qRRnmkkznHUVKgxgVw0cKud6aGjloPQ7RSKQQaRzhTnjiqMl8IWAYL9ScZrqrYz2bUFsghSlPY0wlO2YqpDf2zplpkUjsTVuORHjDxuroe4PFdtHFUpK9jOcJR3QdKkBqlf3kVnGJJXAUn1pNN1O2v1b7O+SK2o4lNvsJ0pOPMloXnkCqSRUMdyHbGefrWLrWtG1JQYGOuazYNSeRBIFAbsc1w5lKsmmnodNDC+0i2dTfXkVnbPNMQFUdK8s13xjFJdMsJ2JnAINX/HfiGIaM9vIyrKwPfmvnzVLm5W6BMp2A54NcsVzQv1PdyjLlJtz3PpHwp4nnuZFgbEqdM9xXYNeLjBGK+fPhlrbjU4ogd4cY5PINeyX7sYwxbBI4rFycdDPHZdGFWzRf1HX4LGHLMNw7k15x4g+KcNrcFUkD4PQdqzfFFjqt9cCOBj5J7ivPta8H6ja7nMLSA816GGq8qstWYUcDRlL95LlR6z4f+JFvqcuzduZuMd67ew1GSUAfMoPqK+U9DkksddgEausisMgjFfUHhiWW9sIndTwBWGMqyquzR04nCUqEfdd0dCrBYclsk1YgfcoIINV0RNvI6dac08EQCh1BPNYYRtO54c430RJOwTJZsVXIWTowK+1Nkk87OB2/Cs+TzbZzsBIqMXiXsjSnSurX1PO/hDrMmpWiW0kjtJ3yc16woMEGBH83rXnfhLS7Lw1MBBtQjuTzXf2+rRvgOysD3FXVkqsrrdnRWw0qd4017qeiL8LExgkYNRPM3mjHAFI94m3IHFVby6VIGbgCsK9Z20OWnRlKW25ox3AK5YYp6XCyD5TXlXij4g22hxlA+9/7tc/onxYE90FkjKqTXTho1q1leyOmpl04RcrM92KsDnrXG/EmK5n0eVLbcDjscVuaL4ht9Ws45Ij8xHOKo+KrzyrZg20KOea5sXR9lPlZnlrl7eMkrnybqsN1b30iuWznpWc0EyfM+SznpmvQ/EwtL3UzJvAbdzt6V0Nv4R0vXtBSO3lEV2vKyDufQ12U+Zw5rH3lXF0oKLmmrnkNrZsLhd3B6kDvX0b8EUnXTZFmWRISOC1ZPgr4aJplzHdam4uZOu0jgV7DYiCKMRwxpEqjGAMUSxEYe5vc+XzfGQrR9nThZXvfr/wB7Wx4+YnFVJrbYWYjlu9aPmc9c1FI4H3ulcdd0bc0GeFCc0zzzxr4bXVLOVMgsBxzXz34g8K31jfMv2d3TPBAr66ltIpm3j5T6VRl8P2d5N5jupx2xWNCu4yse/QzXkp8sj5Ks/DmozsFW2ZB6sK7bwr4bu9K1WyuXjLtvGQO1e7XPhe0eTEQBVR1Aqra6UbNvkVWw2ct2roniNU46nRLHLEU3Bvc7Gyc/YY2cbeB14pHljLYDA1yt9rcSusM1woI4wDwKzPGnim38P6JFNbzCSeY7UGeB70TpyqQt0PFWXzcl3Z3oIx8nOKkQnAOMGvI/h/8ULe7vzZau4jLfdc9DXsUarJGskbBo2GQR3FVTw1aEbwOTFUZYebhM53x9qL6d4ZuJYJVjlJCjJ6jvivmHWLqS7vZGMgaNj0Y969M/aFu7lb+1tmcrbeXuAU45rwKeV42ba5IX3611UqrqK8j6/JKH1fC+0/m1O28O65LpWqwTW1wYmVgAqHqM96+l7fVfPgguUk3BkDMM9a+TdEuYRLD5UAJYjcTX0r4etXbSrVydg2DisMTOUbNPYzzfC05NVn1O1tbhLiIMjDp+VPd9gJPSsC3Z7Fy0Lb1PUU3UNaItnZ1EYHP1FdtLMPaQtF6ny7wTc/c1iaz3sQOC2KbHdRSH5WH515T4k8ZwxIfIchh096XwT4l+3TKJHJZzj6VjVhOS5m9Ts/s9KN0etI4bI9OKd5YPqPxqpYPuDDOaukt2A+tVgpKXxHm1IuDsEcW3vmpSo2mhc8U/BPFewoQjB2Rg22yBo96lTyCK+ffjhr91ba7BHaSOiRJ0U45r6OjSvnz9onw/cx6pBqNtEXgkXDFR0NeVUwLgvaHpZZVh9YUZnlC+L9WHzy3EgJOB81ehfD34i3ttIlrcyl4n7N2rx2ZN0gVg2Rz0rY0S2kaGeRGw6DIFYyikk4n1ioU5RlGSvG257b468ZQ3EHkwy84wcVq/CO3uJGBMzNG3OCc4rwmWSXCscuRya9s+Evie0ht44WKJL0IPFddNbI4cZhlh6ElBXudT8SNIu5YGltywwMgivJtM8R3djfC2v5XU5K5NfS7G31C2ZMq6MK848Y+ArK7XzmRUlHII71242Kr01Z7HgYDEqleMtzxbxtqTTXe5mZgfu8159fTyvIwUnFeneKvCl8WMiozoOm0c1m6d8OtS1O3ee3G0qM7XH3jXjJ8jsz6+jWo/V171vzOd8H6jPYatby5wNwr6wt4xeaRBITu3KGH5V88aF8ONYm1FBdRCGJGG4seor3TVdRh8OaCszZxDHgZ6VhUjKdS0UceZzg4x9nK7TJzbFgUC4PpXNeOftOnacZsIVC4yK4W6+K9y826OP5c/pWb4v+I0msW6wLCVjxz70UKThLV6GawFWbi5R0Zx9/4iZdSdlQM4Od1etfCj4gLd3X9n6gVjYj5Gz1rwS6A+0OxA+fkH3p+nyzpIZInKSRkFWHUV01Kd1dM7KmHU4+zmtdT6t8VeIxZ2dwY3K47g147P44vPt5MUz7VPc0j65d33hpDc5d2XaT3rz68EglzyvNEJXha1hYHLoQupq7Ppvwl4nOqWUQ81A4AyM11amRwGDBlxXyr4Y1a6s7pQjtgnnmvorwhePdafGXYs2M8VwThaXKzjzDLnh1zrY8NHje9u7z5/uM2M17F4GjnvrdXyWBwRXzVZSuLkRyqVIPSvpv4T30KaXDk8la9J001zIjNmsPyulszs5LKVEHmHA9M1k6uFW2fe+0YPU1ravdwqpk8zPHTNePeO9Zu7iORLZX4yBg150KDnJ32OXBRnNqTep5P45ldvEFxufegY4welZFjIfNHlsc9hW3Homp31wWFq7Ank1vad4OuYvnaBlbsMda9KnB0rX6H0ssTSs4po9V+Dwm+xxtMD06ZrovGsRuYmGw4HGK5zwNFc6fEEn3L2Fdxdq8sG4kknqawx9SFSSadz5ajT+r13Puz508VxCyuyI4u9XfDOs3Qlhht4gj5x0r2DVPDun3qBrgZfrwKgg0K2s1VorWMY5B2c1hGvKCtc9+eYUa1NRcNS/YX72dpHJfTLnGetWoPGFhI5jULu7nNeeeN7HUPIMsbMIx0UV5nqGo3Nux27l7ZrenOk3qrnHTypYtu2h9S2eoWlw6+TIAevXitJnUjlc/yr42HirV7Z1W3uZEOeoNe7/C3xhLremG3uZN00fU96zq4eLTlDTyPLx2Wzw8l2vY9IkgMpXaMHPrUr2cUcJcvt2jLMar2wmZwRhqj8VR3J8NX6wkmQxNjHXpWKw8eXVHC1LnjT5tzhrv4qaRaas9qiyNEhKmUfdY1dl8Rwazo1zJp8uGKnjPNfNeoLLLlSdrKSCD1BrT8Oy6rAQts0iIe/Y10U8NTtbY+jq5ZGhyVKbTv3Ok1O8uYY5Czkyg4JzXG6/qt3fhEnmJEf3RnpXoNhplzcAyXced3GQOtUz4AuNQu28jZGM9W9KrWO56WGxFBQcaiszzSKd2JYZDr3HWvcfgd48vzfR6XqUxltWGELcla5c/CTXGuXMDQbO25sZrs/Bnw9uPD8gvL6VBcx/dCnIFOOK9nfle55mZww2Kgot3ktjP+O8q6jfQzID5aZXNeJm1ae4WKEZlY4C45NfQ/i1tPuI9k86O+OUHSvINb8QWen3ZTSrKFZ0bHnYzj6VnTnKT0PQoYinRw6owizuPBPgC5ighmuLcsVALKa9lsrYpaxKpPAC7cdK+dfC3jrU7K4WZ76RjnLI54Ir6X8L6ta+ItEgv7VQCwwwx0asa9CU4uzueNm1WvTUfaax6DI7WTD7uPasrXbBZ7IqeDgjjvXSXFuzjJcg+3eqctusSky/Nn9K56NKVOV2eTRr2lzXPC/FHg+62g2yl8mrHgPwvqccuJ0aMbsivamsoniB2Z5yD2q5FAIwCiqDjnivW9omttTrq5j7nJEh0yz+yW6BjubHJq8pFVp5mjXIVnPtUUE7nc0i7V7VzLGRoy0R5coyqe8zSQ84xXCeLfiPZ6JdvaxKGlTgluma62+uGt7CaSMbnCfKK+UvGjzXGt3U1ySAWJwR0r0KeNdSndnoZTl8cVUbnsj3bQvipbX0gSW3CHuQeK7S9hs/EmlK/yvH718bWV/IlyDCzIvQ4PWvpD4Y63HdaJFas5BI5BNKWIXLZnbmGUrDJVqBieJfhWl55j2Kqj+uKwPCXw2ube9kF6MovVR3r337GfJ/dyfKR2NZl1qlhozA3sgX6815bbk7QMo5xW9m6e55rdeA7BYJd0DKT0NeZa7pzaHqieQzoAcjtX05banpWtoDaTRsR6Y/lXNeLPCVnqkgZ0Xf0ziu+hXfM4S0HQx7uvaJ27HLfDXxvJNcizmJ4GMk17KEjuoFMihgRmvKNH8GWmkzmUMAOu70rttP1+0j2wLcI23gDNdUarjPXY4cbCFaXPRVi/PpMAnLtGGXHpVSayhiRntv3WeoxxW5FMtxGGQg02aFZEKsOCK58RS5p88NjkhiJx0kec+I9YOnsGSMscdfevNPFPiufWLV7K6BiQ9M969u1XRbaWHDqh5rjb3wJaXdwGdARmuqjRUo81zupYqnFrmVzwO30e8lm2xwuyseoGa7fw/8ADK/1RS8o8hcfLu716npHgaO1kIidlHYdcV2mj6YbFNpO8j1rgqQlCVj1a+fTcLQ0Z85X/wAJ9Vhn2BUkUnAOa0bX4QXJClrpVx94ba+h7iBXBylRJGF3REAccUnZy8jjWdYiSu3qeG3PhCS2Rbe3VmRRjNYl18Obp2afzAvcqa95vdPmLAxxZUdxVTVNHaa2J5U1tUoqNoxZvTzmdk+p4JYeHHg1FInUkE9RXt3g+yhtLRQGJI7Gq9l4eWA+ZIoJB6102n2sZiABCmvMnGTnZajxuO9rDVngmq+FLWfWN1uQCWyQK9I09LDwtoH2u/fair8qjqa8Rj8VyxXyyxtuXPU1Y8Z+MpdX0+C2BIReTXRacYqKPQqYOVatFVFodZrPxPgm3LBblcn5QT2qjpfiFr6Ub4w+7tivL7W0l1G6RIQx7cV614L8KzoI2bC4GSTW8J+ze4sTSw+HTSV+x3Gg20bRCUoE4z0roYIoXQkLk+uKh06zk+WP5REOtdVYwwxx4CAjpXNWm6srRZ4c6vs/etqZVvp4nGcYIq47pFD5cjAY4zV+aDaGdGC8dO1eU/FLxBLplqfKJDeorlceXQqhzYuW+iO8WSNCSoEgHvUwkSQDKY+tfLsHxD1i0cusjMp7E13/AII+KrX1yltqEarnABPeuqGCc476mmJhOg/fi7dz1nUbO3uE2v8AdxzmvGviDa6PHM5SUJIo5Ud69A8Y+JoLDSTPEwaRxwua+dvFOry6lcPIcLk9BXPToyc7bWPZy2nUcOeLdincCCa6VLYk5OMmvZ/h34bOgWJvJZszTgEDsteF2cjLcRFEzhh+NfQnhuRpdFhku32kKDtrqrRajZDx05TrRjLVfqdzpepSq6YlBGcGu0hZbi3GcMGGDXh0PiOKO/NsEZcHgZ616N4W1VzANx496KdZQj7x4WY4VzleCs0Vb34YaHeai941siu53EdifpSXHw3tHmR4XVUXgIBxV/xT40g0SBmkZAQM9etZfg74m2euziEqFOcZNduGnSquyucUpYunD2j2Nm38JrCipuG0elWP7GEBXZGpx3xXSo6uoZTwRkGkYA101MBTqq8ZHL9erX1ZhPB5aksCAvPyivM/iV4nnsF8uKORWPAPrXspUd8GsnW/Dmn6wmLuBSfXFckculD3m7nThcfCnO9RXPlGMahqNwzuJSjHJOK5fW7V7G6cSxsBngkda+vNQ8PaRoOlT3bxKIoVzjFfMfjvWv7RvpTHAscW75RiptFH12BzB4lNUo+73scxpMnmzgNGTk4FfVfwhu1Ok2ltbx4iWMiRh/er5e0q7kgmBjwD34r6c+Gl5DZaHasEwzqGbApJq5hm1CboNPU9FlIB9Ka6hlwwBBrntd8Q21qFnkmCoBmse3+JGi+ekMlwMucA56Vzq6ctLnybws4xTO0VQhwvC+lSAArg1Te5SYRi2YPvwQR6VbQnADdaWFxCVRxmjKcGkmyt5oWYo3ynHU96ry25mYgv3zxVy5RRhnHPbFZt3q+n2ULNd3UduT93ecZrkxCbnytG9K/xRL0cbshRcEgYIz1ry/4l+EbSXTby+kjMMkSliR3rhta8fajBr101rqZCpIdhU8EV2UHxCt/Gfhe90m8QRam0JMbL0kxXbhKLvy30PV+rYnB8tZbPt09TwGNlM2w/IM8GvWfhReeRdD7RnyIfm3V5XeR7L0BhhlPI9K6yz1sWOlDy+HIwfetJQu7H1eNhKeHdtWz0vxN8V2s7mSOwUMi8c9K8g8UeONT1a5LSTNtzkAdBWDe6jNJcSbYwVbncazpBIx6Ak9+1WtNNkeVQwFClD3YvmXVnYeF/El3YapbXCzOoDAMAeCK92v8A4gRWenwySRb2cda+dvDGnTajqNrbRIXO4ZI6V3/xDmFlbQWRiKlAOcd6x5eep6Dx1Ci5wv1NzWviXFNC6iAoDx1rhovGcy6gDDHhc9a564R5Uwc1PomnSyXsKspwSMVo6rSsjto5ZQpRb6H1H8OdRl1LS4pWyABzmuyZCRXIeCLWLTNEh81whK5JrhfiZ8TnsXa20qX5l43itKVTmg+Y+Lr4V18U6dBHr06WvmHzmTd6E09LO3B3JGK+SZPiNq06kvcs0uchs16h8LfiFd6iPs+pPuYdD61PtvZa9Depk+IjG61PbBGqnhcUpAxWWmtWuzJfmhNZgcnaDx15rshiadrtHlvDVVujRYZHBrNvJXgmUsuV9ad/bFsXxmoL2+V1wiAg+tceIqU5I1o0Z82sdDThnjdMhhWbqk4kcLnCj9aoQNKG7hTUkx5BYZNcn1525bHTDCck7plOe5iiYbmbb6VE+qwIQyk1i+J9RFuTuKrjt3rnoPFlgp2EZPfvWjailJHZGj7SOqZ4vbW2nw2TzSyb5APlUcc1jz7pJQq9SelVctMQAWwK1dB066vtQiWFSTu/Kt1BRleTPsZS5YSf4nrnww8JOmlieZAryfMMjtXoQtHtFUKMj0FO8IW0ttpUUUhJ2qATW5Mka2xbqw9TUVo8sm10PifaSqS993vcq2FyA6rcKF9ia6i0ELxgoRn0rzea8j+0bnJGD61v6RqKOy+XJ8uO5qqDhe9jOvhm1pI624gMkZVTzXj/AMVvDlzf2UhjU5HIr2Gyl82PtxVLXLZrmEoEB4qq9CErSTsZYHEyw9TlZ8Tarpd5ZS7ZoyPrU2gQXUt4i28TiXPDAV7f448PIFaRkGRz0rA8OmG2kCbY0frnbV0Fd2kfVSxEqlBygrvz2OX8RR6pBbouoO7LjpXE3LfMxGTX0VqGjQ65pzBsbyOGrzK68C3UN6yAZjJ64olSanoXl+KhClyvQ4zQ7WSa/i4JG4YAr6DstPni0aEhONvTFUfAPgaG3lSWdVdvT0r1TWtL/wCJXthXaFXtU16UoQu0eZXxdOWISTPnXVdQXTtdJlQZ7CrUXxGltpiq/wCpHYdqxviRY3EOqF/LYDnnFcCXKuQWzXN7JT1PXp06dR80ju/GOtt4hkj+ySSSt1ZfSqHhKe5sdZjGWjA+9imeArI3msRhSQGODXtMXgrTLaGS6uGWPauWZjipjL2TtExr8vI6L6lKb4uzadCLVEEjoODms+z+M+oC63XEeU/uiuH8b2WjLPJJpOoK8ueU/wAK4+2gnuJwIgSe9dXtLrVCjk+ElDmSufV3hX4lafrUqwyAxytwB716AkiyIGQ5Br5U+HFvHFqaS3Uu2cHCKK96utYa1ggyxBxzinRxns3ydz57GZRy1XGk9Df8SacNX0a5sif9YuK+WPGHg/WNMvXt5rCSRdx2yIuQRX0ppeuCQHJ4PetC6SK6tGaVV6dT3oqU9XJMvA4qvlrdNrRnxrFo95DdqJoXijBGdwxmvSLXxbNpixblxCigYHSrXxNe1tLiQCMh+xryrUL2WdHy3y9gKw36n1sofWqXNJHYeNPGJ1W1VYWGea4e0uWLKDkEGqFvLl9rHnNaqRhnjVF5OMmiUeXRkYalBRcovofSnwsu5T4fgkvH3ZG0EnoK9Eh2yIrRkMPUV8o6d4jvnYWEF00NpEuBjjJq1p3j3XtKuWgtLx2iz/Ec1zRwvPLmbseHiclqVY89Nq/Y+rGjBUZHPvXzx8fWdNcgjwVhEeRg9TnmvQPhd49n17fa6jE7snSdV4+hqf4x+DBr+jm7tSFu7dSV9CPSvQxOHd1UjtY8vLp/UsUlXR8kXMyLcDZuODWnpOoy2FzHPbNtmQ7lB9azb6zlt55RKCrqeQR0NMgmcurnG4GhaJOPQ+tp1I1IyUvtfkdzqoXUFN6YBFNP85QDoe9TaZ4cudXSOAKV9wK6vwAtv4ws2tb9FW5tlGGQYyteqeGdAtNJYCP5mbua5ale8tiK+Yxp0PZtNSWn3Hi+o/CfW1t1e2eKZW6A8MKueG/hJf3Eq/2rthgHUJyTX0M0WUUjAwcGlLIvAwDWcqvNpseD/bNfWzOO8M+BtM0R1FlENw/jbk5rP8c+Fm1LdmJT/tY6V3lvMQxCrnHJqG6n8wsChAxkUUKvI3bqcrxNWdRSn0PA4/AN7520AMgNdr4W8GwwTrJeYLL0FdTKJ3YGJNuD0xWxZabIyZkIXNXJt+71PSrZhenaUjM111g0mSGLptx+lfLPjIu9/cBM8Nnmvr2axVUMboX9/UV4745+Hlxd6hLPpqovmHlWq4VnGPJLoZZdWpQqt/zK1zwyxtZp4fMjhkYZxkDivRvhtaXNnfCZkIBGMEV6T4K8DQ6dpKw3ZBkHLYFdLFoenWw3xqNy+tc1Su6uiR6bxsYr2e/mZd9crHEHkbaSOQK4nV/GEdnL5cEzFlPrXbeJbJJLVpASq45FfO/iaaK31OWOOTzGz+VdlGKcLnLTUa1bkex6KnxBMed/zEnsea7Xwp4sa/8AK3IzK1fM0cz+cfnOa9/+E1gZ9Lhk3Dd1IrCulTXqb1cLBRv2Pa7W3F1Akhwq49K80+IHxDsvDlybdIzIw6EV1niXxH/YWhuCQG2nk9a+T/GWsS6pqss8w3xMTt9q68PhaSpe1mryeyPAwuGq4mu0pcsF1NjxH8RBrNycBol9zWPFqKFwytnPvXLTW6zJ+6HOe9OCeXPCseQ3fmrlRjLY+owynhoezauu57APAkss2Ygoj6c11Phnwzb6LIHlIaQ9T6Utz4psrEBZHBAHAFZf/CW211PiKRQx6DNYJOFm1ocNTGVqkXCT0PTYLtVjG18L6VV1C982AhJGx35rl7S4laLzDzxT7R55pDsHHrmlKqqjsctPDQ5edkepEtGXUtuHYUzTNXayHnXcqwxDu5xW1DYlYXd0yRzgV8/+PdSnl1q6EztsjYhI88CsYwbq8kWdcKEZ0pW6H1BpXjrTzDEkFxHJn0rq9P1X7UASOD6V8L6Lrtza3IlikKmPoM8V9LfCjxS+t2EbSYEnTrXZLDy3T2PnK9J0pLnV0+p2fjSwF1C5ULwM4FeBa7dTabftvQrg8V9EX8JkVmUk+ua8M+I9hI2otkDBGeO1ckcQ1NJH0uUTs/Zy2NjwTr63jCIPl/SumvUlNyOig+or56sNaudHvvMtG2lWr2Xwv4sbxBpqkIouV4avQVflXMzPMML7Ct/dZ6V4bKw4LYLetdrEUubcggEHgivLtPuLqEKDxu6mu80a/QQJGzgn1rq+uUKkeVng43CyiuaJzHjfwZBqNs/l8OeQcV4Jqfw6vlvHSMKVz+lfXbKsic4INc3qWjRCQyoo9TXHiqHso80djfA5nJe5M8n+Gfg8Wk6yyoMpVH43anPFexWEZZIQm4qvAY+9es2BhtGY7QuT0rnPGXhrT/EsuZsicDAZTXnxUrqVj18LioU8RzVdrHyrOWM2SeafHczWsgW2kZXccn2r2e7+Dkyo720hd+oBFcHfeBdbtL1ll06d8HAKLkGurnSWp6ssVRqRajLdlnwLFNcazZxwhpHDhmbPavcb6UywOHU7l4Fcz8HvCs+mzSX2qQGFmXCIw5r0uSwgnRmRflJPauGq25e7qeXXxtP211srJHHaNdSyTrGkblc4OK7qTbFaorykbuMVmW9stozJHGF5zkVanjWWAFmOaft5JWZx4mftZpo8q+L9qXhDpHlRxnFeLRbluMSD5M819XX2jRaxYy283JxgV4x4h+HV/b6gfKj3R5zkVrGVj3MsxtPl9nN2aMrw34RTU7qJkjGGOcV6hpvgW0t3jhNsCD1OKPh/4YvrKFJJjyT09BXqcNkURX/j71NWfupo8rG5hyzcU9L6Hntp8NtBsY557uJpS+SRuxiuQm+GelX2pFtPvJoYSf8AVg5/WvQfiBrsWmabcMr7ZMfdPevD38dXMaSfZ5fLkPTHaunCuEkubQrDrEVqcpp3Z9E+ErDS/CemR2ytGoI69yfU11MwjvrRljkBRx2r4zuvGes306l7qTcDxX0j8LZ7uXwxb3V27NMw5B9K9F1KKjyxPHxeXV6S9rU3Oc8Z/Ckai0ssAQFskkV4vrHgfUtDuGWe3Lxg8Oo4NfYJuwy9iT2rMubaG6DCWFGU9cjNeTUqxV1Fm2BzKpQleaukeMfBHTnt5Lu6mjMaMAoyOtezJbwMN0TBW61Rnis7SERRRCNR/dGKrRYMuN/yn3rz3N3uzfE1HipOqtDTkuXTC5J7DHemRXEhkBkQ46VIYCYAY2yO1R2TlZT52SP0q3La5we7yuyHW/mLI237rGrkjKVCjGRUsbR87MZFQz7GZQpANdcKKfvHO588tiBNryAhencVoIzbRxjiqUYaFj0Iz2q1FcJJkA8+lbQhH0Jq3exKWBXPSqzKJCxZRuHrTZ52QsApNRJKxySMA1E1zaMIQaV0Qzod27YOPSqsoRV8woSp6kDpWnG6vJtzxjvVmKGBvkJGD2rnjQTmdPt3BanNXkdvdWcifwkHmvl/xv4fe01y5xG4y5KnFfXN9pSZxAfkPUVm3Pg6zvvmuI1dh0LCutXp+5E68LjoUpe0mrpnyd4e8L3upXSxwxOxY/M2Ogr6T8D+GZNF0+JWOHUV1GneF7Sw+aCNFx6CpriTyiqpgp3rCdGpVd5m+IzSNX3aex5V8Y0upbB1Vj+Ar5/3NDIyuuc5HIr638VaZHqdq0ZwWIrxHxX4IW3t5rln2GME47Gtm7WT1OnKsVSpU5QqdX+Z5xp+hveybIZmVieB1roY/AN3bDzpiWbsaoeGrlbTWYZJmIjVq9xtWh1m0BtXDrjt1FZVa1WMrX0O/GN0JpwWh5nr3h8T3P8Ao7k/jmp9B8JOl0jyDnrxXbWNkJXV1Gc+1dZp1mqFWaIFhyOK78RRlSimzxHmftL01sZdppEyW4BBxikKLbdBsI6+9dNI0jKVHye1cL4xN1DbSeQSznoRXm8j5jajOMo8p0FpdeYpj8xORjGa8M+KukpHrruina/OR61u+HZ9Whvd9ysrAnNdFr9pZa1Z7Z/3cw6MfWnOE6NRVFqdOErQo1HTqr3WeBm0CnAHWvdPgNA4YADagNcFceGpBc7IGVxng5r1z4YaXPpUGZ8DJBzXbTxavcrNqND2X7t6s9eu4lEB284FeN/ECzfbLOFOQDXqj3jXUe2HhR1bPWuM8Y2F3dW7iPbtA54rzZNOV0cWXuVKSufNF6GM8gxznNdZ8PLueyui2CAwq7d+EL2dmligypNdT4Q8IyW6SNcx4YjCCtalZclj6TF1aNWnq9WYXiT4h3QmNvZHHlnDY6VL4V+JN7Hfxi7fKE4zXGeN9CutH1W5jZGMchLK1c9p8UhnjTBABySa3oxg4KSPLxOXwnDl+0+v5H2roHiBLlIwsisrAHNb90ouIfkkByOMGvnz4e6g6SxRPIx3dOe1e12TjyU8tiG7A1osQmuVnzuIwM6E7PdHNeKobu1t3eIkkelct4XvtTudSxOrYBwDXpOo2U0qGOTkNyc1SgsItMiaUKCRzjFdWGxNOmmpF1KSrwXfyOt0lW+yr5mCattBH1KLn6V4f4g+Lg0i6ls4B86n8jXDXXxj1cXyyvKdgOQgPWt70pJ3scv9nYl3lBaL5H07PaI5OFAHtUEVokIO3mvOfCHxYstXSBZyEY8NnivToJormFZYHDowyCK5JYJx1scrqzXuyuig1mGcsRVK8t8ZDfL3rcbOcDqa5vxLdLbxsfO5AzXn1sPde6deGnOc0iSBjC6kDhuKtX6LIikwhzXAyeKkKFAwDitLS/Esskfz/OD360qfOo2Z3VMPO6kkdnpkYCgbNtaMxKwuQMnFYVlqwmjUIpDfyrZt5vOiIyM4xXVTjBxanueZXhOMuaSPCPjU8kpR4l3KFJOPWvDYbWW5k2ohZ+wFfWPi3wsl/FKsjYzk9K+fby4tPDnito7cCUI2CSOKyinryo+vweNoxwyhHWXRW3Knh3QpZL1C6E8j5cc19TeFIfsOhwRQoQQoyCK4bwH/AGZrf+mQxL5ykAqPWvTYWIQhVwRxjFVTk1K0jyszxrxMYprYxNQ1Fw7oEwwPUGliunKYhdsn17Gk1BkE3llCXJzmpY5FSJmKhcDvWdemqkrROeEUoLQZLbyzRncQxqmluEIViQ4NcZrnxHt9Fv2ilBwTW/4X8VadrzF4ZQZDyVPBFc88C4x5rmyc4aNaHW2r/JhzzVxYDszgYIqlbMpBJPPYmtWGRGi5YZq6MVN2kebXTi7oyblSjloyQ46is2a4YzjqFPWrOv6hFaDeGAx1Oetc9HqCXUiNHJuGegNdsKHs7q+5vSSktUdXDE8iDD5FMS3dJWc5FWNKV3QMM4xV5YOSWOc0/qsp7M551uSTRmtLgkMSy4pEkUgDHWtGW3QLkACsy5ikO7bgDtWVajKmtSqUozGXkyWq7mZV9eaoJ4gtTMqRzIWPvXlPxS8TX2mNLAr9eF9RXjK+J9SF2ZUncEc9a3eGgoWe504bD1K/vvRfmfR/xB+JP9jI1vaEGcDGQe9Ynw4+LN1fX/2bWZEETHCtnpXz7qGo3Op3TzXUhZm6mtvwVYT3+rWlvbqSTIOcdqVVqlT00SO3C5VBxbqL3nf5fLsfbUbLcWoeKQ4YZzVCa1ds4XI9aXw/bNDp8MchJKqBT9a1FNOgLDuM8V0YaM8ZCNtDwKjjQm4x1OZ12T7HGzTNtC+9eM+L9YfV/Ptra4QdQAT1qD4xeMr+ScwW7NFE3BbNeNGeYT7vtEgfOc5rXEYdUnywd2enl1KrNOdSNuxtzwTWs5EyNuBrr/B3iG6067QQ8AkKR25rF8O6p9slgstURZQ5CrL3r0yLwElusd1AX8vIJ4rx69Xk91rU+oq4mHs+SurM73wpDBLZxvlHAAPFdOkcZPAFfLvgvxlqFndQWrO/lZAPPNfQmnak0likjnBI719TUjTqw5k7o+GdCrRq+zqrXujbuBEgyPvVj3lrbyPudcjvkVE98GJBOaq3eooq4IzXlV8LZc0D0KLadmI9hZ4ZwOO3Fea/EJpLZt9tkD1Fejw3JkxuQEHpis7V/D0urqQYgFrjjFrRs9GjWjTl7yujwBdWv0mBWZhz0r1/4ca49+FjnLNgAGsu9+GkpnLIdo+nSvQfAHhePR40BUO3ckVpKheDZnmNbDySdJe8dfEyfZwIxtXFZ88xlDxBC2eK6C4+yOm3gMOoFRW1vD5gcjCrXkRVpWOaNe0b6owo7FnTaIQAKtzW0VnbmZlBkA4HpW8ZreOOR3wiqMknsK8k8Z/FPTopZrawi81Uypk7E1qqHtNjSjUqVZJKLZznjHxTpUepmO7t1mIOGBGcUyyi8Oa/Dm0tRC3QYGOa8f8AEV+t9qkl2mcOckE1veBdWuIHcqAFPAB5rZ4RKmpLRno1Y1Kck6cm/L9T2jwn4cisL9HB37Rwc8CvSrcK5CpgADOa8h0HWLiWeMbisfcmvQ9OvvkJD5K81lOPJBNvU5KtOU25PS52U5MdiJGYEjrXk/xA8ctpBKxxkhgQD6mu6Oom5hZWYBRzivIfHFoup3Ti6yFA4wOKvnT1auRgcNGL99/ceL6veyXl9NcyE7pGLE07S9MutWmEdlE0zDkkDpXSXvhmxibP2pj/ALOK6LwrGunIsenttJPJ9a39qlH3T6Gcm17kbrzOMgtrrS71YJt0R7kCvoL4R65PPaNBM7FV6E1gReFjrEkckqq7d+K9B8M+H49Gh+VFGcDA7UvrbjFxkeNmLp1opNWa/qx1y3AETSE9BwK4PxOJbpZC/AOQPauwvbu3iCRBlDAZJrgPHfiG1stPmw67tpx9aVGq726HBgKCcr23PJtUf7Bqr75WKg+tdPomvQJAHyNo968c13U7m+u3beeT61b8KyXU1z9nLGtqllHmR79WhtzOyPpPw7rsEnLsADXd6ZIJNkkLBkI5xXhvh+wn2xqSR0zXqfh2cacNkkmVPT2rkjiFKVmeVmOEtFuDudde26z2k4x8xRsH0OK+JfFMckGuXaXJZZllbdu+tfbEN7FLETvRcjua8N+M3gyA3Z1eFF+cfPjv713VZRjFWOXIpunXcJ9dNTT+AloItAEy8u7FsmvV7mdoQMKC3fFfOPwv8Vy6XffZpHC2/wB0L2Fe8adrdtdP8zqSRxz1rgd46xZrmmFnTrvmV0XSgmBdovm61ga/IyROcbEx6110LoIeeh9K4fx+zDS7g24ySpIrup0XGKk92cWGqXm01sfNfxDkkbxBMch4yeKh8Nalc6bMtzBKyOGHA6EVlao88t7I0jFiSeK3/A9hLqur21kqbgzgvx0XNROVlc+yp0IU6Nproe0eL/Fk+l6Bp88eVkuowQffFecQ/FrVNOkaGb99Gehz0NeyfEXwmus+DBb2aD7TaIGhx7dq+U9ailSTbKm10OGBp4afLZHgU8LQxUZtr3r/AIHZ6l8SdSvUkjnx5b9CO1O8D+Kb2PWrfEjNG8gUqe4rz6NT5Zx19DXVfD6znuvEFq0Cl1hYO2PaniZvkcmz0o4SnShaK0PszS2D2cbgYyORV0ciuY0PVGkRVaMquK37a5VwcD8KeDxdkos+QxVCUZt20JJJIoImknYJGOSWrltT8S6SJlijukUnjlsVxnxs8UXFlZeXakoQOgr5rudWvLmZzPOxY88HpXpYmNP2a59ZM2y7A1sRLnTtH8z1n40wLcuJ4n3Z7g8V4iBIEIZeQea6XQtVaa5W11S6drRuMsc7a7mw8FaVcIs8cpmibjK+teXKt7N2tc+kpRWFpqM3rqeeaDo8+oNiKJmzxwM19A/CvwYulKt3OoNww49hWj4W0G2022jijtRj+9jNd7ZIkMYwoFcypzxb97RdjHF5m40vZU1bzNexDheSMYxWV4ltVuUKE4JGKtRXJU8HFLKqzj5m5r6TBtUFynyNWLcuY8F+JHg6O5sJ5N5EoGVPvXgnkGKeSGZf3i8V9neJNHF1Cy84Irw3xT8P2jvjcRdCckVOMpKMeeOrPYyrGWqctXY898N2lxPqtsiDnePwr6osrrydASCRQWAXmvLvB/h+20+VJZuXzwa9KnvoItOZdykHHf3r5iblVqqTWiPVzHEU6seWD0R84eFYIzrEBKAnNewPcSqgAcgccUUV6UZOyNszS9sTQzSC3LbzmooZXlfEjEiiivVhrHU8t7m/pPMoBrudKjXZ90dKKKlpWZw4hu5cmgibqimoxGiQkqoBoorzcX8DIg20jHuOJhj1rShOYxn0oorxobHbV3MzxCA2kXqnoUI6+1fJOqjFxMo+6GPFFFdGH+M+kyZe4zBv+DgcV0vw/wDmnKsARjoRRRXqV1+5OXFN+1+a/M9H012WdFBwu7pXoVixS0+U4zRRXn2ujHH6ONjmn1C7TxBJEs7CPH3e1b88aTWQMihj6kUUUVEuVHDg2/bM8p8aIsN4BENufSsvQppFvo8ORRRU0+h9o9cPqfQ3g0D7LC2Ocda29bnkitz5blfpRRTkkz4urrUPPNevLgSOwlbOBzXiHijUryfUJFmuHdcng0UVtA6sJ/Fic3uJkOTXT+DP+P8AVu+etFFViPgPcq60pH0BoKK0UZIGSBXT28SNFLlQcCiivFl8R4FVvlKQdknjRWIXcOM1U+IzGTw3dK5yoU4FFFdsWzFJe0ifMRleK+BjYqc9q7jQNVvlu4sXMnGO9FFbS6H0WNSad/60PoTwhczXFgPOcvx3qfWYImgYMgIIORRRXqT+CJ8ctK2h86eNtIsItZnMVsqZOTgkV3Xwc0uygSSaK3VZT1bkmiivAqyfNa59LUb+rr0PYeiLivmn40aXZQeJ3MNuqFyGbaSMmiit02mrHlZf/EOC1G3iVEKoAcDpXoXwtijhVmjUKxbqOtFFFd3po+uzFJUWz3DSycD6Vs2THzutFFc8NJKx8TV1izyL41xoyjcoOTXz4yL9ol470UV7lR+8vQ9/Jkvq0AVF2dBz1r0z4QTymW6ty5MIGQh5ANFFc1fY7cZFfV3oe66G7eSOa3p+lFFbYXc+LrfECcqaR2IYYNFFd8ThnuMlYsp3HNY2p28T5DxqRjuKKK6PslUviOB8RIttbyGACMg9q8z1PVb7dIv2mTb6ZoorgnGKhoj0sB79Z82p/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An asteroid body, composed of a pair of budding yeasts of S. schenckii surrounded by a layer of Splendore-Hoeppli substance, with radiating projections.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Rubin, E, Farber, JL. Pathology, 3rd Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 1999. Copyright &copy; 1999 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_38_29284=[""].join("\n");
var outline_f28_38_29284=null;
var title_f28_38_29285="Pulmonary contusion in children";
var content_f28_38_29285=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pulmonary contusion in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/38/29285/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/38/29285/contributors\">",
"     Alison Chantal Caviness, MD, MPH, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/38/29285/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/38/29285/contributors\">",
"     Richard G Bachur, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/38/29285/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/38/29285/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?28/38/29285/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 22, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary contusion is defined as pulmonary parenchymal damage with edema and hemorrhage, in the absence of an associated pulmonary laceration. Although thoracic trauma, in general, is uncommon in children, pulmonary contusion is the injury that occurs most frequently. In addition, it is typically associated with significant mechanisms of injury (ie, motor vehicle collisions), with most patients sustaining damage to other major organ systems as well.",
"   </p>",
"   <p>",
"    This topic will discuss the epidemiology, clinical features, and management of pulmonary contusion in children. The approach to thoracic trauma in children and other thoracic injuries are presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/63/27640?source=see_link\">",
"     \"Initial evaluation and stabilization of children with thoracic trauma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/32/12807?source=see_link\">",
"     \"Chest wall injuries in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/26/3495?source=see_link\">",
"     \"Intrathoracic injuries in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thoracic injury in children is uncommon, occurring in 4 to 8 percent of injured children identified through trauma registries or as patients at trauma centers [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29285/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. Of those with thoracic injury, most have a pulmonary contusion.",
"   </p>",
"   <p>",
"    The vast majority of pulmonary contusions are the result of blunt trauma, usually involving a motor vehicle. In one retrospective series, 56 percent of injuries occurred in a motor vehicle crash, while 39 percent were the result of auto-pedestrian collisions [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29285/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Associated thoracic injuries (ie, pleural effusion, pneumothorax, hemothorax, and fractures of the bony thorax) occur in the majority of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29285/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Flail chest and scapular fractures are uncommon in children, but they are almost always associated with pulmonary contusion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/32/12807?source=see_link\">",
"     \"Chest wall injuries in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    More than 80 percent of children with pulmonary contusion have extrathoracic injuries. Mortality for children with pulmonary contusion in one series was 22 percent, with the cause of death attributable to brain injury, hemorrhage, or multiple organ system injury in all cases [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29285/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary contusion results when kinetic energy is transmitted to the pulmonary parenchyma. The lungs are damaged in the following ways:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hemorrhage occurs when deceleration at different rates, such as occurs in a motor vehicle crash, causes shearing of lighter alveolar tissue from heavier bronchial structures.",
"     </li>",
"     <li>",
"      Energy transmitted to the liquid-gas interface of the alveolar membrane and the intraalveolar air disrupts the lipid bilayer, resulting in increased cell membrane permeability and extravasation of fluid [",
"      <a class=\"abstract\" href=\"UTD.htm?28/38/29285/abstract/2,6\">",
"       2,6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Rebound or overexpansion of intrapulmonary air, after a pressure wave passes, overstretches and damages lung parenchyma.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Damage to lung tissue, including extravasation of fluid into the interstitium and inactivation of surfactant, results in alveolar collapse, ventilation-perfusion mismatch, and hypoxemia.",
"   </p>",
"   <p>",
"    The clinical features of pulmonary contusion in children are also influenced by mechanical differences in the chest wall, which is more compliant and elastic than that of an adult. As a result, more kinetic energy can be transmitted to the intrathoracic structures without bony injury. For this reason, pulmonary contusion without rib fracture occurs more often in children than adults [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29285/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial presentation of children with pulmonary contusion is often dominated by clinical features associated with extrathoracic injuries. Nevertheless, pulmonary contusion should be suspected in any child with significant blunt force to the thorax, whether or not there are signs of respiratory distress or chest wall injury.",
"   </p>",
"   <p>",
"    Although the majority of children with pulmonary contusion have some degree of tachypnea, hypoxemia, or respiratory distress at initial presentation, these features may be subtle [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29285/abstract/7\">",
"     7",
"    </a>",
"    ]. As an example, among children with pulmonary contusion in one series, mild tachypnea (respiratory rate between 20 and 30 breaths per minute) was noted in 16 percent, while another 16 percent had respiratory rates over 30 breaths per minute [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29285/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Decreased breath sounds, rales, or rhonchi may be noted on physical examination. Limited evidence suggests that these abnormal findings may be absent in more than half of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29285/abstract/5\">",
"     5",
"    </a>",
"    ]. Similarly, the majority of patients may not have signs of chest wall injury, such as rib or soft tissue tenderness [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29285/abstract/4,5\">",
"     4,5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PRIMARY EVALUATION AND MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because pulmonary contusion is associated with significant mechanisms of injury and frequent multiple organ system involvement, the initial evaluation and management must be directed toward identifying life-threatening conditions, such as tension pneumothorax or significant hemorrhage. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Epidemiology'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/12/7367?source=see_link\">",
"     \"Classification of trauma in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/63/27640?source=see_link\">",
"     \"Initial evaluation and stabilization of children with thoracic trauma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Initial assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once life-threatening conditions have been identified and treated, a careful physical examination should note signs of respiratory distress (ie, increased respiratory rate or retractions), abnormal breath sounds, or signs of chest wall injury (ie, focal tenderness, swelling, or abrasions). Pulse oximetry should be monitored for all patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Diagnostic tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial laboratory testing is generally directed toward the evaluation of associated injuries. Arterial blood gas measurements are unnecessary, since they are normal in the early stages of pulmonary contusion and do not change initial management.",
"   </p>",
"   <p>",
"    Chest radiography should be performed for all children with suspected pulmonary contusion. This study is initially abnormal in 65 to 97 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29285/abstract/3-5,8\">",
"     3-5,8",
"    </a>",
"    ]. Findings on chest x-ray include nonanatomic areas of consolidation that are located in the region of impact or chest wall injury (when this is present). In addition, associated injuries, such as pneumothorax or hemothorax, may be identified.",
"   </p>",
"   <p>",
"    Further imaging with computed tomography (CT) may be useful when the plain films are negative, if identification of a pulmonary contusion would affect management (ie in anesthetic management for patients requiring emergent surgery). Otherwise, a pulmonary contusion diagnosed by CT alone may be of limited clinical significance [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29285/abstract/9\">",
"     9",
"    </a>",
"    ]. In addition, CT may distinguish contusion from other causes of consolidation seen on plain radiography, such as aspiration, atelectasis, or infection, although this is of less concern during the primary evaluation [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29285/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Priority is given to the maintenance of oxygenation, ventilation, and cardiovascular support, as well as the management of immediately life-threatening injuries that are frequently associated with pulmonary contusion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/59/41912?source=see_link\">",
"     \"Hypovolemic shock in children: Initial evaluation and management\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33768?source=see_link\">",
"     \"Overview of blunt abdominal trauma in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/63/27640?source=see_link\">",
"     \"Initial evaluation and stabilization of children with thoracic trauma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Following initial stabilization, hypoxic patients should continue to receive supplemental oxygen&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29285/abstract/7\">",
"     7",
"    </a>",
"    ]. In addition, ventilation should be carefully monitored. Airway support should be provided as needed to maintain oxygenation and ventilation. For children with pulmonary contusion, intubation is typically required for management of extrathoracic injuries, rather than for respiratory insufficiency as the result of the pulmonary injury [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29285/abstract/4\">",
"     4",
"    </a>",
"    ]. In the absence of shock, fluids should be administered carefully to avoid increasing edema in the contused lung.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DEFINITIVE MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The definitive management of pulmonary contusion is supportive. Patients must be carefully monitored for respiratory deterioration, although the extent of lung injury is often apparent at the initial evaluation [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29285/abstract/5\">",
"     5",
"    </a>",
"    ]. Good pulmonary care, careful fluid management, and adequate analgesia reduce complications and the need for intubation [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29285/abstract/11-13\">",
"     11-13",
"    </a>",
"    ]. Specific interventions include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intercostal nerve blocks and continuous epidural opiates may provide additional pain relief.",
"     </li>",
"     <li>",
"      Placing the child in a position where the injured portion of the lung is dependent may improve perfusion [",
"      <a class=\"abstract\" href=\"UTD.htm?28/38/29285/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      For children requiring mechanical ventilation, positive end expiratory pressure (PEEP) improves alveolar recruitment [",
"      <a class=\"abstract\" href=\"UTD.htm?28/38/29285/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Inhaled nitric oxide, a potent vasodilator, may produce benefit by diverting blood away from injured lung tissue toward well-ventilated alveoli and by reversing hypoxia-induced pulmonary hypertension. However, the use of nitric oxide for patients with pulmonary contusion is limited to case reports [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29285/abstract/14\">",
"     14",
"    </a>",
"    ]. In addition, randomized trials in children and adults have not demonstrated a convincing benefit for nitric oxide therapy in acute respiratory distress syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29285/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/52/9033?source=see_link&amp;anchor=H5274368#H5274368\">",
"     \"Novel therapies for the acute respiratory distress syndrome\", section on 'Nitric oxide'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following complications are associated with pulmonary contusion:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pneumonia is the most frequent complication of pulmonary contusion, occurring in 20 to 50 percent of patients [",
"      <a class=\"abstract\" href=\"UTD.htm?28/38/29285/abstract/12,17\">",
"       12,17",
"      </a>",
"      ]. The radiographic findings of pulmonary contusion may be difficult to distinguish from those of pneumonia. Therefore, children who develop fever with worsening respiratory function should receive appropriate antibiotic coverage. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/48/25354?source=see_link&amp;anchor=H22#H22\">",
"       \"Inpatient treatment of pneumonia in children\", section on 'Nosocomial pneumonia'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Acute respiratory distress syndrome (ARDS) may develop in patients who survive the initial injury. Limited evidence suggests that ARDS occurs infrequently as a complication of pulmonary contusion in children [",
"      <a class=\"abstract\" href=\"UTD.htm?28/38/29285/abstract/11,18\">",
"       11,18",
"      </a>",
"      ]. ARDS is generally associated with a mortality rate of 40 to 60 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?28/38/29285/abstract/18,19\">",
"       18,19",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/16/10505?source=see_link\">",
"       \"Acute respiratory distress syndrome: Clinical features and diagnosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/15/29945?source=see_link\">",
"       \"Acute respiratory distress syndrome: Epidemiology; pathophysiology; pathology; and etiology\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     OUTCOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with pulmonary contusion who survive their initial injuries appear to have an excellent outcome. This was demonstrated in one retrospective series in which children with pulmonary",
"    <span class=\"nowrap\">",
"     contusion/laceration",
"    </span>",
"    were evaluated several years after the initial injury [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29285/abstract/20\">",
"     20",
"    </a>",
"    ]. All of the subjects had normal chest radiographs and pulmonary function, with the exception of one child who had asthma. This is in contrast to adult populations, in whom long-term respiratory dysfunction frequently occurs [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29285/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The effect of pulmonary contusion on the outcome of children with other injuries is uncertain. As an example, evidence regarding the outcome of children with severe head injury who also had a pulmonary contusion, compared with those with no lung injury, is limited and conflicting [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29285/abstract/22,23\">",
"     22,23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pulmonary contusion develops as the result of blunt trauma to the thorax. Although thoracic injury is uncommon in children, it is associated with significant mechanisms (ie, motor vehicle crashes), and the vast majority of children have multiple organ system injury. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Injury to lung tissue results in hemorrhage, edema, and alveolar collapse. Because the chest wall in children is more elastic and compliant, associated fractures to the bony thorax are less common than in adults. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Clinical features may be subtle, although most children will have some respiratory symptoms. Signs of chest wall injury are frequently absent. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children with suspected pulmonary contusion should receive a chest radiograph. The injury can be identified on the initial film in most patients. A pulmonary contusion diagnosed by CT alone may be of limited clinical significance unless it would affect management (ie, in anesthetic management for patients requiring emergent surgery). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Diagnostic tests'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Initial management is directed toward identifying and stabilizing life-threatening injuries, as well as maintaining oxygenation, ventilation, and cardiovascular support. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hypoxic patients should receive supplemental oxygen. In addition, ventilation should be carefully monitored. Airway support should be provided as needed to maintain oxygenation and ventilation. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The definitive management of pulmonary contusion is supportive and includes good pulmonary care, careful fluid management, and adequate analgesia to reduce complications and the need for intubation. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Definitive management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Complications of pulmonary contusion include pneumonia and acute respiratory distress syndrome. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Outcomes for children who survive the initial injury are generally good. The impact of pulmonary contusion on associated injuries is uncertain. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Outcomes'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29285/abstract/1\">",
"      Cooper A, Barlow B, DiScala C, String D. Mortality and truncal injury: the pediatric perspective. J Pediatr Surg 1994; 29:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29285/abstract/2\">",
"      Peclet MH, Newman KD, Eichelberger MR, et al. Thoracic trauma in children: an indicator of increased mortality. J Pediatr Surg 1990; 25:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29285/abstract/3\">",
"      Holmes JF, Sokolove PE, Brant WE, Kuppermann N. A clinical decision rule for identifying children with thoracic injuries after blunt torso trauma. Ann Emerg Med 2002; 39:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29285/abstract/4\">",
"      Allen GS, Cox CS Jr, Moore FA, et al. Pulmonary contusion: are children different? J Am Coll Surg 1997; 185:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29285/abstract/5\">",
"      Bonadio WA, Hellmich T. Post-traumatic pulmonary contusion in children. Ann Emerg Med 1989; 18:1050.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29285/abstract/6\">",
"      Fung YC, Yen RT, Tao ZL, Liu SQ. A hypothesis on the mechanism of trauma of lung tissue subjected to impact load. J Biomech Eng 1988; 110:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29285/abstract/7\">",
"      Ruddy RM. Trauma and the paediatric lung. Paediatr Respir Rev 2005; 6:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29285/abstract/8\">",
"      Gittelman MA, Gonzalez-del-Rey J, Brody AS, DiGiulio GA. Clinical predictors for the selective use of chest radiographs in pediatric blunt trauma evaluations. J Trauma 2003; 55:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29285/abstract/9\">",
"      Kwon A, Sorrells DL Jr, Kurkchubasche AG, et al. Isolated computed tomography diagnosis of pulmonary contusion does not correlate with increased morbidity. J Pediatr Surg 2006; 41:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29285/abstract/10\">",
"      Donnelly LF, Klosterman LA. Subpleural sparing: a CT finding of lung contusion in children. Radiology 1997; 204:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29285/abstract/11\">",
"      Allen GS, Cox CS Jr. Pulmonary contusion in children: diagnosis and management. South Med J 1998; 91:1099.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29285/abstract/12\">",
"      Bliss D, Silen M. Pediatric thoracic trauma. Crit Care Med 2002; 30:S409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29285/abstract/13\">",
"      Cullen ML. Pulmonary and respiratory complications of pediatric trauma. Respir Care Clin N Am 2001; 7:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29285/abstract/14\">",
"      Johannigman JA, Campbell RS, Davis K Jr, Hurst JM. Combined differential lung ventilation and inhaled nitric oxide therapy in the management of unilateral pulmonary contusion. J Trauma 1997; 42:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29285/abstract/15\">",
"      Fioretto JR, de Moraes MA, Bonatto RC, et al. Acute and sustained effects of early administration of inhaled nitric oxide to children with acute respiratory distress syndrome. Pediatr Crit Care Med 2004; 5:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29285/abstract/16\">",
"      Taylor RW, Zimmerman JL, Dellinger RP, et al. Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. JAMA 2004; 291:1603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29285/abstract/17\">",
"      Clark GC, Schecter WP, Trunkey DD. Variables affecting outcome in blunt chest trauma: flail chest vs. pulmonary contusion. J Trauma 1988; 28:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29285/abstract/18\">",
"      Davis SL, Furman DP, Costarino AT Jr. Adult respiratory distress syndrome in children: associated disease, clinical course, and predictors of death. J Pediatr 1993; 123:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29285/abstract/19\">",
"      Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342:1334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29285/abstract/20\">",
"      Haxhija EQ, N&ouml;res H, Schober P, H&ouml;llwarth ME. Lung contusion-lacerations after blunt thoracic trauma in children. Pediatr Surg Int 2004; 20:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29285/abstract/21\">",
"      Kishikawa M, Yoshioka T, Shimazu T, et al. Pulmonary contusion causes long-term respiratory dysfunction with decreased functional residual capacity. J Trauma 1991; 31:1203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29285/abstract/22\">",
"      Orliaguet G, Rakotoniaina S, Meyer P, et al. [Effect of a lung contusion on the prognosis of severe head injury in the child]. Ann Fr Anesth Reanim 2000; 19:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29285/abstract/23\">",
"      Leone M, Alban&egrave;se J, Rousseau S, et al. Pulmonary contusion in severe head trauma patients: impact on gas exchange and outcome. Chest 2003; 124:2261.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6562 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-197.136.42.3-1591A33FAF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_38_29285=[""].join("\n");
var outline_f28_38_29285=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PRIMARY EVALUATION AND MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Initial assessment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Diagnostic tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DEFINITIVE MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/16/10505?source=related_link\">",
"      Acute respiratory distress syndrome: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/15/29945?source=related_link\">",
"      Acute respiratory distress syndrome: Epidemiology; pathophysiology; pathology; and etiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/32/12807?source=related_link\">",
"      Chest wall injuries in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/12/7367?source=related_link\">",
"      Classification of trauma in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/59/41912?source=related_link\">",
"      Hypovolemic shock in children: Initial evaluation and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/63/27640?source=related_link\">",
"      Initial evaluation and stabilization of children with thoracic trauma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/48/25354?source=related_link\">",
"      Inpatient treatment of pneumonia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/26/3495?source=related_link\">",
"      Intrathoracic injuries in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/52/9033?source=related_link\">",
"      Novel therapies for the acute respiratory distress syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33768?source=related_link\">",
"      Overview of blunt abdominal trauma in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_38_29286="Cutaneous manifestations of gonorrhea";
var content_f28_38_29286=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Cutaneous manifestations of gonorrhea",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/38/29286/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/38/29286/contributors\">",
"     Abdul-Ghani Kibbi, MD, FACP, FAAD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/38/29286/contributors\">",
"     Ossama Abbas, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/38/29286/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/38/29286/contributors\">",
"     Ted Rosen, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/38/29286/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/38/29286/contributors\">",
"     Abena O Ofori, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?28/38/29286/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 20, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H3288287\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gonorrhea is a common bacterial sexually transmitted disease caused by infection with",
"    <em>",
"     Neisseria gonorrhoeae",
"    </em>",
"    , a Gram-negative aerobic diplococcus. Although gonorrhea primarily affects the mucosa, cutaneous manifestations also may occur, particularly in patients with disseminated gonococcal infection (DGI).",
"   </p>",
"   <p>",
"    Early diagnosis and treatment of gonorrhea is desirable, as untreated infection may result in pelvic inflammatory disease, chronic pelvic pain, ectopic pregnancy, or infertility, and may facilitate human immunodeficiency virus (HIV) transmission [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29286/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. The recognition of gonorrhea-related skin manifestations may assist with early diagnosis, thereby decreasing transmission of the disease and reducing the risk for complications.",
"   </p>",
"   <p>",
"    The clinical manifestations of primary cutaneous gonorrhea, secondary cutaneous gonorrhea, and disseminated gonococcemia will be reviewed here. The epidemiology, pathogenesis, extracutaneous manifestations, diagnosis, and management of gonococcal infection are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/20/38217?source=see_link\">",
"     \"Epidemiology, pathogenesis, and clinical manifestations of Neisseria gonorrhoeae infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/35/26166?source=see_link\">",
"     \"Diagnosis of gonococcal infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/3/19514?source=see_link\">",
"     \"Treatment of uncomplicated gonococcal infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/56/3976?source=see_link\">",
"     \"Disseminated gonococcal infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/34/39462?source=see_link\">",
"     \"Gonococcal infection in the newborn\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2414086\">",
"    <span class=\"h1\">",
"     BIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <em>",
"     Neisseria gonorrhoeae",
"    </em>",
"    is a Gram-negative, intracellular aerobic diplococcus that exclusively infects humans. The bacterium is capable of colonizing various mucosal surfaces including genitourinary, rectal, and pharyngeal sites. The outer membrane proteins and pili structures of",
"    <em>",
"     Neisseria gonorrhoeae",
"    </em>",
"    facilitate its attachment to host mucosal epithelial cells and allow for the penetration of the organism into the subepithelium [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29286/abstract/1,4,5\">",
"     1,4,5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/20/38217?source=see_link&amp;anchor=H21428192#H21428192\">",
"     \"Epidemiology, pathogenesis, and clinical manifestations of Neisseria gonorrhoeae infection\", section on 'Pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The presence of",
"    <em>",
"     Neisseria gonorrhoeae",
"    </em>",
"    in host tissue usually elicits an acute inflammatory response that can manifest clinically as purulent discharge, epithelial sloughing, or abscess formation. Infrequently, hematologic dissemination occurs. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/56/3976?source=see_link\">",
"     \"Disseminated gonococcal infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Gonorrheal infection is highly transmissible, with an infectious risk per contact estimated at 20 to 50 percent for men and 60 to 90 percent for women [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29286/abstract/1\">",
"     1",
"    </a>",
"    ]. The incubation period is usually between two and five days, but initial signs of infection may occur up to two weeks after transmission.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3288294\">",
"    <span class=\"h1\">",
"     CUTANEOUS MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cutaneous lesions related to gonorrheal infection may occur as results of direct inoculation (primary cutaneous gonorrhea), primary mucosal infections (secondary cutaneous gonorrhea), or disseminated disease (disseminated gonococcal infection). The features of these clinical presentations are reviewed below. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/20/38217?source=see_link&amp;anchor=H5248334#H5248334\">",
"     \"Epidemiology, pathogenesis, and clinical manifestations of Neisseria gonorrhoeae infection\", section on 'Clinical manifestations in women'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/20/38217?source=see_link&amp;anchor=H5248641#H5248641\">",
"     \"Epidemiology, pathogenesis, and clinical manifestations of Neisseria gonorrhoeae infection\", section on 'Clinical manifestations in men'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3288303\">",
"    <span class=\"h2\">",
"     Primary cutaneous gonorrhea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary cutaneous gonorrhea may occur in genital or extragenital sites. Because the clinical features are nonspecific, recognition of these lesions as manifestations of gonorrhea requires a high index of clinical suspicion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H385298\">",
"    <span class=\"h3\">",
"     Extragenital",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extragenital primary cutaneous gonorrhea is rare. It is usually preceded by a history of cutaneous trauma, which likely facilitates entry of the organism into the nonmucosal skin [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29286/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]. A variety of clinical presentations have been described in the literature, including herpetiform or non-herpetiform digital pustules, abscesses, chancriform lesions, and suprapubic ecthyma [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29286/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]. As an example, digital pustules with lymphangitis and regional lymphadenopathy have developed following contact with contaminated laboratory equipment [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29286/abstract/1\">",
"     1",
"    </a>",
"    ]. In addition, a neonatal scalp abscess has occurred after the use of a fetal monitor contaminated by maternal cervical infection [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29286/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2414114\">",
"    <span class=\"h3\">",
"     Genital",
"    </span>",
"    &nbsp;&mdash;&nbsp;Though not as rare as extragenital primary cutaneous gonorrhea, primary gonorrhea of the genital skin is uncommon. It most frequently occurs in the clinical absence of signs or symptoms of urethral or cervical infection, although concomitant involvement of these sites may occur [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29286/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. Unlike extragenital primary cutaneous gonorrhea, a preceding history of trauma (aside from normal sexual activity) is usually absent.",
"   </p>",
"   <p>",
"    Potential clinical features of this variant include penile erythematous 1 to 2 mm pustules, fluctuant furuncle-like nodules up to 2 cm in diameter, indurated abscesses, shallow erosions several millimeters in diameter, and punched-out, indurated ulcers of varying size (",
"    <a class=\"graphic graphic_picture graphicRef58116 \" href=\"UTD.htm?43/24/44417\">",
"     picture 1",
"    </a>",
"    ). In men, involvement of the ventral penoscrotal raphe is common.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3288310\">",
"    <span class=\"h2\">",
"     Secondary cutaneous gonorrhea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cutaneous involvement in gonorrhea may occur in association with genitourinary, anorectal, or pharyngeal infections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2414266\">",
"    <span class=\"h3\">",
"     Genital",
"    </span>",
"    &nbsp;&mdash;&nbsp;Genitourinary gonococcal infections tend to be more symptomatic in men (90 percent) than women (50 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29286/abstract/10-12\">",
"     10-12",
"    </a>",
"    ]. In addition to the dysuria and the spontaneous profuse and purulent penile discharge that typically characterizes gonococcal urethritis in men [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29286/abstract/10\">",
"     10",
"    </a>",
"    ], edema and erythema commonly develop at the urethral meatus and less frequently occur on the glans or foreskin (",
"    <a class=\"graphic graphic_picture graphicRef77674 graphicRef68498 graphicRef54221 \" href=\"UTD.htm?23/13/23770\">",
"     picture 2A-C",
"    </a>",
"    ). In severe cases, phimosis may occur. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/20/38217?source=see_link&amp;anchor=H5248641#H5248641\">",
"     \"Epidemiology, pathogenesis, and clinical manifestations of Neisseria gonorrhoeae infection\", section on 'Clinical manifestations in men'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In women the cervix is the primary site of infection, and although many women are asymptomatic, symptoms such as dysuria, dyspareunia, blood-tinged vaginal discharge, and intercourse-induced vaginal bleeding may occur [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29286/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. Infrequently, involvement of the genital skin may develop due to spread of the infection, manifesting as 1 to 2 mm pustules, tender fluctuant nodules, or small ulcers. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/20/38217?source=see_link&amp;anchor=H5248334#H5248334\">",
"     \"Epidemiology, pathogenesis, and clinical manifestations of Neisseria gonorrhoeae infection\", section on 'Clinical manifestations in women'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Infection of the glandular structures of the genital mucosa may also result in cutaneous lesions. Invasion of",
"    <em>",
"     Neisseria gonorrhoeae",
"    </em>",
"    into Tyson&rsquo;s or Cowper&rsquo;s glands in men or Bartholin or Skene&rsquo;s glands in women occasionally presents with inflammatory papules or pustules on the genital skin [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29286/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2414273\">",
"    <span class=\"h3\">",
"     Anal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anorectal infections may result from anal intercourse or may occur secondary to perianal contamination from cervical infections in women, and are often asymptomatic [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29286/abstract/10-12\">",
"     10-12",
"    </a>",
"    ]. When symptoms are present, anal pruritus is the primary cutaneous finding with occasional secondary erythema and lichenification. Other potential manifestations of anorectal infection include rectal discharge, painful bowel movements, and bloody stools. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/20/38217?source=see_link&amp;anchor=H5248357#H5248357\">",
"     \"Epidemiology, pathogenesis, and clinical manifestations of Neisseria gonorrhoeae infection\", section on 'Anorectal infection and proctitis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/20/38217?source=see_link&amp;anchor=H5248686#H5248686\">",
"     \"Epidemiology, pathogenesis, and clinical manifestations of Neisseria gonorrhoeae infection\", section on 'Proctitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H385938\">",
"    <span class=\"h3\">",
"     Oral",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rarely, small oral ulcers and mucosal erythema may occur in patients with pharyngeal gonorrheal infection [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29286/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/20/38217?source=see_link&amp;anchor=H5248365#H5248365\">",
"     \"Epidemiology, pathogenesis, and clinical manifestations of Neisseria gonorrhoeae infection\", section on 'Oropharyngeal infection'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/20/38217?source=see_link&amp;anchor=H5248693#H5248693\">",
"     \"Epidemiology, pathogenesis, and clinical manifestations of Neisseria gonorrhoeae infection\", section on 'Pharyngitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3288317\">",
"    <span class=\"h2\">",
"     Disseminated gonococcal infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disseminated gonococcal infection (DGI) occurs in less than 3 percent of patients with gonorrhea. DGI is divided into two clinical syndromes: tenosynovitis-dermatitis syndrome (triad of dermatitis, tenosynovitis, and polyarthralgias without purulent arthritis) and purulent arthritis syndrome without associated skin lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29286/abstract/1,14-16\">",
"     1,14-16",
"    </a>",
"    ]. Patients with features of both syndromes have been observed, and thus, these variants are often considered to be on the ends of a continuous spectrum. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/56/3976?source=see_link&amp;anchor=H6#H6\">",
"     \"Disseminated gonococcal infection\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2414284\">",
"    <span class=\"h3\">",
"     Tenosynovitis, dermatitis, polyarthralgia syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tenosynovitis, dermatitis, polyarthralgia syndrome is characterized by the triad of oligoarthralgia, tenosynovitis, and dermatitis. In addition, constitutional symptoms such as fever, chills, and generalized malaise occur during the acute stage of illness [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29286/abstract/1,16\">",
"     1,16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/56/3976?source=see_link&amp;anchor=H6#H6\">",
"     \"Disseminated gonococcal infection\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cutaneous involvement occurs in 60 to 90 percent of patients with tenosynovitis, dermatitis, polyarthralgia syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29286/abstract/1,14-16\">",
"     1,14-16",
"    </a>",
"    ]. Skin lesions are believed to arise secondary to bacterial embolization and the formation of cutaneous microabscesses. Patients develop pinpoint petechial macules that progress to form papules, pustules, vesicles, or bullae, which may become hemorrhagic or necrotic (",
"    <a class=\"graphic graphic_picture graphicRef71303 graphicRef59399 graphicRef69978 graphicRef56764 graphicRef82060 \" href=\"UTD.htm?41/37/42586\">",
"     picture 3A-E",
"    </a>",
"    ). The hemorrhagic vesicles or pustules, approximately 2 to 5 mm in diameter, are considered to be a characteristic finding [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29286/abstract/1,14-16\">",
"     1,14-16",
"    </a>",
"    ]. Lesions in an individual patient may be in multiple stages of evolution.",
"   </p>",
"   <p>",
"    Cutaneous lesions are most likely to occur on the dorsal surfaces of the distal extremities near joints. Involvement of the trunk, scalp, or face is exceptionally rare. Usually 2 to 10 asymptomatic lesions are present; infrequently, patients develop more than 40 lesions.",
"   </p>",
"   <p>",
"    Unlike joint involvement, which usually progresses without treatment, skin lesions are often transient, lasting only for three to four days even without treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29286/abstract/1,16\">",
"     1,16",
"    </a>",
"    ]. The lesions heal without scarring. Rarely, urticarial, target-like, erythema nodosum-like, or vasculitic lesions occur [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29286/abstract/17,18\">",
"     17,18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2414454\">",
"    <span class=\"h3\">",
"     Purulent arthritis syndrome without skin lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Purulent arthritis syndrome without skin lesions usually follows untreated tenosynovitis, dermatitis, polyarthralgia syndrome and is typified by suppurative arthritis, which results in pain, redness, swelling, and decreased range of motion of one or several joints. The knees, wrists, and ankles are most commonly affected [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29286/abstract/1,16\">",
"     1,16",
"    </a>",
"    ]. Rarely, skin lesions similar to those observed in DGI are seen, supporting the concept that these disorders may represent two ends of a spectrum.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2416262\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The accurate diagnosis of gonorrheal infection requires a thorough patient history, physical examination, and laboratory studies. Laboratory tests utilized for diagnosis include microscopy, culture, and nucleic acid amplification tests. The diagnosis of genitourinary, anorectal, and pharyngeal gonococcal infection is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/35/26166?source=see_link\">",
"     \"Diagnosis of gonococcal infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients with suspected DGI, in addition to cultures of blood and synovial fluid, cultures should be performed on skin lesions via swabbing of pustules or from tissue specimens if pustules are not present [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29286/abstract/1\">",
"     1",
"    </a>",
"    ]. Only 10 to 20 percent of skin cultures are positive in patients with cutaneous lesions of DGI; however, culture results may be useful for identifying other infectious causes. The diagnosis of DGI is discussed in greater detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/56/3976?source=see_link&amp;anchor=H9#H9\">",
"     \"Disseminated gonococcal infection\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The diagnostic utility of laboratory investigations in primary cutaneous gonorrhea has not been specifically studied. Diagnosis of primary cutaneous gonorrhea via Gram stain and culture of spontaneous or expressible purulent drainage from pustules or furuncular lesions has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29286/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In general, a presumptive clinical diagnosis of gonorrhea warrants therapy while the results of laboratory investigations are pending.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3288324\">",
"    <span class=\"h2\">",
"     Histopathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The histopathological findings in cutaneous gonorrhea are typically nonspecific, limiting the use of skin biopsy for diagnosis. The epidermis may show mild spongiosis, intraepidermal vesiculation, exocytosis of neutrophils, pustulation, or necrosis. In the dermis, features of leukocytoclastic vasculitis with associated microthrombi within blood vessels are usually present [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29286/abstract/1,19-21\">",
"     1,19-21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The detection of diplococci on tissue Gram stain from lesions in DGI is rare. When found, bacteria are typically located in the walls and lumina of cutaneous vessels or within the dermal inflammatory infiltrate. Pustular lesions of primary cutaneous gonorrhea are much more likely to demonstrate diplococci on histopathologic examination [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29286/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Gonococcal antigens may be detected using direct immunofluorescence in more than 50 percent of cases of DGI [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29286/abstract/19-21\">",
"     19-21",
"    </a>",
"    ]. However, direct immunofluorescence is not typically performed due to the presence of more highly specific and sensitive nucleic acid amplification tests (such as polymerase chain reaction [PCR]) that may be able to detect even the presence of one organism. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/35/26166?source=see_link\">",
"     \"Diagnosis of gonococcal infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3288331\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cutaneous manifestations of gonorrheal infection are not pathognomonic. Thus, multiple other disorders share similar clinical features. Other cutaneous bacterial infections may present with pustules or furuncles similar to those seen in primary cutaneous gonorrhea, and the possibility of syphilis, herpes simplex, donovanosis, lymphogranuloma venereum, and noninfectious disorders (such as Beh&ccedil;et's syndrome) must be considered in patients who present with genital ulcers.",
"   </p>",
"   <p>",
"    The acral hemorrhagic pustules of DGI should be distinguished from the acral Janeway lesions and Osler nodes that may occur in infective endocarditis and the hemorrhagic petechiae or pustules that can occur in the setting of meningococcemia. Unlike DGI, frank arthritis and tenosynovitis are usually absent in meningococcemia. The possibility of infective endocarditis is suggested by the presence of additional clinical findings such as a new-onset heart murmur or splinter hemorrhages on the nails. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/52/37704?source=see_link\">",
"     \"Clinical manifestations of meningococcal infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/24/41352?source=see_link\">",
"     \"Diagnostic approach to infective endocarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The differential diagnosis of DGI is discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/56/3976?source=see_link&amp;anchor=H13#H13\">",
"     \"Disseminated gonococcal infection\", section on 'Differential diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Anal pruritus in anorectal gonorrhea can be easily mistaken for contact dermatitis, candidiasis, nonspecific intertrigo, lymphogranuloma venereum in homosexual men, and other disorders. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/48/15110?source=see_link&amp;anchor=H3#H3\">",
"     \"Approach to the patient with anal pruritus\", section on 'Etiology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2416288\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of gonococcal infections is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/3/19514?source=see_link\">",
"     \"Treatment of uncomplicated gonococcal infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/56/3976?source=see_link&amp;anchor=H20#H20\">",
"     \"Disseminated gonococcal infection\", section on 'Evaluation and management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3288345\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Gonorrhea is a common sexually transmitted disorder that primarily infects mucosal surfaces. Cutaneous lesions may occur as a result of direct inoculation, as a secondary feature of mucosal infection, or as a manifestation of disseminated disease. (See",
"      <a class=\"local\" href=\"#H3288287\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Primary cutaneous gonorrhea may occur in genital or extragenital sites. Pustules, abscess, erosions, or ulcers may develop as a result of direct inoculation. (See",
"      <a class=\"local\" href=\"#H3288303\">",
"       'Primary cutaneous gonorrhea'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Depending on the site or primary infection, secondary cutaneous gonorrhea may manifest with features such as inflammation of the genital skin, anal pruritus, or oral ulcers. (See",
"      <a class=\"local\" href=\"#H3288310\">",
"       'Secondary cutaneous gonorrhea'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cutaneous lesions frequently occur in patients with the tenosynovitis, dermatitis, polyarthralgia syndrome of disseminated gonococcal infection (DGI). Acral hemorrhagic vesicles or pustules are a characteristic finding of this variant of gonorrhea. Patients typically have only 2 to 10 skin lesions. (See",
"      <a class=\"local\" href=\"#H3288317\">",
"       'Disseminated gonococcal infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinical findings of cutaneous lesions in patients with gonorrhea are nonspecific. The combination of a thorough patient history, a physical examination, and laboratory studies are beneficial for diagnosis. (See",
"      <a class=\"local\" href=\"#H2416262\">",
"       'Diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3288331\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29286/abstract/1\">",
"      Ghosn SH, Kibbi AG. Cutaneous gonococcal infections. Clin Dermatol 2004; 22:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29286/abstract/2\">",
"      Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993; 7:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29286/abstract/3\">",
"      Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet 1997; 349:1868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29286/abstract/4\">",
"      Hook EW 3rd, Holmes KK. Gonococcal infections. Ann Intern Med 1985; 102:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29286/abstract/5\">",
"      Alcorn TM, Cohen MS. Gonococcal pathogenesis: Adaptation and immune evasion in the human host. Curr Opin Infect Dis 1994; 7:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29286/abstract/6\">",
"      Rosen T. Unusual presentations of gonorrhea. J Am Acad Dermatol 1982; 6:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29286/abstract/7\">",
"      Scott MJ Jr, Scott MJ Sr. Primary cutaneous Neisseria gonorrhoeae infections. Arch Dermatol 1982; 118:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29286/abstract/8\">",
"      Siboulet AC, Majewski E. Manifestation Cutane&acute;es de la gonococcie. Nouveaux Aspects. Chancre cutane&acute; gonococcique. Bull Soc Fr Dermatol Syphilol 1974; 81:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29286/abstract/9\">",
"      Varady E, Nsanze H, Slattery T. Gonococcal scalp abscess in a neonate delivered by caesarean section. Sex Transm Infect 1998; 74:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29286/abstract/10\">",
"      Sherrard J, Barlow D. Gonorrhoea in men: clinical and diagnostic aspects. Genitourin Med 1996; 72:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29286/abstract/11\">",
"      McNeeley SG Jr. Gonococcal infections in women. Obstet Gynecol Clin North Am 1989; 16:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29286/abstract/12\">",
"      Stansfield VA. Diagnosis and management of anorectal gonorrhoea in women. Br J Vener Dis 1980; 56:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29286/abstract/13\">",
"      Bruce AJ, Rogers RS 3rd. Oral manifestations of sexually transmitted diseases. Clin Dermatol 2004; 22:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29286/abstract/14\">",
"      Brown TJ, Yen-Moore A, Tyring SK. An overview of sexually transmitted diseases. Part I. J Am Acad Dermatol 1999; 41:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29286/abstract/15\">",
"      Martin DH, Mroczkowski TF. Dermatologic manifestations of sexually transmitted diseases other than HIV. Infect Dis Clin North Am 1994; 8:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29286/abstract/16\">",
"      O'Brien JP, Goldenberg DL, Rice PA. Disseminated gonococcal infection: a prospective analysis of 49 patients and a review of pathophysiology and immune mechanisms. Medicine (Baltimore) 1983; 62:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29286/abstract/17\">",
"      Ostlere LS, Harris D, Johnson M, Rustin MH. Gastrointestinal and cutaneous vasculitis associated with gonococcal infection in an HIV-seropositive patient. J Am Acad Dermatol 1993; 29:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29286/abstract/18\">",
"      Mastrolonardo M, Loconsole F, Conte A, Rantuccio F. Cutaneous vasculitis as the sole manifestation of disseminated gonococcal infection: case report. Genitourin Med 1994; 70:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29286/abstract/19\">",
"      Shapiro L, Teisch JA, Brownstein MH. Dermatohistopathology of chronic gonococcal sepsis. Arch Dermatol 1973; 107:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29286/abstract/20\">",
"      Barr J, Danielsson D. Septic gonococcal dermatitis. Br Med J 1971; 1:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29286/abstract/21\">",
"      Kahn G, Danielsson D. Septic gonococcal dermatitis. Demonstration of gonococci and gonococcal antigens in skin lesions by immunofluorescence. Arch Dermatol 1969; 99:421.",
"     </a>",
"    </li>",
"    <li>",
"     Weedon D. Bacterial and rickettsial infections. In: Weedon's Skin Pathology, 3rd, Elsevier Limited, 2010. p.547.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15867 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-122.72.76.133-BCBD45DDC8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_38_29286=[""].join("\n");
var outline_f28_38_29286=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H3288345\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3288287\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2414086\">",
"      BIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3288294\">",
"      CUTANEOUS MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3288303\">",
"      Primary cutaneous gonorrhea",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H385298\">",
"      - Extragenital",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2414114\">",
"      - Genital",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3288310\">",
"      Secondary cutaneous gonorrhea",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2414266\">",
"      - Genital",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2414273\">",
"      - Anal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H385938\">",
"      - Oral",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3288317\">",
"      Disseminated gonococcal infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2414284\">",
"      - Tenosynovitis, dermatitis, polyarthralgia syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2414454\">",
"      - Purulent arthritis syndrome without skin lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2416262\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3288324\">",
"      Histopathology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3288331\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2416288\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3288345\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/15867\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/15867|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?43/24/44417\" title=\"picture 1\">",
"      Gonorrhea penile ulcer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?18/31/18929\" title=\"picture 2A\">",
"      Gonorrhea and penile discharge",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?32/61/33750\" title=\"picture 2B\">",
"      Gonorrhea penis edema and discharge",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/42/43682\" title=\"picture 2C\">",
"      Gonorrhea penile edema",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?18/49/19219\" title=\"picture 3A\">",
"      Gonococcal skin lesion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?40/27/41407\" title=\"picture 3B\">",
"      Disseminated gonorrhea skin lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?26/23/26996\" title=\"picture 3C\">",
"      Disseminated gonorrhea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?32/43/33459\" title=\"picture 3D\">",
"      Gonorrhea hemorrhagic bulla",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?40/2/40998\" title=\"picture 3E\">",
"      Gonorrhea purpura",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/48/15110?source=related_link\">",
"      Approach to the patient with anal pruritus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/52/37704?source=related_link\">",
"      Clinical manifestations of meningococcal infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/35/26166?source=related_link\">",
"      Diagnosis of gonococcal infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/24/41352?source=related_link\">",
"      Diagnostic approach to infective endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/56/3976?source=related_link\">",
"      Disseminated gonococcal infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/20/38217?source=related_link\">",
"      Epidemiology, pathogenesis, and clinical manifestations of Neisseria gonorrhoeae infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/34/39462?source=related_link\">",
"      Gonococcal infection in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/3/19514?source=related_link\">",
"      Treatment of uncomplicated gonococcal infections",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_38_29287="Epidemiology, pathophysiology and clinical manifestations of diphtheria";
var content_f28_38_29287=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Epidemiology, pathophysiology and clinical manifestations of diphtheria",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/38/29287/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/38/29287/contributors\">",
"     Luis F Barroso, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/38/29287/contributors\">",
"     P Samuel Pegram, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/38/29287/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/38/29287/contributors\">",
"     Daniel J Sexton, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/38/29287/contributors\">",
"     Sheldon L Kaplan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/38/29287/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/38/29287/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?28/38/29287/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 15, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diphtheria is an infectious disease caused by the gram-positive bacillus Corynebacterium diphtheriae. Infection may lead to respiratory disease, cutaneous disease or an asymptomatic carrier state. The word diphtheria comes from the Greek word for leather, which refers to the tough pharyngeal membrane that is the clinical hallmark of infection. Rarely, a similar disease can be caused by other Corynebacterium species: C. ulcerans, C. hemolyticum, and C. pseudotuberculosis.",
"   </p>",
"   <p>",
"    The epidemiology, pathophysiology, and clinical manifestations of diphtheria will be reviewed here. The diagnosis, treatment, and prevention are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/50/11046?source=see_link\">",
"     \"Diagnosis and treatment of diphtheria\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/56/39818?source=see_link&amp;anchor=H19#H19\">",
"     \"Standard immunizations for children and adolescents\", section on 'Diphtheria, tetanus, and/or pertussis vaccines'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/54/7014?source=see_link\">",
"     \"Tetanus-diphtheria toxoid vaccination in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9250687\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are at least four biotypes of Corynebacterium diphtheriae: gravis, intermedius, mitis, and belfanti. All biotypes have been associated with both endemic and epidemic diphtheria, although in general, mitis strains are less toxigenic and cause less severe disease [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The primary modes of spread consist of close contact with infectious material from respiratory secretions (direct or via airborne droplet) or from skin lesions. Humans are believed to be the only known reservoir for C. diphtheriae, although transmission of C. ulcerans via cow&rsquo;s milk has been observed [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Infection may occur throughout the year with a peak incidence in the colder months.",
"   </p>",
"   <p>",
"    Asymptomatic carriers are important for transmission of diphtheria. Immunity (either via natural infection or vaccine-induced) does not prevent carriage [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. In areas of endemicity, up to 5 percent of healthy individuals may have positive pharyngeal cultures [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the pre-vaccine era, diphtheria was a major cause of morbidity and mortality worldwide, primarily affecting children under the age of 15 [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/7\">",
"     7",
"    </a>",
"    ]. Until the beginning of the 20th century, as many as 10 percent of American children developed clinical diphtheria, and a significant number died from its complications (case fatality rate of 5 to 10 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/8\">",
"     8",
"    </a>",
"    ]. By adolescence, 70 to 80 percent of the urban population was immune to diphtheria from natural infection [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    During the 1930s and 1940s, diphtheria was virtually eliminated in many developed countries following the introduction of routine childhood vaccination with diphtheria toxoid. As a result of vaccination, toxigenic strains of C. diphtheriae lose the selective advantage conferred by the tox+ gene and are less prevalent [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/10\">",
"     10",
"    </a>",
"    ]. As the general population becomes immune, there are fewer cases of clinical diphtheria (from toxigenic strains) and less asymptomatic colonization with toxigenic strains and therefore decreased transmission to non-immune people. However, there does not appear to be any reduction in the prevalence of carriers of non-toxigenic C. diphtheriae [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/11\">",
"     11",
"    </a>",
"    ]. Immunized individuals can develop clinical diphtheria, although disease is less severe and occurs less frequently.",
"   </p>",
"   <p>",
"    Diphtheria is reappearing in some regions. In countries experiencing a resurgence of diphtheria, epidemics have involved children as well as insufficiently immunized adults [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/12,13\">",
"     12,13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9250694\">",
"    <span class=\"h2\">",
"     Developed countries",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since the availability of vaccination, respiratory diphtheria has remained rare in developed countries. However, approximately 20 to 60 percent of adults are susceptible to diphtheria because of waning vaccine-induced immunity and failure to receive booster immunization [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]. Among 1000 British adults who underwent evaluation of serum",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/15/21745?source=see_link\">",
"     diphtheria antitoxin",
"    </a>",
"    titers, 38 percent were susceptible to diphtheria (serum diphtheria antitoxin concentration below 0.01",
"    <span class=\"nowrap\">",
"     IU/mL);",
"    </span>",
"    31 percent had basic protection; and only 31 percent were fully protected [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/14\">",
"     14",
"    </a>",
"    ]. Similarly, in a large US serologic survey, immunity among adults over the age of 60 years was 30 percent; immunity among children between the ages of 6 and 11 years was 91 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/16\">",
"     16",
"    </a>",
"    ]. The CDC recommends that adults receive a diphtheria-toxoid-containing vaccine (Tdap) every 10 years after completing a primary childhood vaccination series [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite incomplete immunity, the rate of clinical disease is low because immunization has minimized the transmission of toxigenic strains; since 1980, the US incidence has been approximately 0.001 cases per 100,000 population [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/18\">",
"     18",
"    </a>",
"    ]. If toxigenic strains became widely disseminated again, the incidence could increase. The last major American outbreak of diphtheria occurred in Seattle in the 1970s [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    C. ulcerans is a rare cause of respiratory illness that resembles diphtheria. It has been reported predominantly in industrialized countries, which may be due in part to detection bias [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/20-23\">",
"     20-23",
"    </a>",
"    ]. Isolated cases of diphtheria-like illness due to C. ulcerans were reported in the United States in 2008 and 2010 [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. Like C. diphtheria, C. ulcerans can produce diphtheria toxin and lead to life-threatening disease that requires urgent treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/15/21745?source=see_link\">",
"     diphtheria antitoxin",
"    </a>",
"    and macrolide antibiotics. However, unlike C. diphtheriae, C. ulcerans is a zoonotic illness; evidence for human-to-to human transmission is limited.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9251138\">",
"    <span class=\"h3\">",
"     Former Soviet Union",
"    </span>",
"    &nbsp;&mdash;&nbsp;An epidemic of diphtheria spread throughout the newly independent states (NIS) of the former Soviet Union in the 1990s [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. Between 1990 and 1998, more than 80 percent of all cases of diphtheria in the world were reported from the former Soviet Union; more than 157,000 cases were registered with the World Health Organization (WHO) from NIS, with 5000 deaths [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/26\">",
"     26",
"    </a>",
"    ]. Factors contributing to the spread of the epidemic included shortages of antibiotics, antitoxin, and vaccine (resulting in the presence of a susceptible child and adult population), socioeconomic instability, population movement, and a deteriorating health infrastructure.",
"   </p>",
"   <p>",
"    Several other European countries have experienced outbreaks, often characterized by high case fatality rates, a large proportion of patients with complications, and a high percentage of cases in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9250701\">",
"    <span class=\"h2\">",
"     Developing countries",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diphtheria remains a serious disease throughout much of the world. Areas of endemicity include Africa (Algeria, Egypt, and the countries in sub-Saharan region), the Americas (Brazil, Colombia, Dominican Republic, Ecuador, Haiti, and Paraguay), Asia (Afghanistan, Bangladesh, Bhutan, Cambodia, China, India, Indonesia, Laos, Mongolia, Burma [Myanmar], Nepal, Pakistan, Papua New Guinea, Philippines, Thailand, and Vietnam), the Middle East (Iran, Iraq, Syria and Yemen), and Europe (Turkey, Albania, and all countries of the former Soviet Union) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/28,29\">",
"     28,29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Close contacts of unvaccinated or inadequately vaccinated travelers to endemic areas are also at risk for infection. For example, a case of respiratory diphtheria was reported in 2004 in a 60 year old Haitian-born Massachusetts resident with unknown vaccination status against diphtheria with no recent travel [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/30\">",
"     30",
"    </a>",
"    ]. The patient presented with fever and respiratory symptoms and was misdiagnosed with streptococcal pharyngitis based on a rapid antigen test. The throat culture yielded toxigenic C. diphtheriae. Her asymptomatic spouse also had a throat culture positive for toxigenic diphtheria, and two months earlier had traveled to an area of Haiti where cases of diphtheria had been reported.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptomatic diphtherial infection results from localized inflammation of the respiratory tract or skin, as well as local and systemic effects of a potent diphtheria exotoxin.",
"   </p>",
"   <p>",
"    Exotoxin production depends on the presence of a lysogenic bacteriophage that carries the gene encoding for toxin (tox+) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/24,31\">",
"     24,31",
"    </a>",
"    ]. The toxin has a total of three domains. One domain is present in fragment A (the catalytic unit), and the remaining two domains are in fragment B: one for receptor binding and one that may participate in membrane insertion and translocation [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Diphtheria toxin acts inside the cells, where it causes cell death by inactivating elongation factor 2 [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/33\">",
"     33",
"    </a>",
"    ]. The toxin binds to a membrane receptor providing a mechanism of cell entry [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. Diphtheria toxin exploits a growth factor precursor as a receptor: diphtheria toxin receptor appears to be identical to the precursor of a heparin-binding epidermal growth factor-like growth factor [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Respiratory diphtheria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Respiratory diphtheria is typically caused by toxin-producing strains of C. diphtheriae; rarely, it is caused by toxigenic strains of other Corynebacterium species (C. ulcerans, C. hemolyticum, or C. pseudotuberculosis) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/35\">",
"     35",
"    </a>",
"    ]. Symptoms typically begin two to five days after infection. In addition to respiratory symptoms, absorption and dissemination of diphtheria toxin can lead to toxin damage of the heart (myocarditis), nervous system, and kidneys.",
"   </p>",
"   <p>",
"    The onset of symptoms is typically gradual; the most common presenting symptoms are sore throat, malaise, cervical lymphadenopathy, and low grade fever. The earliest pharyngeal finding is mild erythema, which can progress to isolated spots of gray and white exudate. In at least one-third of cases, local elaboration of toxin induces the formation of a coalescing pseudomembrane (composed of necrotic fibrin, leukocytes, erythrocytes, epithelial cells, and organisms) (",
"    <a class=\"graphic graphic_picture graphicRef52701 \" href=\"UTD.htm?21/31/22003\">",
"     picture 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef51058 \" href=\"UTD.htm?2/20/2369\">",
"     picture 2",
"    </a>",
"    ). This membrane adheres tightly to the underlying tissue and bleeds with scraping.",
"   </p>",
"   <p>",
"    This membrane can extend to any portion of the respiratory tract from the nasal passages to the tracheobronchial tree. Up to two-thirds of cases are tonsillopharyngeal; involvement of the laryngeal, nasal, and tracheobronchial areas is less common [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/36\">",
"     36",
"    </a>",
"    ]. Systemic toxicity increases as the pseudomembrane spreads from the tonsillopharyngeal area. A form of malignant diphtheria is associated with extensive \"membranous pharyngitis\" plus massive swelling of the tonsils, uvula, cervical lymph nodes, submandibular region, and anterior neck (the so-called \"bull neck\" of toxic diphtheria). In such cases, respiratory stridor may ensue, leading to respiratory insufficiency and death. In addition, aspiration of the membrane can lead to suffocation.",
"   </p>",
"   <p>",
"    In untreated patients, the infectious period begins at symptom onset and lasts for two weeks in the majority of patients; in some cases, it can last as long as six weeks. In patients treated with appropriate antibiotics, the infectious period usually lasts less than four days.",
"   </p>",
"   <p>",
"    Other respiratory tract symptoms vary with the site of involvement:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with nasal diphtheria usually experience mild disease and present with a",
"      <span class=\"nowrap\">",
"       serosanguineous/purulent",
"      </span>",
"      nasal discharge, which can cause mild irritation of the external nares and upper lip.",
"     </li>",
"     <li>",
"      Laryngeal diphtheria often presents with hoarseness and cough. The larynx may be the only site of infection (laryngoscopy will demonstrate a laryngeal pseudomembrane) or may be part of a continuum of respiratory tract involvement.",
"     </li>",
"     <li>",
"      Tracheobronchial infection usually develops secondary to membrane spread, and may result in respiratory compromise, especially in children who have small airways.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Corynebacterium diphtheriae may be cultured from mucous membranes or skin from asymptomatic carriers, who are an important reservoir for the organism in endemic areas.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Systemic manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Absorption and dissemination of diphtheria toxin can lead to toxin damage of the heart (myocarditis), nervous system, and kidneys. In one retrospective study of 676 patients hospitalized with diphtheria in the Kyrgyz Republic, 30 percent had severe forms including 22 percent with myocarditis; 28 percent had exclusively tonsillar disease [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/37\">",
"     37",
"    </a>",
"    ]. A report from Finland noted a 28 percent incidence of cardiac involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The risk of developing cardiac",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    neurologic toxicity is proportional to the severity of local infection. Myocarditis (as evidenced by electrocardiographic changes such as ST-T wave changes, QTc prolongation,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    first-degree heart block) can be detected in up to two-thirds of cases. The onset typically begins as local respiratory symptoms are improving [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/38,39\">",
"     38,39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinically evident cardiac dysfunction (decreased heart sounds, gallop rhythm, cardiac dilatation, dyspnea) occurs in 10 to 25 percent of patients with diphtheria [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/40\">",
"     40",
"    </a>",
"    ]. Severe myocarditis is manifested by complex heart blocks and arrhythmias, heart failure, and circulatory collapse. Patients should be monitored with serial electrocardiograms and measurements of cardiac enzymes that reflect the intensity of myocardial damage. Cardiac complications are a major cause of mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/41\">",
"     41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/50/11046?source=see_link&amp;anchor=H14#H14\">",
"     \"Diagnosis and treatment of diphtheria\", section on 'Prognosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The time course for onset of myocarditis is variable; it typically occurs 7 to 14 days after the onset of respiratory symptoms. In one cohort, severe pseudomembrane and the &ldquo;bull neck&rdquo; of diphtheria preceded cardiomyopathy with positive predictive value of approximately 80 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/42\">",
"     42",
"    </a>",
"    ]. The presence of myocarditis is a poor prognostic factor; in one cohort of children in India, it was the strongest predictor of mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Neurologic toxicity occurs in approximately 5 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/37\">",
"     37",
"    </a>",
"    ]. Neurological toxicity is unusual in patients with mild disease, but it may develop in up to 75 percent of patients with severe diphtheria. Local neuropathies (paralysis of the soft palate and posterior pharyngeal wall) are followed by cranial neuropathies (usually oculomotor and ciliary, followed by facial or laryngeal paralyses) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/43\">",
"     43",
"    </a>",
"    ]. Peripheral neuritis develops weeks to months later and can span the clinical spectrum from mild weakness to total paralysis. The severity of disease correlates with the severity of membrane formation (and therefore toxin production) as well as the time between the onset of symptoms and administration of antitoxin [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Renal failure from direct toxin activity or hypotension may occur in severe cases.",
"   </p>",
"   <p>",
"    Non-toxigenic C. diphtheriae strains have been implicated in cases of endocarditis, mycotic aneurysms, osteomyelitis, and septic arthritis [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/44-46\">",
"     44-46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Cutaneous diphtheria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cutaneous diphtheria can be caused by toxigenic and non-toxigenic strains of C. diphtheriae, though systemic toxicity is rare. Cutaneous diphtheria is characterized by chronic, nonhealing sores or shallow ulcers with a dirty gray membrane; the appearance is fairly non-specific (",
"    <a class=\"graphic graphic_picture graphicRef53408 \" href=\"UTD.htm?15/27/15797\">",
"     picture 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef63145 \" href=\"UTD.htm?16/23/16755\">",
"     picture 4",
"    </a>",
"    ). Cutaneous diphtheria can also present in the form of colonization and infection of preexisting dermatoses [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/47\">",
"     47",
"    </a>",
"    ]. The diagnosis is made by culturing the organism from a skin lesion. Local trauma frequently precedes cutaneous infection. Previous outbreaks of cutaneous disease have occurred in impoverished populations with poor access to the health care system, such as the homeless and intravenous drug abusers [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/48\">",
"     48",
"    </a>",
"    ]. Skin infections typically result in a brisk antibody response, in contrast to pharyngeal infections (which may not result in subsequent immunity). Therefore, individuals with skin infection have a relatively low likelihood of developing the pharyngeal form of the disease; however, skin ulcers serve as a reservoir to infect susceptible hosts, particularly in regions where herd immunity is low due to suboptimal vaccination [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/49-52\">",
"     49-52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Outbreaks of cutaneous diphtheria in the United States have been described among alcoholic homeless men and other impoverished groups [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29287/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. However, since 1980, the CDC has dropped cutaneous diphtheria caused by non-toxigenic strains from its list of reportable diseases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4154543\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Diphtheria is an infectious disease caused by the gram-positive bacillus Corynebacterium diphtheriae. Infection may lead to respiratory disease, cutaneous disease, or an asymptomatic carrier state. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The primary modes of spread consist of close contact with infectious material from respiratory secretions (direct or via airborne droplet) or from skin lesions. Infection occurs throughout the year with a peak incidence in the colder months. (See",
"      <a class=\"local\" href=\"#H9250687\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Humans are the only known reservoir for C. diphtheriae. Therefore, asymptomatic carriers are important in diphtheria transmission. Immunity (either via natural infection or vaccine-induced) does not prevent carriage. In areas of endemicity, up to 5 percent of healthy individuals may have positive pharyngeal cultures. Immunization has minimized the transmission of toxigenic strains; since 1980, the US incidence has been approximately 0.001 cases per 100,000 population. (See",
"      <a class=\"local\" href=\"#H9250687\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Respiratory diphtheria is typically caused by toxin-producing strains of C. diphtheriae; rarely, it is caused by toxigenic strains of other Corynebacterium species (C. ulcerans, C. hemolyticum, or C. pseudotuberculosis). Symptoms typically begin two to five days after infection. The most common presenting findings are sore throat, malaise, cervical lymphadenopathy, and low grade fever. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Respiratory diphtheria'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In at least one-third of cases, local elaboration of toxin induces the formation of a coalescing pseudomembrane (composed of necrotic fibrin, leukocytes, erythrocytes, epithelial cells, and organisms). This membrane can extend to any portion of the respiratory tract from the nasal passages to the tracheobronchial tree. Up to two-thirds of cases have tonsillopharyngeal involvement; involvement of the laryngeal, nasal, and tracheobronchial areas is less common. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Respiratory diphtheria'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diphtheritic membrane is classically gray in color and adheres tightly to the underlying tissue, such that dislodgement results in bleeding (",
"      <a class=\"graphic graphic_picture graphicRef52701 \" href=\"UTD.htm?21/31/22003\">",
"       picture 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef51058 \" href=\"UTD.htm?2/20/2369\">",
"       picture 2",
"      </a>",
"      ). Systemic toxicity increases as the pseudomembrane spreads from the tonsillopharyngeal area. Absorption and dissemination of diphtheria toxin can lead to toxin damage of the heart and nervous system. Clinically evident cardiac dysfunction occurs in about 10 to 25 percent of patients; neurologic toxicity occurs in approximately 5 percent of patients. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Systemic manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cutaneous diphtheria is characterized by chronic, nonhealing sores or shallow ulcers with a dirty gray membrane. Cutaneous diphtheria can also present in the form of colonization and infection of preexisting dermatoses. Systemic toxicity is rare. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Cutaneous diphtheria'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/1\">",
"      Brooks GF, Bennett JV, Feldman RA. Diphtheria in the United States, 1959-1970. J Infect Dis 1974; 129:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/2\">",
"      Bostock AD, Gilbert FR, Lewis D, Smith DC. Corynebacterium ulcerans infection associated with untreated milk. J Infect 1984; 9:286.",
"     </a>",
"    </li>",
"    <li>",
"     Rosenau MJ. Diseases spread by milk. In: Preventive Medicine and Hygiene, 5th Ed, Appleton, New York 1928. p.718.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/4\">",
"      Doull JA, Lara H. The epidemiologic importance of diphtheria carriers. Am J Hyg 1925; 5:508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/5\">",
"      Miller LW, Older JJ, Drake J, Zimmerman S. Diphtheria immunization. Effect upon carriers and the control of outbreaks. Am J Dis Child 1972; 123:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/6\">",
"      Kalapothaki V, Sapounas T, Xirouchaki E, et al. Prevalence of diphtheria carriers in a population with disappearing clinical diphtheria. Infection 1984; 12:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/7\">",
"      English PC. Diphtheria and theories of infectious disease: centennial appreciation of the critical role of diphtheria in the history of medicine. Pediatrics 1985; 76:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/8\">",
"      Frost WH. Infection, immunity and disease in the epidemiology of diphtheria, with special reference to some studies in Baltimore. J Prev Med 1928; 2:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/9\">",
"      Zingher A. The Schick test performed on more than 150,000 children in public and parochial schools in New York (Manhattan and the Bronx). Am J Dis Child 1923; 25:392.",
"     </a>",
"    </li>",
"    <li>",
"     Pappenheimer AM. Diphtheria: Studies on the biology of an infectious disease. In: The Harvey Lectures, Series 76, Academic Press, New York 1980-81. p.45.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/11\">",
"      Wilson AP. The return of Corynebacterium diphtheriae: the rise of non-toxigenic strains. J Hosp Infect 1995; 30 Suppl:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/12\">",
"      Centers for Disease Control and Prevention (CDC). Diphtheria outbreak--Saraburi Province, Thailand, 1994. MMWR Morb Mortal Wkly Rep 1996; 45:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/13\">",
"      Centers for Disease Control and Prevention (CDC). Diphtheria epidemic--New Independent States of the former Soviet Union, 1990-1994. MMWR Morb Mortal Wkly Rep 1995; 44:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/14\">",
"      Maple PA, Efstratiou A, George RC, et al. Diphtheria immunity in UK blood donors. Lancet 1995; 345:963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/15\">",
"      Weiss BP, Strassburg MA, Feeley JC. Tetanus and diphtheria immunity in an elderly population in Los Angeles County. Am J Public Health 1983; 73:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/16\">",
"      McQuillan GM, Kruszon-Moran D, Deforest A, et al. Serologic immunity to diphtheria and tetanus in the United States. Ann Intern Med 2002; 136:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/17\">",
"      Advisory Committee on Immunization Practices. Recommended adult immunization schedule: United States, 2010. Ann Intern Med 2010; 152:36.",
"     </a>",
"    </li>",
"    <li>",
"     CDC. www.cdc.gov/nip (Accessed 3/9/05). www.cdc.gov/nip (Accessed on March 09, 2005).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/19\">",
"      Coyle MB, Groman NB, Russell JQ, et al. The molecular epidemiology of three biotypes of Corynebacterium diphtheriae in the Seattle outbreak, 1972-1982. J Infect Dis 1989; 159:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/20\">",
"      Centers for Disease Control and Prevention (CDC). Notes from the field: respiratory diphtheria-like illness caused by toxigenic Corynebacterium ulcerans --- Idaho, 2010. MMWR Morb Mortal Wkly Rep 2011; 60:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/21\">",
"      Tiwari TS, Golaz A, Yu DT, et al. Investigations of 2 cases of diphtheria-like illness due to toxigenic Corynebacterium ulcerans. Clin Infect Dis 2008; 46:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/22\">",
"      Taylor J, Saveedra-Campos M, Harwood D, et al. Toxigenic Corynebacterium ulcerans infection in a veterinary student in London, United Kingdom, May 2010. Euro Surveill 2010; 15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/23\">",
"      Wagner KS, White JM, Crowcroft NS, et al. Diphtheria in the United Kingdom, 1986-2008: the increasing role of Corynebacterium ulcerans. Epidemiol Infect 2010; 138:1519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/24\">",
"      Nakao H, Pruckler JM, Mazurova IK, et al. Heterogeneity of diphtheria toxin gene, tox, and its regulatory element, dtxR, in Corynebacterium diphtheriae strains causing epidemic diphtheria in Russia and Ukraine. J Clin Microbiol 1996; 34:1711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/25\">",
"      Hardy IR, Dittmann S, Sutter RW. Current situation and control strategies for resurgence of diphtheria in newly independent states of the former Soviet Union. Lancet 1996; 347:1739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/26\">",
"      Dittmann S, Wharton M, Vitek C, et al. Successful control of epidemic diphtheria in the states of the Former Union of Soviet Socialist Republics: lessons learned. J Infect Dis 2000; 181 Suppl 1:S10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/27\">",
"      Galazka AM, Robertson SE. Diphtheria: changing patterns in the developing world and the industrialized world. Eur J Epidemiol 1995; 11:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/28\">",
"      Galazka AM, Robertson SE, Oblapenko GP. Resurgence of diphtheria. Eur J Epidemiol 1995; 11:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/29\">",
"      Centers for Disease Control and Prevention (CDC). Fatal respiratory diphtheria in a U.S. traveler to Haiti--Pennsylvania, 2003. MMWR Morb Mortal Wkly Rep 2004; 52:1285.",
"     </a>",
"    </li>",
"    <li>",
"     Bureau of Communicable Disease Control. Toxigenic diphtheria cultured from a patient with respiratory symptoms. Department of Public Health, The Commonwealth of Massachusetts, 2004.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/31\">",
"      FREEMAN VJ. Studies on the virulence of bacteriophage-infected strains of Corynebacterium diphtheriae. J Bacteriol 1951; 61:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/32\">",
"      Choe S, Bennett MJ, Fujii G, et al. The crystal structure of diphtheria toxin. Nature 1992; 357:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/33\">",
"      Naglich JG, Rolf JM, Eidels L. Expression of functional diphtheria toxin receptors on highly toxin-sensitive mouse cells that specifically bind radioiodinated toxin. Proc Natl Acad Sci U S A 1992; 89:2170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/34\">",
"      Naglich JG, Metherall JE, Russell DW, Eidels L. Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor. Cell 1992; 69:1051.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/35\">",
"      Wong TP, Groman N. Production of diphtheria toxin by selected isolates of Corynebacterium ulcerans and Corynebacterium pseudotuberculosis. Infect Immun 1984; 43:1114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/36\">",
"      NAIDITCH MJ, BOWER AG. Diphtheria; a study of 1,433 cases observed during a ten-year period at the Los Angeles County Hospital. Am J Med 1954; 17:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/37\">",
"      Kadirova R, Kartoglu HU, Strebel PM. Clinical characteristics and management of 676 hospitalized diphtheria cases, Kyrgyz Republic, 1995. J Infect Dis 2000; 181 Suppl 1:S110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/38\">",
"      Lumio JT, Groundstroem KW, Melnick OB, et al. Electrocardiographic abnormalities in patients with diphtheria: a prospective study. Am J Med 2004; 116:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/39\">",
"      BOYER NH, WEINSTEIN L. Diphtheritic myocarditis. N Engl J Med 1948; 239:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/40\">",
"      MORGAN BC. CARDIAC COMPLICATIONS OF DIPHTHERIA. Pediatrics 1963; 32:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/41\">",
"      Kneen R, Nguyen MD, Solomon T, et al. Clinical features and predictors of diphtheritic cardiomyopathy in Vietnamese children. Clin Infect Dis 2004; 39:1591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/42\">",
"      Jayashree M, Shruthi N, Singhi S. Predictors of outcome in patients with diphtheria receiving intensive care. Indian Pediatr 2006; 43:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/43\">",
"      Dobie RA, Tobey DN. Clinical features of diphtheria in the respiratory tract. JAMA 1979; 242:2197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/44\">",
"      Wilson AP, Efstratiou A, Weaver E, et al. Unusual non-toxigenic Corynebacterium diphtheriae in homosexual men. Lancet 1992; 339:998.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/45\">",
"      Tiley SM, Kociuba KR, Heron LG, Munro R. Infective endocarditis due to nontoxigenic Corynebacterium diphtheriae: report of seven cases and review. Clin Infect Dis 1993; 16:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/46\">",
"      Gruner E, Opravil M, Altwegg M, von Graevenitz A. Nontoxigenic Corynebacterium diphtheriae isolated from intravenous drug users. Clin Infect Dis 1994; 18:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/47\">",
"      H&ouml;fler W. Cutaneous diphtheria. Int J Dermatol 1991; 30:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/48\">",
"      Lowe CF, Bernard KA, Romney MG. Cutaneous diphtheria in the urban poor population of Vancouver, British Columbia, Canada: a 10-year review. J Clin Microbiol 2011; 49:2664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/49\">",
"      Bray JP, Burt EG, Potter EV, et al. Epidemic diphtheria and skin infections in Trinidad. J Infect Dis 1972; 126:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/50\">",
"      Sing A, Heesemann J. Imported cutaneous diphtheria, Germany, 1997-2003. Emerg Infect Dis 2005; 11:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/51\">",
"      Zeegelaar JE, Faber WR. Imported tropical infectious ulcers in travelers. Am J Clin Dermatol 2008; 9:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/52\">",
"      de Benoist AC, White JM, Efstratiou A, et al. Imported cutaneous diphtheria, United Kingdom. Emerg Infect Dis 2004; 10:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/53\">",
"      Harnisch JP, Tronca E, Nolan CM, et al. Diphtheria among alcoholic urban adults. A decade of experience in Seattle. Ann Intern Med 1989; 111:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29287/abstract/54\">",
"      Belsey MA, Sinclair M, Roder MR, LeBlanc DR. Corynebacterium diphtheriae skin infections in Alabama and Louisiana. A factor in the epidemiology of diphtheria. N Engl J Med 1969; 280:135.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8051 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-200.131.240.2-C9BE2142DC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_38_29287=[""].join("\n");
var outline_f28_38_29287=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H4154543\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9250687\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9250694\">",
"      Developed countries",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9251138\">",
"      - Former Soviet Union",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9250701\">",
"      Developing countries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Respiratory diphtheria",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Systemic manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Cutaneous diphtheria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4154543\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/8051\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/8051|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?21/31/22003\" title=\"picture 1\">",
"      Early diphtheritic membrane",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?2/20/2369\" title=\"picture 2\">",
"      Diphtheritic membrane",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?15/27/15797\" title=\"picture 3\">",
"      Diphtheria cutaneous lesion 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?16/23/16755\" title=\"picture 4\">",
"      Diphtheria cutaneous lesion 2",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/50/11046?source=related_link\">",
"      Diagnosis and treatment of diphtheria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/56/39818?source=related_link\">",
"      Standard immunizations for children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/54/7014?source=related_link\">",
"      Tetanus-diphtheria toxoid vaccination in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_38_29288="Stasis dermatitis";
var content_f28_38_29288=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Stasis dermatitis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/38/29288/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/38/29288/contributors\">",
"     Anthony F Fransway, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/38/29288/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/38/29288/contributors\">",
"     Joseph Fowler, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/38/29288/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/38/29288/contributors\">",
"     Rosamaria Corona, MD, DSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?28/38/29288/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 4, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H358752\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stasis dermatitis, or stasis eczema, is a common inflammatory dermatosis of the lower extremities occurring in patients with chronic venous insufficiency, often in association with varicose veins, dependent chronic edema, hyperpigmentation, lipodermatosclerosis, and ulcerations. Stasis dermatitis may rarely involve the upper limbs in patients with artificial arteriovenous (AV) fistulas for hemodialysis or congenital AV malformations [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29288/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will discuss the pathogenesis, clinical presentation, complications, and treatment of stasis dermatitis. The pathophysiology, clinical and diagnostic evaluation, and treatment of lower extremity chronic venous disease are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/22/43365?source=see_link\">",
"     \"Pathophysiology of chronic venous disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/43/33462?source=see_link\">",
"     \"Diagnostic evaluation of chronic venous insufficiency\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/37/23127?source=see_link\">",
"     \"Post-thrombotic (postphlebitic) syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/41/32410?source=see_link\">",
"     \"Medical management of lower extremity chronic venous disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H214055\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Skin changes related to chronic venous insufficiency, including edema, hyperpigmentation, eczema, fibrosis, atrophy, and ulceration, are reported in 1 to 20 percent of women and in 1 to 17 percent of men [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29288/abstract/2\">",
"     2",
"    </a>",
"    ]. In one study, stasis dermatitis was reported in 6.2 percent of patients over the age of 65 [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29288/abstract/3\">",
"     3",
"    </a>",
"    ]. Established risk factors for varicose veins and chronic venous insufficiency include age, family history of venous disease, female sex, standing occupation, obesity, and history of deep vein thrombosis [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29288/abstract/2,4\">",
"     2,4",
"    </a>",
"    ]. Heart failure and hypertension are aggravating factors.",
"   </p>",
"   <p>",
"    The epidemiology of chronic venous insufficiency is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/45/34521?source=see_link&amp;anchor=H2#H2\">",
"     \"Overview and management of lower extremity chronic venous disease\", section on 'Epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26659689\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The final common pathway that leads to chronic venous insufficiency is the development of venous hypertension. In most cases, venous hypertension results from dysfunction of the venous valves, obstruction to the venous flow, or failure of the \"venous pump\" [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29288/abstract/5\">",
"     5",
"    </a>",
"    ]. If the valves of deep or perforator veins are incompetent, the increased pressure generated during standing or calf muscle contraction causes blood to reflux into the superficial venous system, converting it into a high pressure system. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/22/43365?source=see_link&amp;anchor=H4#H4\">",
"     \"Pathophysiology of chronic venous disease\", section on 'Genesis and consequences of chronic venous hypertension'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H311755\">",
"    <span class=\"h1\">",
"     PATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although biopsy generally is not necessary, hyperkeratosis, parakeratosis, acanthosis, and mild spongiosis are the epidermal changes usually seen in uncomplicated stasis dermatitis. Spongiosis may be prominent in cases with a superimposed contact dermatitis. Dermal changes include proliferation of small blood vessels in the papillary dermis, variable dermal fibrosis, perivascular lymphocytic infiltration, extravasated erythrocytes, and hemosiderin laden macrophages [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29288/abstract/6\">",
"     6",
"    </a>",
"    ]. Signs of venous hypertension also may be seen in the dermis, including dilated capillaries with fibrin cuffs, hemosiderin deposits, and hyperplastic venules. Morphometric and ultrastructural findings include increased mast cell number, thickening of basal lamina of capillaries, and presence of transforming growth factor-beta 1 (TGF-beta 1) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29288/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H310245\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stasis dermatitis is a late manifestation of chronic venous disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/29/11735?source=see_link&amp;anchor=H6#H6\">",
"     \"Classification of lower extremity chronic venous disorders\", section on 'CEAP classification'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Stasis dermatitis typically presents with erythematous, scaling, and eczematous patches or plaques affecting the lower extremities. The medial ankle is most frequently and severely involved, although the skin changes may extend up to the knee and down to the foot (",
"    <a class=\"graphic graphic_picture graphicRef70596 graphicRef50640 graphicRef56758 graphicRef78163 graphicRef64878 \" href=\"UTD.htm?42/33/43546\">",
"     picture 1A-E",
"    </a>",
"    ). Pruritus is variable but, when present, results in lichenification from chronic scratching. Acute forms may present with severely inflamed weeping plaques and vesiculation. Impetiginized crusts",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pustules due to bacterial or candidal superinfection may also be seen. Advanced cases may show circumferential encasement (",
"    <a class=\"graphic graphic_picture graphicRef65447 \" href=\"UTD.htm?11/14/11490\">",
"     picture 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Patients with stasis dermatitis may present with other signs of chronic venous insufficiency and comorbidities, including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Varicosities (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/17/13592?source=see_link&amp;anchor=H11#H11\">",
"       \"Clinical evaluation of lower extremity chronic venous disease\", section on 'Varicose veins'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/17/13592?source=see_link&amp;anchor=H12#H12\">",
"       \"Clinical evaluation of lower extremity chronic venous disease\", section on 'Edema'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Hyperpigmentation, from extravasation of erythrocytes and hemosiderin accumulation",
"     </li>",
"     <li>",
"      Lipodermatosclerosis, resulting from chronic inflammation, fat degeneration, and fibrosis (",
"      <a class=\"graphic graphic_picture graphicRef65447 \" href=\"UTD.htm?11/14/11490\">",
"       picture 2",
"      </a>",
"      ) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/17/13592?source=see_link&amp;anchor=H14#H14\">",
"       \"Clinical evaluation of lower extremity chronic venous disease\", section on 'Lipodermatosclerosis'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Atrophie blanche (stellate, porcelain white scarring areas) (",
"      <a class=\"graphic graphic_picture graphicRef54537 graphicRef56185 graphicRef87627 \" href=\"UTD.htm?14/4/14410\">",
"       picture 3A-C",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Ulceration (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/17/13592?source=see_link&amp;anchor=H15#H15\">",
"       \"Clinical evaluation of lower extremity chronic venous disease\", section on 'Venous ulceration'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Secondary cellulitis (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12825?source=see_link\">",
"       \"Cellulitis and erysipelas\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Secondary lymphedema",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H310424\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H311023\">",
"    <span class=\"h2\">",
"     Autosensitization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Autosensitization (autoeczematization or &ldquo;id&rdquo; reaction) refers to an acute, pruritic papulovesicular eruption that develops at cutaneous sites distant from a primary focus and is unrelated to the inciting cause of the primary inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29288/abstract/8\">",
"     8",
"    </a>",
"    ]. Autosensitization has been reported in association with stasis dermatitis, contact dermatitis, and bacterial or fungal infections [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29288/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. Typically, the autoeczematization develops one to two weeks after the primary inflammation and most frequently involves the forearms, thighs, trunk, and face [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29288/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The pathogenesis is not fully understood. One hypothesis is that autoeczematization is due to hyperirritability of the skin induced by immunologic or nonimmunologic stimuli and mediated by epidermal cytokines. Histologic findings are nonspecific and include spongiosis and a dermal lymphohistiocytic infiltrate with eosinophils.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H107526\">",
"    <span class=\"h2\">",
"     Contact sensitization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with stasis dermatitis and venous leg ulcers have a higher frequency of contact allergy than the general population. The prevalence of contact sensitization to at least one substance among patch tested patients with stasis dermatitis or leg ulcers ranged from 46 to 82 percent in several case series [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29288/abstract/12-19\">",
"     12-19",
"    </a>",
"    ]. Poly-sensitization is common; a multicenter study of 423 patients found an average of four positive patch tests per patient [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29288/abstract/12\">",
"     12",
"    </a>",
"    ]. The number of sensitivities appears to increase with the disease duration [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29288/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The increased susceptibility to contact dermatitis in patients with stasis dermatitis and leg ulcers may be due to several factors, including [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29288/abstract/20-22\">",
"     20-22",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Prolonged and repeated contact with topical preparations containing strong sensitizers",
"     </li>",
"     <li>",
"      Local hypervascularization",
"     </li>",
"     <li>",
"      Increased number of lymphocytes and Langerhans cells in the affected skin",
"     </li>",
"     <li>",
"      Impairment of the skin barrier function",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/3/7223?source=see_link\">",
"     \"Basic mechanisms and pathophysiology of allergic contact dermatitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/42/11943?source=see_link\">",
"     \"Clinical features and diagnosis of allergic contact dermatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The substances most frequently responsible for contact sensitization among patients with stasis dermatitis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    leg ulcers are ingredients of many emollients and topical prescription or over-the-counter preparations, including [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29288/abstract/12-14,23-26\">",
"     12-14,23-26",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Balsam of Peru and fragrances",
"     </li>",
"     <li>",
"      Lanolin (wool alcohol or Amerchol L101",
"      <sup>",
"       &reg;",
"      </sup>",
"      )",
"     </li>",
"     <li>",
"      Rubber and constituents of rubber, rubber accelerators, and latex products",
"     </li>",
"     <li>",
"      Bandages, dressings, or adhesives",
"      <strong>",
"      </strong>",
"      (eg, colophony, epoxy resin, and formaldehyde resin). Modern hydrocolloid dressings are generally well tolerated. However, reactions to hydrocolloid gels have been reported and may be due to pentaerythritol ester of hydrogenated rosin, a tackifying agent that commonly cross-reacts with colophony [",
"      <a class=\"abstract\" href=\"UTD.htm?28/38/29288/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Topical antibiotics (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?13/57/14229?source=see_link\">",
"       neomycin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/20/6469?source=see_link\">",
"       bacitracin",
"      </a>",
"      , and aminoglycosides) and antiseptics",
"      <strong>",
"      </strong>",
"      (eg, povidone-iodine, benzalkonium chloride,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/36/12870?source=see_link\">",
"       chlorhexidine",
"      </a>",
"      , and clioquinol)",
"     </li>",
"     <li>",
"      Topical corticosteroids. A list of cross-reacting topical corticosteroids is provided in a figure (",
"      <a class=\"graphic graphic_figure graphicRef63402 \" href=\"UTD.htm?10/52/11075\">",
"       figure 1",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H523344193\">",
"    <span class=\"h2\">",
"     Superinfection",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with acute stasis dermatitis, moist, exudative lesions are often extensively colonized by bacteria and fungi. The disruption of the epidermal barrier integrity by inflammation or scratching favors the secondary infection of eczematous lesions.",
"    <em>",
"     S. aureus",
"    </em>",
"    and",
"    <em>",
"     S. pyogenes",
"    </em>",
"    are the most frequent cause of superficial (impetiginization) or deep (cellulitis and erysipelas) superinfection of stasis dermatitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/21/21846?source=see_link\">",
"     \"Impetigo\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12825?source=see_link\">",
"     \"Cellulitis and erysipelas\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26659798\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of stasis dermatitis is straightforward, based upon the clinical appearance of the skin lesions (ranging from erythema, scaling, and hyperpigmentation to edema, erosions, and crusts) (",
"    <a class=\"graphic graphic_picture graphicRef70596 graphicRef50640 graphicRef56758 \" href=\"UTD.htm?21/7/21626\">",
"     picture 1A-C",
"    </a>",
"    ); history of venous insufficiency; and other clinical signs of chronic venous insufficiency, including varicosities, pitting edema, and hyperpigmentation.",
"   </p>",
"   <p>",
"    In patients in whom the diagnosis of stasis dermatitis is uncertain or who have atypical features (eg, solitary lesion or lack of ankle involvement), biopsy and histopathologic examination may confirm the diagnosis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    exclude other skin diseases such as allergic contact dermatitis, asteatotic eczema, lichen simplex chronicus, or cutaneous malignancies (particularly in patients with a solitary lesion) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29288/abstract/27\">",
"     27",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H108539\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Color Doppler assessment of the blood flow in the lower limbs is helpful in evaluating venous incompetence",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    diagnosing deep venous thrombosis in patients with skin findings but without obvious manifestations of venous insufficiency. Arterial study may be necessary to evaluate arterial disease in patients with trophic changes (eg, atrophie blanche or ulcerations). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/43/33462?source=see_link&amp;anchor=H3#H3\">",
"     \"Diagnostic evaluation of chronic venous insufficiency\", section on 'Duplex ultrasonography'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H106493086\">",
"    <span class=\"h1\">",
"     ADDITIONAL EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory tests are not usually necessary for the diagnosis of stasis dermatitis. However, laboratory evaluation may be indicated in the assessment of chronic venous insufficiency. As an example, screening for thrombophilia is indicated in patients with stasis dermatitis and a history of thrombosis at a young age or in patients with recurrent deep vein thrombosis [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29288/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/41/11930?source=see_link&amp;anchor=H8#H8\">",
"     \"Evaluation of the patient with established venous thrombosis\", section on 'Screening for inherited thrombophilia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Additional evaluation also may be necessary for patients with complications and for those who fail to respond to appropriate treatment:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Culture",
"      </strong>",
"      &mdash; Bacterial cultures",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      mycologic studies (eg, potassium hydroxide (KOH) preparation) are useful when bacterial or fungal superinfection or primary tinea corporis are suspected.",
"     </li>",
"     <li>",
"      <strong>",
"       Epicutaneous patch testing",
"      </strong>",
"      &mdash; Patch testing for contact sensitization may be warranted for patients with acute, weeping dermatitis or chronic, recalcitrant stasis dermatitis. Standard series of allergens should be used, in addition to other series selected on the basis of exposure history and clinical suspicion (eg, corticosteroids, rubber, preservative, excipients, antioxidants, fragrance, textiles, and topical medicines or products used by the patient). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/31/28150?source=see_link\">",
"       \"Patch testing\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      The specific standard series may vary depending upon the location of the patch testing center. The European Standard Series and the North American Contact Dermatitis Group Series are most commonly used in Europe and in the United States, respectively. Other series include International Standard, Belgium Standard, Finnish Standard, GIRDCA Series, Korean Standard, Swedish Standard, and Hungarian Standard [",
"      <a class=\"abstract\" href=\"UTD.htm?28/38/29288/abstract/29\">",
"       29",
"      </a>",
"      ]. Descriptions of the test substances included in the most common standard series are available through DermNet NZ (",
"      <a class=\"external\" href=\"file://dermnetnz.org/dermatitis/standard-patch.html\">",
"       file://dermnetnz.org/dermatitis/standard-patch.html",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H108539\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stasis dermatitis may be difficult to differentiate from other skin disorders. Biopsy can help to distinguish other conditions that may be confused with stasis dermatitis. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Irritant contact dermatitis (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/40/3721?source=see_link&amp;anchor=H18#H18\">",
"       \"Overview of dermatitis\", section on 'Irritant contact dermatitis'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Allergic contact dermatitis (",
"      <a class=\"graphic graphic_picture graphicRef51220 \" href=\"UTD.htm?1/55/1910\">",
"       picture 4",
"      </a>",
"      ), which may also be a complication of stasis dermatitis (see",
"      <a class=\"local\" href=\"#H107526\">",
"       'Contact sensitization'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/40/3721?source=see_link&amp;anchor=H12#H12\">",
"       \"Overview of dermatitis\", section on 'Allergic contact dermatitis'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Asteatotic eczema (eczema craquel&eacute;) (",
"      <a class=\"graphic graphic_picture graphicRef63945 \" href=\"UTD.htm?4/3/4147\">",
"       picture 5",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Lichen simplex chronicus (",
"      <a class=\"graphic graphic_picture graphicRef73843 \" href=\"UTD.htm?5/57/6035\">",
"       picture 6",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Psoriasis (",
"      <a class=\"graphic graphic_picture graphicRef77308 \" href=\"UTD.htm?37/20/38212\">",
"       picture 7",
"      </a>",
"      ) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27625?source=see_link&amp;anchor=H10#H10\">",
"       \"Epidemiology, clinical manifestations, and diagnosis of psoriasis\", section on 'Plaque psoriasis'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Dermatophyte infection (tinea corporis) (",
"      <a class=\"graphic graphic_picture graphicRef53823 \" href=\"UTD.htm?21/6/21602\">",
"       picture 8",
"      </a>",
"      ), which may also be a complication of stasis dermatitis (see",
"      <a class=\"local\" href=\"#H523344193\">",
"       'Superinfection'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/58/7082?source=see_link&amp;anchor=H23#H23\">",
"       \"Dermatophyte (tinea) infections\", section on 'Tinea corporis'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Actinically damaged skin (multiple actinic keratoses) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/49/18200?source=see_link\">",
"       \"Epidemiology, natural history, and diagnosis of actinic keratosis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Hypertrophic lichen planus (",
"      <a class=\"graphic graphic_picture graphicRef54396 graphicRef81589 \" href=\"UTD.htm?3/13/3290\">",
"       picture 9A-B",
"      </a>",
"      ) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/27/9656?source=see_link&amp;anchor=H6#H6\">",
"       \"Lichen planus\", section on 'Clinical features'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Necrobiosis lipoidica (",
"      <a class=\"graphic graphic_picture graphicRef50781 graphicRef63574 \" href=\"UTD.htm?17/44/18119\">",
"       picture 10A-B",
"      </a>",
"      ) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/7/7285?source=see_link&amp;anchor=H9#H9\">",
"       \"Metabolic and inherited diseases affecting the skin\", section on 'Necrobiosis lipoidica'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Pretibial myxedema (",
"      <a class=\"graphic graphic_picture graphicRef64524 \" href=\"UTD.htm?2/54/2913\">",
"       picture 11",
"      </a>",
"      ) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/50/1828?source=see_link\">",
"       \"Pretibial myxedema in autoimmune thyroid disease\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Skin cancer (squamous cell carcinoma, basal cell carcinoma) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/11/7351?source=see_link\">",
"       \"Clinical features and diagnosis of cutaneous squamous cell carcinoma (SCC)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/39/14970?source=see_link&amp;anchor=H21#H21\">",
"       \"Epidemiology and clinical features of basal cell carcinoma\", section on 'Clinical presentation'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26659847\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1081671955\">",
"    <span class=\"h2\">",
"     Treatment of chronic venous insufficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of the underlying venous hypertension and slowing the progression of the venous disease is the most important component of the treatment of stasis dermatitis.",
"   </p>",
"   <p>",
"    The management of the patient with chronic venous disease is discussed in detail separately and may involve:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      General measures to reduce edema and venous hypertension (eg, leg elevation, daily walking, exercise, weight reduction) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/41/32410?source=see_link&amp;anchor=H3#H3\">",
"       \"Medical management of lower extremity chronic venous disease\", section on 'General measures'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Continuous compression therapy (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/41/32410?source=see_link&amp;anchor=H6#H6\">",
"       \"Medical management of lower extremity chronic venous disease\", section on 'Continuous compression therapy'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/55/9079?source=see_link\">",
"       \"Compression bandaging for chronic venous insufficiency\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Systemic therapy, including venoactive or phlebotonic drugs (eg, hydroxyethylrutoside, escin [horse chestnut extract], calcium dobesilate) or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?13/28/13765?source=see_link\">",
"       pentoxifylline",
"      </a>",
"      (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/41/32410?source=see_link&amp;anchor=H13#H13\">",
"       \"Medical management of lower extremity chronic venous disease\", section on 'Systemic agents'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Surgical therapy (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/29/21977?source=see_link\">",
"       \"Open surgical techniques for lower extremity vein ablation\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/34/30250?source=see_link\">",
"       \"Endovenous laser ablation for the treatment of lower extremity chronic venous disease\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/5/30809?source=see_link\">",
"       \"Radiofrequency ablation for the treatment of lower extremity chronic venous disease\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1081672000\">",
"    <span class=\"h2\">",
"     Skin care",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to treatment of underlying venous insufficiency, patients with stasis dermatitis also may require symptomatic treatment for dryness, pruritus, and inflammation. There are few randomized trials evaluating skin care in patients with stasis dermatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29288/abstract/26,30\">",
"     26,30",
"    </a>",
"    ]. Most experts follow a stepwise-approach to topical therapy based upon observational studies and case series, as described below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H106493305\">",
"    <span class=\"h3\">",
"     Skin cleansing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients should gently wash their legs daily using mild non-soap cleansers to remove scale, bacteria, and crusts. Products without artificial colors or fragrance may be less irritating, and petrolatum-based body washes can minimize the dryness that occurs with daily washing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1081672141\">",
"    <span class=\"h3\">",
"     Emollients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Emollients provide a film of oil to lubricate the skin, which limits dryness and itching. We suggest emollients as the initial treatment for skin dryness and pruritus in patients with stasis dermatitis. Petrolatum-based products are preferred to emollients containing lanolin or fragrances to reduce the risk of contact sensitization. White petroleum jelly is effective, inexpensive, and non-sensitizing.",
"   </p>",
"   <p>",
"    Emollients can be applied multiple times per day. Emollients are best applied when the skin is damp (ie, immediately after showering or bathing) and may be applied after wet dressings to seal in hydration. (See",
"    <a class=\"local\" href=\"#H26659861\">",
"     'Wet dressings'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H312177\">",
"    <span class=\"h3\">",
"     Topical corticosteroids",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest topical corticosteroid ointments for patients with stasis dermatitis and erythema, inflammation, pruritus, and vesiculation that do not improve with emollients.",
"   </p>",
"   <p>",
"    High- or mid-potency corticosteroids (group III and IV) (",
"    <a class=\"graphic graphic_table graphicRef62402 \" href=\"UTD.htm?38/56/39809\">",
"     table 1",
"    </a>",
"    ) may be applied to the affected skin once or twice daily for one to three weeks. Corticosteroid preparations containing emulsifiers and additives should be avoided to minimize the risk of sensitization; petrolatum is the preferred vehicle because it does not contain any additives. Nonetheless, contact sensitization to topical corticosteroids may occur; a list of cross-reacting topical corticosteroids is provided in a figure (",
"    <a class=\"graphic graphic_figure graphicRef63402 \" href=\"UTD.htm?10/52/11075\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In the only randomized trial of topical corticosteroids for stasis dermatitis, patients treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/5/44120?source=see_link\">",
"     betamethasone",
"    </a>",
"    valerate foam 0.12% applied twice daily for 28 days had greater improvement compared with baseline than those treated with placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29288/abstract/31\">",
"     31",
"    </a>",
"    ]. Both groups had similar improvement of edema, postinflammatory hyperpigmentation, or pruritus. Whether stronger potency corticosteroids or an ointment preparation (rather than foam, which has limited penetration) would be more beneficial is not known.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11135877\">",
"    <span class=\"h3\">",
"     Systemic corticosteroids",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients in whom topical corticosteroids do not adequately relieve symptoms of inflammation or who have secondary allergic contact dermatitis, we suggest a short course of systemic corticosteroids (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    20 to 30 mg daily for five to seven days). An alternative is a single dose of intramuscular",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/38/39520?source=see_link\">",
"     triamcinolone",
"    </a>",
"    (40 mg).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26659861\">",
"    <span class=\"h3\">",
"     Wet dressings",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest the use of wet dressings to facilitate removal of crusted or exudative lesions and to reduce pruritus in patients with stasis dermatitis.",
"   </p>",
"   <p>",
"    Dermatologic wet dressings are applied using tap water, saline, or an appropriate anti-infectious solution diluted from stock&nbsp;(eg, zinc and copper sulfate solution;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/36/19011?source=see_link\">",
"     acetic acid",
"    </a>",
"    ; potassium permanganate; or aluminum acetate [Burow&rsquo;s solution] or subacetate). Saturated, but not dripping, soft cotton dermatologic roll gauze or cloths are applied directly to affected areas and covered with dry cotton that is light and air permeable.&nbsp;The wet dressing is left in place for two to three hours and may be applied two to three times daily, or continuously in more severe cases and motivated patients.&nbsp;Emollients may be applied after removal to moisturize and to seal in attained hydration.",
"   </p>",
"   <p>",
"    Wet dressings may be used in conjunction with topical corticosteroids. The addition of dermatologic wet dressings to topical corticosteroids may increase the penetration and absorption of the corticosteroids.",
"   </p>",
"   <p>",
"    In patients with bacterial superinfection, antibacterial wet dressings may help clear secondary impetiginization and obviate the need for topical or oral antibiotic therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26659868\">",
"    <span class=\"h3\">",
"     Closed topical dressings",
"    </span>",
"    &nbsp;&mdash;&nbsp;The",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/14/23777?source=see_link\">",
"     Unna boot",
"    </a>",
"    is a closed topical dressing consisting of a moist zinc oxide-impregnated bandage that provides non-elastic compression and topical treatment. Unna boots may be of benefit in decreasing cutaneous inflammation, improving hydration, decreasing pruritus, improving impetiginized eczema, and preventing manipulation [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29288/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H523344201\">",
"    <span class=\"h2\">",
"     Treatment of superinfection",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26659882\">",
"    <span class=\"h3\">",
"     Impetiginized lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest topical antibiotic therapy for patients with stasis dermatitis and impetiginized lesions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/21/21846?source=see_link&amp;anchor=H2#H2\">",
"     \"Impetigo\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Topical antibacterial ointments should be selected based upon the results of bacterial culture, if available, and risk of contact sensitization.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/30/33252?source=see_link\">",
"     Mupirocin",
"    </a>",
"    is the topical antibiotic of choice because it is unlikely to cause cutaneous sensitization [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29288/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. Topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"     erythromycin",
"    </a>",
"    ointment is an alternative treatment when mupirocin is not tolerated [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29288/abstract/35\">",
"     35",
"    </a>",
"    ]. Contact sensitivity to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/20/6469?source=see_link\">",
"     bacitracin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/57/14229?source=see_link\">",
"     neomycin",
"    </a>",
"    , and aminoglycosides is frequently seen in patch tested patients with stasis dermatitis or contact dermatitis and these agents should be avoided. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/21/21846?source=see_link&amp;anchor=H12#H12\">",
"     \"Impetigo\", section on 'Topical therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Triclosan-based topical antimicrobial preparations are an infrequent cause of contact sensitization and may be used as an alternative to topical antibiotics [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29288/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H523344235\">",
"    <span class=\"h3\">",
"     Secondary cellulitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest systemic antibiotics for patients with more extensive stasis dermatitis and signs of cellulitis or other soft tissue infection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12825?source=see_link&amp;anchor=H6#H6\">",
"     \"Cellulitis and erysipelas\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H523344250\">",
"    <span class=\"h2\">",
"     Treatment of ulcers",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of ulcers in patients with stasis dermatitis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/41/32410?source=see_link&amp;anchor=H28#H28\">",
"     \"Medical management of lower extremity chronic venous disease\", section on 'Ulcer care'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26659945\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Stasis dermatitis, or stasis eczema, is a common inflammatory dermatosis of the lower extremities that occurs in patients with chronic venous insufficiency, often in association with other signs of chronic venous disease such as varicose veins, dependent chronic edema, hemosiderin deposition, lipodermatosclerosis, and ulcerations. (See",
"      <a class=\"local\" href=\"#H358752\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Signs and symptoms of stasis dermatitis include edema, inflammatory and trophic skin changes, pruritus, and hyperpigmentation. Manifestations of more advanced venous disease include lipodermatosclerosis (",
"      <a class=\"graphic graphic_picture graphicRef65447 \" href=\"UTD.htm?11/14/11490\">",
"       picture 2",
"      </a>",
"      ), lymphedema, and ulceration. (See",
"      <a class=\"local\" href=\"#H310245\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Autosensitization dermatitis, a skin eruption occurring in sites distant from the primary focus, is a common complication of stasis dermatitis. (See",
"      <a class=\"local\" href=\"#H311023\">",
"       'Autosensitization'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Contact sensitization is another common complication of stasis dermatitis. Contact sensitization should be suspected in patients with atypical presentations and in patients failing to respond to appropriate treatment for stasis dermatitis. The most common contact allergens include balsam of Peru, fragrances, lanolin, and topical antibiotics and antiseptics. (See",
"      <a class=\"local\" href=\"#H107526\">",
"       'Contact sensitization'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of stasis dermatitis is based upon the clinical appearance of the skin lesions (ranging from erythema, scaling, and hyperpigmentation to edema, erosions, and crusts) (",
"      <a class=\"graphic graphic_picture graphicRef70596 graphicRef50640 graphicRef56758 \" href=\"UTD.htm?21/7/21626\">",
"       picture 1A-C",
"      </a>",
"      ); history of venous insufficiency; and other clinical signs of chronic venous insufficiency, including varicosities, pitting edema, and hyperpigmentation. In patients with atypical presentations or solitary lesions, biopsy and histopathologic examination may confirm the diagnosis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      exclude other dermatoses or skin cancer. (See",
"      <a class=\"local\" href=\"#H26659798\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The mainstay of therapy for stasis dermatitis is treatment of the underlying venous insufficiency. Treatment of venous insufficiency is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/45/34521?source=see_link&amp;anchor=H26#H26\">",
"       \"Overview and management of lower extremity chronic venous disease\", section on 'Summary and recommendations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      We suggest emollients as the initial treatment for skin dryness and pruritus in patients with stasis dermatitis. Petrolatum-based emollients are preferred to preparations containing lanolin or fragrances to avoid contact sensitization. (See",
"      <a class=\"local\" href=\"#H1081672141\">",
"       'Emollients'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with stasis dermatitis and erythema, inflammation, pruritus, and vesiculation that do not improve with emollients, we suggest topical corticosteroid ointments. High- or mid-potency corticosteroids (group III and IV) (",
"      <a class=\"graphic graphic_table graphicRef62402 \" href=\"UTD.htm?38/56/39809\">",
"       table 1",
"      </a>",
"      ) may be applied once or twice daily for one to three weeks to the affected skin. (See",
"      <a class=\"local\" href=\"#H312177\">",
"       'Topical corticosteroids'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients in whom topical corticosteroids do not adequately relieve symptoms of inflammation or who have secondary allergic contact dermatitis, we suggest a short course of systemic corticosteroids (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      20 to 30 mg daily for five to seven days). An alternative is a single dose of intramuscular",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/38/39520?source=see_link\">",
"       triamcinolone",
"      </a>",
"      (40 mg).",
"     </li>",
"     <li>",
"      For patients with signs of bacterial superinfection, we suggest topical",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/30/33252?source=see_link\">",
"       mupirocin",
"      </a>",
"      ointment. Ointments containing",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/20/6469?source=see_link\">",
"       bacitracin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?13/57/14229?source=see_link\">",
"       neomycin",
"      </a>",
"      , and aminoglycosides should be avoided because of the high risk of contact sensitization. (See",
"      <a class=\"local\" href=\"#H26659882\">",
"       'Impetiginized lesions'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29288/abstract/1\">",
"      Deguchi E, Imafuku S, Nakayama J. Ulcerating stasis dermatitis of the forearm due to arteriovenous fistula: a case report and review of the published work. J Dermatol 2010; 37:550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29288/abstract/2\">",
"      Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol 2005; 15:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29288/abstract/3\">",
"      Yal&ccedil;in B, Tamer E, Toy GG, et al. The prevalence of skin diseases in the elderly: analysis of 4099 geriatric patients. Int J Dermatol 2006; 45:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29288/abstract/4\">",
"      Fiebig A, Krusche P, Wolf A, et al. Heritability of chronic venous disease. Hum Genet 2010; 127:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29288/abstract/5\">",
"      Bergan JJ, Schmid-Sch&ouml;nbein GW, Smith PD, et al. Chronic venous disease. N Engl J Med 2006; 355:488.",
"     </a>",
"    </li>",
"    <li>",
"     Stasis dermatitis. In: Weedon's Skin Pathology, Third edition, Weedon D.  (Ed), Churchill Livingstone Elsevier, 2010.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29288/abstract/7\">",
"      Pappas PJ, DeFouw DO, Venezio LM, et al. Morphometric assessment of the dermal microcirculation in patients with chronic venous insufficiency. J Vasc Surg 1997; 26:784.",
"     </a>",
"    </li>",
"    <li>",
"     Belsito DV. Autosensitization dermatitis. In: Fitzpatrick's Dermatology in General Medicine, Seventh, Wolff K, Goldsmith Lowell A, Katz SI, et al.  (Eds), McGraw Hill Medical, New York, NY 2008. Vol I, p.167.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29288/abstract/9\">",
"      Bendl BJ. Nummular eczema of statis origin. The backbone of a morphologic pattern of diverse etiology. Int J Dermatol 1979; 18:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29288/abstract/10\">",
"      HAXTHAUSEN H. Generalized ids autosensitization in varicose eczemas. Acta Derm Venereol 1955; 35:271.",
"     </a>",
"    </li>",
"    <li>",
"     Belsito DV. Autosensitization dermatitis. In: Fitzpatrick's Dermatology in General Medicine, Seventh edition, Wolff K, Goldsmith LA, Katz SI, Gilchrest BA.  (Eds), McGraw Hill Medical, New York, NY 2008. Vol I, p.167.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29288/abstract/12\">",
"      Barbaud A, Collet E, Le Coz CJ, et al. Contact allergy in chronic leg ulcers: results of a multicentre study carried out in 423 patients and proposal for an updated series of patch tests. Contact Dermatitis 2009; 60:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29288/abstract/13\">",
"      Machet L, Couh&eacute; C, Perrinaud A, et al. A high prevalence of sensitization still persists in leg ulcer patients: a retrospective series of 106 patients tested between 2001 and 2002 and a meta-analysis of 1975-2003 data. Br J Dermatol 2004; 150:929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29288/abstract/14\">",
"      Tavadia S, Bianchi J, Dawe RS, et al. Allergic contact dermatitis in venous leg ulcer patients. Contact Dermatitis 2003; 48:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29288/abstract/15\">",
"      Smart V, Alavi A, Coutts P, et al. Contact allergens in persons with leg ulcers: a Canadian study in contact sensitization. Int J Low Extrem Wounds 2008; 7:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29288/abstract/16\">",
"      Janki��evi�� J, Vesi�� S, Vuki��evi�� J, et al. Contact sensitivity in patients with venous leg ulcers in Serbia: comparison with contact dermatitis patients and relationship to ulcer duration. Contact Dermatitis 2008; 58:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29288/abstract/17\">",
"      Lim KS, Tang MB, Goon AT, Leow YH. Contact sensitization in patients with chronic venous leg ulcers in Singapore. Contact Dermatitis 2007; 56:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29288/abstract/18\">",
"      Reichert-P&eacute;n&eacute;trat S, Barbaud A, Weber M, Schmutz JL. [Leg ulcers. Allergologic studies of 359 cases]. Ann Dermatol Venereol 1999; 126:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29288/abstract/19\">",
"      Ebner H, Lindemayr H. [Leg ulcer and allergic eczematous contact dermatitis incidence of contact allergies induced by topical therapy (author's transl)]. Wien Klin Wochenschr 1977; 89:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29288/abstract/20\">",
"      Bahmer FA, Lesch H. Density of Langerhans' cells in ATPase stained epidermal sheet preparations from stasis dermatitis skin of the lower leg. Acta Derm Venereol 1987; 67:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29288/abstract/21\">",
"      Scott HJ, Coleridge Smith PD, Scurr JH. Histological study of white blood cells and their association with lipodermatosclerosis and venous ulceration. Br J Surg 1991; 78:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29288/abstract/22\">",
"      Prakash AV, Davis MD. Contact dermatitis in older adults: a review of the literature. Am J Clin Dermatol 2010; 11:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29288/abstract/23\">",
"      Gooptu C, Powell SM. The problems of rubber hypersensitivity (Types I and IV) in chronic leg ulcer and stasis eczema patients. Contact Dermatitis 1999; 41:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29288/abstract/24\">",
"      Sasseville D, Tennstedt D, Lachapelle JM. Allergic contact dermatitis from hydrocolloid dressings. Am J Contact Dermat 1997; 8:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29288/abstract/25\">",
"      Chang HY, Wong KM, Bosenberg M, et al. Myelogenous leukemia cutis resembling stasis dermatitis. J Am Acad Dermatol 2003; 49:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29288/abstract/26\">",
"      Weiss SC, Nguyen J, Chon S, Kimball AB. A randomized controlled clinical trial assessing the effect of betamethasone valerate 0.12% foam on the short-term treatment of stasis dermatitis. J Drugs Dermatol 2005; 4:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29288/abstract/27\">",
"      Weaver J, Billings SD. Initial presentation of stasis dermatitis mimicking solitary lesions: a previously unrecognized clinical scenario. J Am Acad Dermatol 2009; 61:1028.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29288/abstract/28\">",
"      Gloviczki P, Comerota AJ, Dalsing MC, et al. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2011; 53:2S.",
"     </a>",
"    </li>",
"    <li>",
"     file://dermnetnz.org/dermatitis/standard-patch.html (Accessed on July 27, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29288/abstract/30\">",
"      Henry M, Hanks G, Whelan A. A randomized, double-blind therapeutic trial of 0.25% desoxymethasone and 0.1% hydrocortisone 17-butyrate in the treatment of varicose eczema. Curr Med Res Opin 1980; 6:502.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.wrongdiagnosis.com/symptoms/ankle_swelling/side-effects.htm (Accessed on 10/12/2011)",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29288/abstract/32\">",
"      Mirande LM, Landolfi JM, Pedemonte LH. [Multiple applications of closed permanent wet dressings. Their mode of action]. Med Cutan Ibero Lat Am 1981; 9:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29288/abstract/33\">",
"      Tomljanovi��-Veselski M, Lipozenci�� J, Lugovi�� L. Contact allergy to special and standard allergens in patients with venous ulcers. Coll Antropol 2007; 31:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29288/abstract/34\">",
"      Jindal R, Sharma NL, Mahajan VK, Tegta GR. Contact sensitization in venous eczema: preliminary results of patch testing with Indian standard series and topical medicaments. Indian J Dermatol Venereol Leprol 2009; 75:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29288/abstract/35\">",
"      Bernstein SC, Roenigk RK. Surgical pearl: erythromycin ointment for topical antibiotic wound care. J Am Acad Dermatol 1995; 32:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29288/abstract/36\">",
"      Schena D, Papagrigoraki A, Girolomoni G. Sensitizing potential of triclosan and triclosan-based skin care products in patients with chronic eczema. Dermatol Ther 2008; 21 Suppl 2:S35.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13670 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-115.25.216.6-0D5B978519-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_38_29288=[""].join("\n");
var outline_f28_38_29288=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26659945\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H358752\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H214055\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26659689\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H311755\">",
"      PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H310245\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H310424\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H311023\">",
"      Autosensitization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H107526\">",
"      Contact sensitization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H523344193\">",
"      Superinfection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26659798\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H106493086\">",
"      ADDITIONAL EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H108539\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26659847\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1081671955\">",
"      Treatment of chronic venous insufficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1081672000\">",
"      Skin care",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H106493305\">",
"      - Skin cleansing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1081672141\">",
"      - Emollients",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H312177\">",
"      - Topical corticosteroids",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11135877\">",
"      - Systemic corticosteroids",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26659861\">",
"      - Wet dressings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26659868\">",
"      - Closed topical dressings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H523344201\">",
"      Treatment of superinfection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26659882\">",
"      - Impetiginized lesions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H523344235\">",
"      - Secondary cellulitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H523344250\">",
"      Treatment of ulcers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26659945\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/13670\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/13670|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/52/11075\" title=\"figure 1\">",
"      Cross-reactivity of topical corticosteroids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/13670|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/7/112\" title=\"picture 1A\">",
"      Stasis dematitis early",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/21/342\" title=\"picture 1B\">",
"      Stasis dermatitis advanced",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?3/63/4080\" title=\"picture 1C\">",
"      Skin changes of chronic venous insufficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/3/36917\" title=\"picture 1D\">",
"      Stasis dermatitis advanced 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/24/43397\" title=\"picture 1E\">",
"      Advanced stasis dermatitis 4",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?11/14/11490\" title=\"picture 2\">",
"      Stasis dermatitis sclerotic",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/38/4719\" title=\"picture 3A\">",
"      Atrophie blanche",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/22/14692\" title=\"picture 3B\">",
"      Stasis dermatitis advanced 3",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?15/22/15718\" title=\"picture 3C\">",
"      Atrophie blanche lipodermatosclerosis 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?1/55/1910\" title=\"picture 4\">",
"      Contact dermatitis feet",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/3/4147\" title=\"picture 5\">",
"      Asteatotic eczema",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/57/6035\" title=\"picture 6\">",
"      Lichen simplex chronicus ankle",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?37/20/38212\" title=\"picture 7\">",
"      Psoriasis legs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?21/6/21602\" title=\"picture 8\">",
"      Tinea corporis leg",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?23/6/23652\" title=\"picture 9A\">",
"      Hypertrophic lichen planus lesion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/2/4135\" title=\"picture 9B\">",
"      Hypertrophic lichen planus2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?16/29/16849\" title=\"picture 10A\">",
"      Necrobiosis lipoidica 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/21/40274\" title=\"picture 10B\">",
"      Necrobiosis lipoidica 3",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?2/54/2913\" title=\"picture 11\">",
"      Pretibial myxedema",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/13670|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/56/39809\" title=\"table 1\">",
"      Topical corticosteroids",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/3/7223?source=related_link\">",
"      Basic mechanisms and pathophysiology of allergic contact dermatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12825?source=related_link\">",
"      Cellulitis and erysipelas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/29/11735?source=related_link\">",
"      Classification of lower extremity chronic venous disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/17/13592?source=related_link\">",
"      Clinical evaluation of lower extremity chronic venous disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/42/11943?source=related_link\">",
"      Clinical features and diagnosis of allergic contact dermatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/11/7351?source=related_link\">",
"      Clinical features and diagnosis of cutaneous squamous cell carcinoma (SCC)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/55/9079?source=related_link\">",
"      Compression bandaging for chronic venous insufficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/58/7082?source=related_link\">",
"      Dermatophyte (tinea) infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/43/33462?source=related_link\">",
"      Diagnostic evaluation of chronic venous insufficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/34/30250?source=related_link\">",
"      Endovenous laser ablation for the treatment of lower extremity chronic venous disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/39/14970?source=related_link\">",
"      Epidemiology and clinical features of basal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27625?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of psoriasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/49/18200?source=related_link\">",
"      Epidemiology, natural history, and diagnosis of actinic keratosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/41/11930?source=related_link\">",
"      Evaluation of the patient with established venous thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/21/21846?source=related_link\">",
"      Impetigo",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/27/9656?source=related_link\">",
"      Lichen planus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/41/32410?source=related_link\">",
"      Medical management of lower extremity chronic venous disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/7/7285?source=related_link\">",
"      Metabolic and inherited diseases affecting the skin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/29/21977?source=related_link\">",
"      Open surgical techniques for lower extremity vein ablation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/45/34521?source=related_link\">",
"      Overview and management of lower extremity chronic venous disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/40/3721?source=related_link\">",
"      Overview of dermatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/31/28150?source=related_link\">",
"      Patch testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/22/43365?source=related_link\">",
"      Pathophysiology of chronic venous disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/37/23127?source=related_link\">",
"      Post-thrombotic (postphlebitic) syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/50/1828?source=related_link\">",
"      Pretibial myxedema in autoimmune thyroid disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/5/30809?source=related_link\">",
"      Radiofrequency ablation for the treatment of lower extremity chronic venous disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_38_29289="Acute bronchitis in adults";
var content_f28_38_29289=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Acute bronchitis in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/38/29289/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/38/29289/contributors\">",
"     Thomas M File, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/38/29289/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/38/29289/contributors\">",
"     Daniel J Sexton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/38/29289/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/38/29289/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?28/38/29289/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 7, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute bronchitis is one of the most common conditions encountered in clinical practice. It is a self-limited inflammation of the bronchi due to upper airway infection. Patients with acute bronchitis present with a cough lasting more than five days (typically one to three weeks), which may be associated with sputum production. Acute bronchitis should be distinguished from chronic bronchitis, a condition in patients with chronic obstructive pulmonary disease distinguished by a cough for at least three months in each of two successive years. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/14/30954?source=see_link&amp;anchor=H2#H2\">",
"     \"Chronic obstructive pulmonary disease: Definition, clinical manifestations, diagnosis, and staging\", section on 'Definitions'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This respiratory condition is generally caused by a virus. However, reports indicate that more than 60 to 90 percent of patients with acute bronchitis who seek care are given antibiotics [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. Additionally, 75 percent of all antibiotic prescriptions are written for upper respiratory infections [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Guidelines from the American College of Physicians [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/6\">",
"     6",
"    </a>",
"    ] and the Centers for Disease Control and Prevention (CDC) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/7\">",
"     7",
"    </a>",
"    ] are intended to dissuade clinicians from prescribing antibiotics for acute bronchitis [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/7\">",
"     7",
"    </a>",
"    ]. Both guidelines state unequivocally that pertussis is the only indication for antibacterial agents in the treatment of acute bronchitis. However, the frequency of prescriptions for antibiotics for acute bronchitis has decreased only modestly, from approximately 75 to 60 percent in over 10 years from guideline distribution [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/8\">",
"     8",
"    </a>",
"    ]. Additionally, the choice of antibiotics prescribed for the treatment of acute bronchitis has changed substantially during the same time span. Prior to 1990, approximately 20 percent of antibiotics prescribed for the treatment of acute bronchitis were broad spectrum; more recently, approximately 60 percent of all prescriptions written for this condition were for broad-spectrum agents [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/8,9\">",
"     8,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Acute bronchitis caused by microbial infection will be reviewed here. Exacerbations of chronic bronchitis and treatment of viral upper respiratory infections are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/43/7866?source=see_link\">",
"     \"Management of infection in acute exacerbations of chronic obstructive pulmonary disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/52/30537?source=see_link\">",
"     \"The common cold in adults: Treatment and prevention\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The usual causes of acute bronchitis are viral infections of the upper airways including influenza A and B, parainfluenza, coronavirus (types 1-3), rhinovirus, respiratory syncytial virus, and human metapneumovirus [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/10\">",
"     10",
"    </a>",
"    ]. Several case series examined the etiology of acute bronchitis in patients without underlying lung disease [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. An etiologic agent was established in a minority of cases (29 percent of 42 episodes in one study [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/12\">",
"     12",
"    </a>",
"    ], 16 percent of 113 patients in another [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/13\">",
"     13",
"    </a>",
"    ]); viruses were the most common agents identified in both studies.",
"   </p>",
"   <p>",
"    Although it has been suggested that the bacterial pathogens that cause pneumonia (eg, Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, Moraxella catarrhalis, or even gram-negative bacilli) can also cause acute bronchitis, there is no convincing evidence to support the concept of \"acute bacterial bronchitis\" caused by these pathogens in adults. An exception is in patients with airway violations such as tracheostomy or endotracheal intubation, or those with exacerbations of chronic bronchitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/43/7866?source=see_link\">",
"     \"Management of infection in acute exacerbations of chronic obstructive pulmonary disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Influenza",
"    </span>",
"    &nbsp;&mdash;&nbsp;Of the viral agents that cause acute bronchitis, influenza merits special consideration because of its morbidity and the potential for specific therapy. Characteristic features include cough, purulent sputum, fever, and constitutional complaints during the influenza season. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/1/18456?source=see_link\">",
"     \"Clinical manifestations of seasonal influenza in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/13/44249?source=see_link\">",
"     \"Prevention of seasonal influenza in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Other pathogens",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other pathogens that can cause acute bronchitis, although less commonly than viruses, include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Mycoplasma pneumoniae",
"     </li>",
"     <li>",
"      Chlamydophila (formerly Chlamydia) pneumoniae",
"     </li>",
"     <li>",
"      Bordetella pertussis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In one study reviewing all the published papers on acute bronchitis from 1966 to 1995, these three pathogens were the only bacterial organisms shown to be associated with acute bronchitis in previously well adults [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/13\">",
"     13",
"    </a>",
"    ]. However, evidence of clinical response in patients with acute bronchitis to antibacterial agents is only available for pertussis [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Mycoplasma pneumoniae",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mycoplasma pneumoniae is a relatively common cause of upper respiratory tract infection in young adults. Mycoplasma respiratory infections are characterized by pharyngitis, constitutional symptoms, and cough that may be persistent for up to four to six weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/14\">",
"     14",
"    </a>",
"    ]. However, studies of adults with acute cough lasting for more than five days implicate M. pneumoniae in fewer than 1 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/15\">",
"     15",
"    </a>",
"    ]. Data from seroepidemiologic studies suggest that M. pneumoniae is more likely to cause mild upper respiratory symptoms, such as sore throat and head congestion, than pneumonia [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/16\">",
"     16",
"    </a>",
"    ]. For most patients, M. pneumoniae infection usually manifests as a \"nasty cold\" [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/5/3162?source=see_link\">",
"     \"Mycoplasma pneumoniae infection in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Sputum is usually mucoid and shows mononuclear cells with sparse organisms on Gram stain. M. pneumoniae appears to preferentially bind to tracheal epithelial cells in a hamster model and produces eventual sloughing of cells [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/18\">",
"     18",
"    </a>",
"    ]. Bronchial biopsies often show evidence of bronchial inflammation with invasion below the basement membrane by typical organisms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Chlamydophila pneumoniae",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a study of 63 college students with acute bronchitis, C. pneumoniae was the responsible pathogen in 5 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/19\">",
"     19",
"    </a>",
"    ]. Clinical features include pharyngitis, laryngitis, and bronchitis; hoarseness and a low-grade fever, although uncommon, are suggestive findings [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/15,20\">",
"     15,20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/6/7270?source=see_link\">",
"     \"Pneumonia caused by Chlamydophila (Chlamydia) pneumoniae in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Pertussis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bordetella pertussis and B. parapertussis, the etiologic agents of whooping cough, were responsible for substantial morbidity and mortality before a vaccine was introduced in the mid-1940s. However, the incidence of pertussis has increased worldwide over the past 15 to 20 years, including in the United States. Even with this increase, B pertussis only accounts for about 1 percent of cases of acute bronchitis in the US [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/27/20918?source=see_link\">",
"     \"Microbiology, epidemiology, and pathogenesis of Bordetella pertussis infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with partial immunity from prior immunizations often have atypical cases that may resemble viral bronchitis, except for the prolonged duration of the cough. A systematic review of three studies in adults with cough of at least one week duration during nonoutbreak periods for pertussis found that the presence of posttussive emesis and inspiratory whoop increased the likelihood of pertussis only modestly, the specificity of either symptom for pertussis was low, and the absence of either symptom did not rule out the diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/22\">",
"     22",
"    </a>",
"    ]. The likelihood of pertussis increased with increasing duration of cough. One study from San Francisco of 153 adults with cough persisting for at least two weeks found that 12 percent had evidence of pertussis; the diagnosis was not specifically suspected by the evaluating physician in any of the patients [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/37/13911?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Bordetella pertussis infections in adolescents and adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute bronchitis is characterized by self-limited inflammation of the bronchi and clinically expressed as cough, which may include sputum production. Acute bronchitis cannot be distinguished from upper respiratory infections in the first few days of illness, but acute bronchitis should be considered when cough persists for more than five days [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/24\">",
"     24",
"    </a>",
"    ]. Since treatment for either viral upper respiratory infection or acute bronchitis is directed toward symptom control, making the distinction between these diagnoses is not critical. Furthermore, acute bronchitis is often associated with viral upper respiratory infection.",
"   </p>",
"   <p>",
"    It is important, however, to distinguish acute bronchitis from pneumonia, which usually indicates need for antibiotic therapy. Fever is an unusual sign in patients with acute bronchitis and suggests the presence of either influenza or pneumonia. Patients with the combination of cough, fever, sputum production, and constitutional symptoms are more likely to have influenza or pneumonia. Patients with acute bronchitis have few systemic symptoms. They may have chest wall tenderness related to muscle strain from coughing. Wheezing may also occur. Cough in patients with acute bronchitis usually lasts from 10 to 20 days [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/24\">",
"     24",
"    </a>",
"    ]. Cough disappeared by day 14 in three-quarters of patients with viral bronchitis in one study [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/25\">",
"     25",
"    </a>",
"    ]. In another study, the median duration of cough from all causes of acute bronchitis was 18 days, with a mean of 24 days [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Purulent sputum is reported in 50 percent of patients with acute bronchitis [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/24\">",
"     24",
"    </a>",
"    ]. This usually represents sloughing of cells from the tracheobronchial epithelium, along with inflammatory cells. Purulence does",
"    <strong>",
"     not",
"    </strong>",
"    signify bacterial infection, contrary to commonly held beliefs.",
"   </p>",
"   <p>",
"    Physical examination in patients with acute bronchitis may reveal wheezing consistent with bronchospasm. Bronchospasm, evidenced by reduced FEV1, can be found in 40 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/26\">",
"     26",
"    </a>",
"    ] and bronchial hyperreactivity can frequently be demonstrated with provocative testing, although such testing is rarely indicated [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/11\">",
"     11",
"    </a>",
"    ]. Airway hyperreactivity typically improves over five to six weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/24\">",
"     24",
"    </a>",
"    ]. Patients with acute bronchitis may have rhonchi on auscultation, which often clear with after coughing. Physical examination of the lungs that reveals signs of parenchymal consolidation (dullness to percussion, decreased breath sounds, rales, egophony, or bronchophony) or pleural inflammation (pleural rub) indicate pulmonary disease beyond the bronchi. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/26/26026?source=see_link&amp;anchor=H2#H2\">",
"     \"Diagnostic approach to community-acquired pneumonia in adults\", section on 'Clinical evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Chest x-ray findings in patients with acute bronchitis are generally non-specific, though subtle changes consistent with thickening of the bronchial walls in the lower lobes are occasionally reported. Findings of interstitial disease, parenchymal infiltrates, or pleural effusion on x-ray suggest a process other than acute bronchitis. Criteria for ordering a chest radiograph are presented below. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The white blood count is often normal or may be slightly elevated in patients with acute bronchitis. A white count that is significantly elevated or indicates marked neutrophilia (&ldquo;left-shift&rdquo;) is more consistent with bacterial pneumonia. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute bronchitis refers to a self-limited inflammation of the bronchi due to upper airway infection, which is most often viral. Patients with acute bronchitis present with a cough lasting more than five days (typically one to three weeks), which may be associated with sputum production. For most patients with acute bronchitis, the diagnosis is based upon the history and physical examination, and further testing is not needed.",
"   </p>",
"   <p>",
"    The typical history includes the presence of cough that persists for five or more days and lasts up to three weeks, with production of purulent-appearing sputum. The cough may be accompanied by bronchospasm. Mild dyspnea may also be present in some patients. Physical examination of the chest may reveal wheezing or rhonchi, but signs of consolidation or rales should not be present. Patients are generally afebrile, although there may be a low-grade temperature, and there should be no evidence of chronic pulmonary disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/14/30954?source=see_link&amp;anchor=H7#H7\">",
"     \"Chronic obstructive pulmonary disease: Definition, clinical manifestations, diagnosis, and staging\", section on 'Physical examination'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Chest radiographs are indicated only when clinical features suggest pneumonia. The role of procalcitonin (PCT) in distinguishing patients who would benefit from antibiotic therapy is emerging. PCT is a more specific marker of bacterial infection than white blood count or C-reactive protein [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Chest x-ray",
"    </span>",
"    &nbsp;&mdash;&nbsp;The indications for a chest x-ray in patients with an acute cough syndrome, to exclude pneumonia, are abnormal vital signs (pulse",
"    <span class=\"nowrap\">",
"     &gt;100/minute,",
"    </span>",
"    respiratory rate &gt;24",
"    <span class=\"nowrap\">",
"     breaths/minute,",
"    </span>",
"    or temperature &gt;38&ordm;C), or rales or signs of consolidation on chest examination [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. Patients of advanced age (over 75 years of age), however, may have pneumonia without mounting a significant fever [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/28\">",
"     28",
"    </a>",
"    ]. Signs and symptoms suggesting pneumonia in this older population include tachypnea, decreased oxygen saturation, and decreased mental status, often displayed as behavioral change; chest x-ray should be ordered for such older patients who have a cough.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Microbiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bacterial cultures of expectorated sputum in patients with a negative chest radiograph are not recommended, since bacterial pathogens only rarely play a role in acute bronchitis [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/1,2,6,7,29\">",
"     1,2,6,7,29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnosis of pertussis is established by culture of the posterior nasopharynx, sampled by nasopharyngeal swab or aspirate [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/30\">",
"     30",
"    </a>",
"    ]. Where PCR testing is available, culture plus PCR is advised, since cultures are relatively insensitive, and PCR is rapid and sensitive [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. Diagnosing pertussis in adults requires a high index of suspicion, since the presentation is often atypical without whoop or posttussive emesis. Patients with paroxysms of coughing and a cough of at least two weeks duration without an apparent cause may be appropriate for testing. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/37/13911?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Bordetella pertussis infections in adolescents and adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Rapid tests can be used for the diagnosis of seasonal influenza; the sensitivity of these tests is similar to the sensitivity of a clinical diagnosis based upon the presence of fever and typical symptoms during an influenza epidemic. Rapid tests are commercially available at a cost of $10 to $15 per test and provide results in 10 to 20 minutes. The sensitivity of rapid testing for seasonal influenza is approximately 40 to 60 percent and specificity 99 percent, although the sensitivity for the 2009 H1N1 influenza was less [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/33-36\">",
"     33-36",
"    </a>",
"    ]. Testing is appropriate for selected individuals who present during influenza season with fever, cough, and other systemic symptoms suggesting influenza. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/25/5528?source=see_link&amp;anchor=H1018262456#H1018262456\">",
"     \"Diagnosis of seasonal influenza in adults\", section on 'Rapid antigen tests'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is usually unrealistic and unnecessary to attempt to determine if Mycoplasma, or Chlamydophila are the etiologic agents of acute bronchitis. Diagnostic testing may be justified in suspected outbreaks, when antibiotics might limit spread [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/37\">",
"     37",
"    </a>",
"    ]. Diagnostic tests that may be considered include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Diagnostic studies for Mycoplasma include cultures of pharyngeal washings for cell-wall deficient organisms [",
"      <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/38\">",
"       38",
"      </a>",
"      ] (few laboratories offer this test), IgM titers that are usually elevated after seven days [",
"      <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/39\">",
"       39",
"      </a>",
"      ], seroconversion (IgA, IgM, or IgG) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/38\">",
"       38",
"      </a>",
"      ], antigen detection with polymerase chain reaction [",
"      <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/40\">",
"       40",
"      </a>",
"      ], or a cold agglutinin titer exceeding 1:64 (nonspecific) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/41\">",
"       41",
"      </a>",
"      ]. None of these tests has achieved a consensus endorsement by experts [",
"      <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/42\">",
"       42",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/5/3162?source=see_link\">",
"       \"Mycoplasma pneumoniae infection in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Clinical laboratory methods for identification of C. pneumoniae are suboptimal. Even with the use of diagnostic testing, it is rare to make a definitive diagnosis of C. pneumoniae in a timely manner. As a result, treatment is usually empirical. Most laboratories are not well-equipped to culture the chlamydophila, which requires cell culture techniques on nasopharyngeal samples. Other diagnostic modalities for chlamydophila include antibody tests (complement fixation and microimmunofluorescence), direct antigen detection (direct immunofluorescence [DFA] and enzyme immunoassay [EIA]), and polymerase chain reaction (PCR) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/43-45\">",
"       43-45",
"      </a>",
"      ]. PCR-EIA is easier to perform than culture and may nearly match its sensitivity. However, PCR methods are not widely available for clinical diagnosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/6/7270?source=see_link\">",
"       \"Pneumonia caused by Chlamydophila (Chlamydia) pneumoniae in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Procalcitonin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Procalcitonin is released in multiple tissues in response to direct stimulation of cytokines by bacterial infections [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/5\">",
"     5",
"    </a>",
"    ]. Additionally, procalcitonin upregulation is blocked by interferon-gamma released in response to viral infections. Thus, procalcitonin has relatively high specificity for bacterial infection.",
"   </p>",
"   <p>",
"    Serum levels of procalcitonin have been evaluated in randomized trials as a means to distinguish patients with bacterial and nonbacterial infection and thus help identify patients with acute respiratory infection who do not warrant antibiotic treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/46-49\">",
"     46-49",
"    </a>",
"    ]. In a 2012 meta-analysis of 14 trials of 4221 patients with acute respiratory infections (including bronchitis), procalcitonin-guided decision making for antibiotic treatment was associated with a reduction in antibiotic exposure (median eight to four days) without an increase in 30-day treatment failure or mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/50\">",
"     50",
"    </a>",
"    ]. This was true for patients with any type of acute respiratory infection and in any clinical setting (eg, outpatient clinic, emergency department). Limitations of the trials included inadequate powering and lack of blinding.",
"   </p>",
"   <p>",
"    If a valid assay for procalcitonin is available and can be obtained in a timely manner at the point-of-care, this can be useful for assessing patients with manifestations of acute bronchitis [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/51,52\">",
"     51,52",
"    </a>",
"    ]. In one proposed algorithm, antibiotic decisions for patients presenting to primary care with low acuity, nonpneumonic respiratory infections were based on the following procalcitonin parameters [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/49\">",
"     49",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Procalcitonin &lt;0.10",
"      <span class=\"nowrap\">",
"       mcg/L:",
"      </span>",
"      Strongly discourage antibiotic",
"     </li>",
"     <li>",
"      Procalcitonin &lt;0.25",
"      <span class=\"nowrap\">",
"       mcg/L:",
"      </span>",
"      Discourage antibiotic",
"     </li>",
"     <li>",
"      Procalcitonin &gt;0.25",
"      <span class=\"nowrap\">",
"       mcg/L:",
"      </span>",
"      Encourage antibiotic",
"     </li>",
"     <li>",
"      Procalcitonin &gt;0.50",
"      <span class=\"nowrap\">",
"       mcg/L:",
"      </span>",
"      Strongly encourage antibiotic",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These parameters, however, require further validation in large multicenter trials. Clinical reassessment is required in patients with respiratory infections who clinically worsen after a decision was made to withhold antibiotics on the basis of a low procalcitonin [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The use of procalcitonin in the diagnostic evaluation of pneumonia is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/26/26026?source=see_link&amp;anchor=H13#H13\">",
"     \"Diagnostic approach to community-acquired pneumonia in adults\", section on 'Procalcitonin and CRP'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14751396\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14751404\">",
"    <span class=\"h2\">",
"     Chronic bronchitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic bronchitis, by definition, is diagnosed in patients who have cough and sputum production on most days of the month for at least three months of the year during two consecutive years [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/53\">",
"     53",
"    </a>",
"    ]. This condition, and acute exacerbations of chronic bronchitis, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/14/30954?source=see_link\">",
"     \"Chronic obstructive pulmonary disease: Definition, clinical manifestations, diagnosis, and staging\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/43/7866?source=see_link\">",
"     \"Management of infection in acute exacerbations of chronic obstructive pulmonary disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14751411\">",
"    <span class=\"h2\">",
"     Pneumonia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormal vital signs (fever, tachypnea, or tachycardia) and signs of consolidation or rales on physical examination suggest the possibility of pneumonia and the need for a confirmatory chest radiograph to distinguish acute bronchitis from pneumonia [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/54\">",
"     54",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/26/26026?source=see_link\">",
"     \"Diagnostic approach to community-acquired pneumonia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14751418\">",
"    <span class=\"h2\">",
"     Postnasal drip syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of postnasal drip is suggested in patients who describe the sensation of postnasal drainage or the need to frequently clear their throat. Many patients suffering from this condition have mucoid or mucopurulent nasal secretions; when allergies cause the problem, eosinophils usually can be found in the secretions. Postnasal drip can be caused by the common cold, allergic rhinitis, vasomotor rhinitis, postinfectious rhinitis, rhinosinusitis,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    environmental irritants.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14751425\">",
"    <span class=\"h2\">",
"     Gastroesophageal reflux",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastroesophageal reflux (GERD) is a common cause of intermittent or persistent cough. Cough may be present in the absence of complaints of symptoms of reflux, such as heartburn or sour taste in the mouth. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/18/5418?source=see_link\">",
"     \"Evaluation of subacute and chronic cough in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14751432\">",
"    <span class=\"h2\">",
"     Asthma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with acute bronchitis often have airway hyperreactivity with changes in pulmonary function testing. In contrast to patients with asthma, airway obstruction is transient in patients with acute bronchitis and usually resolves in five to six weeks.",
"   </p>",
"   <p>",
"    When patients present with new onset of cough and wheezing or evidence of airway obstruction, it may not be possible to distinguish acute bronchitis from asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/55\">",
"     55",
"    </a>",
"    ]. In one study, 65 percent of patients who had two or more episodes of bronchitis over five years were found to have mild asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with an asthma syndrome often have a history of intermittent symptoms typical of asthma (cough, wheeze, and shortness of breath) plus physical findings of wheezing that resolve when symptoms are treated. Whether or not wheezing is present, many asthmatic patients demonstrate airway obstruction that is reversible with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/61/16344?source=see_link\">",
"     albuterol",
"    </a>",
"    or inducible with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/32/10756?source=see_link\">",
"     methacholine",
"    </a>",
"    inhalation on pulmonary function testing. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/1/19482?source=see_link\">",
"     \"Diagnosis of asthma in adolescents and adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with known asthma may develop superimposed acute bronchitis. It is common that such patients seek treatment and are inappropriately prescribed an antibiotic even though they usually have a viral illness. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Lack of efficacy of routine antibiotic therapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with acute bronchitis require only reassurance and symptomatic treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Symptomatic",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many patients with acute bronchitis have associated symptoms of the common cold and may benefit from symptomatic treatment using a nonsteroidal antiinflammatory drug,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    ,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/37/33360?source=see_link\">",
"     ipratropium",
"    </a>",
"    . Discussion of symptomatic treatment options for the common cold, as well as treatment for subacute cough is presented in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/52/30537?source=see_link\">",
"     \"The common cold in adults: Treatment and prevention\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/16/27913?source=see_link\">",
"     \"Treatment of subacute and chronic cough in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients with acute bronchitis, there are limited data to support the use of cough suppressants for acute bronchitis. An evidence-based practice guideline for the American College of Chest Physicians (ACCP) found that there have been no double blind placebo controlled studies of the effects of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/0/35848?source=see_link\">",
"     codeine",
"    </a>",
"    on cough related to acute bronchitis, and studies of the effect of codeine or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     dextromethorphan",
"    </a>",
"    on cough related to the common cold report variable findings [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/57\">",
"     57",
"    </a>",
"    ]. This review concluded that central cough suppressants have limited efficacy for symptomatic relief in patients with cough due to URI and are not recommended for this use.",
"   </p>",
"   <p>",
"    Routine use of beta-2-agonists for the treatment of acute bronchitis is not supported by systematic review or clinical practice guidelines [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/58-60\">",
"     58-60",
"    </a>",
"    ]. A 2011 meta-analysis of five randomized clinical trials in adults with acute bronchitis found mixed results for oral or inhaled beta-2-agonsists [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/60\">",
"     60",
"    </a>",
"    ]. No significant differences were noted in daily cough scores or persistence of coughing at seven days. Trials that did note a quicker resolution of cough with beta-2-agonists included a higher proportion of patients with airflow obstruction and wheezing.",
"   </p>",
"   <p>",
"    A systematic review of over-the-counter (OTC) medications for acute cough, including 18 trials in adults, found variable results for the efficacy of preparations containing",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16101?source=see_link\">",
"     guaifenesin",
"    </a>",
"    , antihistamine-decongestants, or other combinations and concluded that there is no evidence for or against the effectiveness of OTC preparations for acute cough [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/61\">",
"     61",
"    </a>",
"    ]. There are no clinical trial data to support the role of mucolytic agents [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/59\">",
"     59",
"    </a>",
"    ]. A systematic review found no quality randomized trials to support the use of Chinese herbs for acute bronchitis, with a note of uncertainty about side effects and safety [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Lack of efficacy of routine antibiotic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major therapeutic issue in most cases of acute bronchitis is the decision to use or forgo antibacterial agents. Multiple studies indicate that patients with acute bronchitis do",
"    <strong>",
"     not",
"    </strong>",
"    experience significant benefit from antibiotic therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/63,64\">",
"     63,64",
"    </a>",
"    ]. Representative studies include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A 2012 meta-analysis of 15 randomized trials that included both smokers and non-smokers found a statistically significant reduction of 0.6 days in cough duration with antibiotic treatment, but concluded that this marginal benefit was offset by the risk of potential adverse effects from drug treatment [",
"      <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/64\">",
"       64",
"      </a>",
"      ]. In addition to promoting antibiotic resistance, antibiotic use accounts for over 19 percent of all emergency department visits for adverse drug events [",
"      <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/65\">",
"       65",
"      </a>",
"      ], with many more antibiotic-related adverse drug events occurring that do not require emergent evaluation.",
"     </li>",
"     <li>",
"      In a subsequent trial, 2061 patients with acute lower respiratory tract infections were randomly assigned to seven days of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/10/42152?source=see_link\">",
"       amoxicillin",
"      </a>",
"      or placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/66\">",
"       66",
"      </a>",
"      ]. There was no difference in the primary outcome of duration of symptoms (rated moderately bad or worsening) in the amoxicillin versus placebo group (six versus seven days, respectively). There was also no difference between the younger and older (&gt;60) age groups for symptom duration.",
"     </li>",
"     <li>",
"      A modest benefit for antibiotics in reducing the incidence of pneumonia following common respiratory infections, including acute bronchitis, was demonstrated in a retrospective study of 3.36 million cases of upper respiratory infection [",
"      <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/67\">",
"       67",
"      </a>",
"      ]. Benefit was greatest in older patients; for persons &gt;65 years, it was necessary to treat 39 to prevent one case of pneumonia.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Guidelines from the National Institute for Health and Clinical Excellence (NICE) in the UK advise not treating uncomplicated acute bronchitis with antibiotics [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/68\">",
"     68",
"    </a>",
"    ]. For patients at risk of significant complications (eg, due to heart, lung, renal, liver, neuromuscular disease, immunosuppression, or frailty), further investigation, management, and possible initiation of antimicrobial therapy may be warranted.",
"   </p>",
"   <p>",
"    In recognition of the concern for overuse of antimicrobial agents, avoidance of antibiotics for the treatment of adults with acute bronchitis was included as a component of the Healthcare Effectiveness Data and Information Set reported to the National Committee for Quality Assurance in 2007 and included as a National Quality Forum quality measure in 2009 [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/69\">",
"     69",
"    </a>",
"    ]. A review using data from a large, integrated health system examined trends in antibiotic use for acute bronchitis from 2006 to 2009 and found that an apparent decrease in antibiotic prescribing for patients whose visit was assigned a diagnosis code for &ldquo;acute bronchitis&rdquo; was largely offset by use of other diagnostic codes to categorize patients who received antibiotics for cough [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/70\">",
"     70",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Strategies to reduce use of antimicrobial agents for acute bronchitis have been assessed. In a randomized trial among primary care practices, there was a significant reduction of antimicrobial use for acute bronchitis at practices using decision support material (printed or computer-based) compared with control practices [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/71,72\">",
"     71,72",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Mycoplasma pneumoniae or Chlamydophila pneumoniae",
"    </span>",
"    &nbsp;&mdash;&nbsp;Occasional patients have acute bronchitis caused by M. pneumoniae or C. pneumoniae. These etiologies should be suspected in patients with prolonged cough and typical upper airway symptoms. Unfortunately, diagnostic studies for these organisms are limited in terms of availability, specificity, and sensitivity. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Diagnosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Both organisms are susceptible to tetracyclines, macrolides, and fluoroquinolones. There is a consensus agreement that the practice of routinely using antibiotics directed at these pathogens is not recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/7\">",
"     7",
"    </a>",
"    ]. As a general consideration, we do not suggest testing or empiric treatment for these pathogens unless there is evidence of a local outbreak. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/5/3162?source=see_link\">",
"     \"Mycoplasma pneumoniae infection in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/6/7270?source=see_link\">",
"     \"Pneumonia caused by Chlamydophila (Chlamydia) pneumoniae in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Pertussis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antibiotics provide clinical benefit only if begun early (within the first week) in the course of pertussis [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/73\">",
"     73",
"    </a>",
"    ]. However, antibiotic treatment should be instituted, even if later in the course, with the rationale to limit infection spread, despite minimal effect on the clinical course.",
"   </p>",
"   <p>",
"    Treatment regimens include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"     erythromycin",
"    </a>",
"    500 mg four times daily for 14 days,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/57/10138?source=see_link\">",
"     clarithromycin",
"    </a>",
"    500 mg twice daily for 14 days, or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/43/33456?source=see_link\">",
"     azithromycin",
"    </a>",
"    500 mg once and 250 mg daily for four days. The adverse effects of erythromycin include a high incidence of gastrointestinal side effects and the rare risk of sudden cardiac death due to QT interval prolongation, especially when other drugs metabolized by CYP3A4 are taken concurrently (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/55/23418?source=see_link\">",
"     \"Acquired long QT syndrome\"",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/18\">",
"     18",
"    </a>",
"    ]. For these reasons, adults are usually treated with clarithromycin or azithromycin. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/22/39271?source=see_link\">",
"     \"Treatment and prevention of Bordetella pertussis infection in adolescents and adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Influenza",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most influenza strains are treatable with neuraminidase inhibitors (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/20/40263?source=see_link\">",
"     oseltamivir",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/27/26038?source=see_link\">",
"     zanamivir",
"    </a>",
"    ); for optimal benefit, these drugs should be given within 48 hours of symptom onset for demonstrable clinical benefit [",
"    <a class=\"abstract\" href=\"UTD.htm?28/38/29289/abstract/74,75\">",
"     74,75",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/46/22250?source=see_link\">",
"     \"Treatment of seasonal influenza in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?23/28/24002?source=see_link\">",
"       \"Patient information: Acute bronchitis (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?42/0/43011?source=see_link\">",
"       \"Patient information: Cough in adults (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?12/12/12483?source=see_link\">",
"       \"Patient information: What you should know about antibiotics (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?21/43/22195?source=see_link\">",
"       \"Patient information: Coughing up blood (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (See",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?8/57/9106?source=see_link\">",
"       \"Patient information: Acute bronchitis in adults (Beyond the Basics)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most cases of acute bronchitis are due to viruses. Acute bronchitis is one of the most common causes of antibiotic abuse. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Influenza should be considered in patients who present with symptoms of acute bronchitis and fever. Nonviral pathogens that may cause acute bronchitis include Mycoplasma pneumoniae, Chlamydophila pneumoniae, and Bordetella pertussis. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Acute bronchitis often cannot be distinguished from a simple upper respiratory infection in the first few days of illness; furthermore, acute bronchitis is often associated with simple upper respiratory tract infection. Acute bronchitis is suggested by the persistence of cough for more than five days. In patients with acute bronchitis, cough generally persists two to three weeks, and airway hyperreactivity may last five to six weeks. Fever is relatively unusual in acute bronchitis and suggests either influenza or pneumonia. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Indications for a chest x-ray in patients with an acute cough, to exclude pneumonia, are abnormal vital signs (pulse",
"      <span class=\"nowrap\">",
"       &gt;100/minute,",
"      </span>",
"      respiratory rate &gt;24, or temperature &gt;38&ordm;C), rales or signs of consolidation on chest examination, evidence of hypoxemia (eg, pulse oxygen assessment), mental confusion, or signs of systemic illness. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Chest x-ray'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bacterial cultures of expectorated sputum are not recommended in patients with acute bronchitis. Patients with severe paroxysmal cough should be evaluated for pertussis. The use of procalcitonin testing in ambulatory patients to reduce unwarranted antimicrobial use for acute bronchitis has been shown to be helpful in several studies; however, there is insufficient evidence to presently warrant a recommendation for routine use. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend NOT treating patients with presumed acute bronchitis with empiric antibiotic therapy (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). Symptomatic treatment may include nonsteroidal antiinflammatory drugs,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"       acetaminophen",
"      </a>",
"      ,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/37/33360?source=see_link\">",
"       ipratropium",
"      </a>",
"      . (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/1\">",
"      Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 1997; 278:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/2\">",
"      Gonzales R, Steiner JF, Lum A, Barrett PH Jr. Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA 1999; 281:1512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/3\">",
"      Evertsen J, Baumgardner DJ, Regnery A, Banerjee I. Diagnosis and management of pneumonia and bronchitis in outpatient primary care practices. Prim Care Respir J 2010; 19:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/4\">",
"      Kroening-Roche JC, Soroudi A, Castillo EM, Vilke GM. Antibiotic and bronchodilator prescribing for acute bronchitis in the emergency department. J Emerg Med 2012; 43:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/5\">",
"      Schuetz P, Amin DN, Greenwald JL. Role of procalcitonin in managing adult patients with respiratory tract infections. Chest 2012; 141:1063.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/6\">",
"      Snow V, Mottur-Pilson C, Gonzales R, et al. Principles of appropriate antibiotic use for treatment of acute bronchitis in adults. Ann Intern Med 2001; 134:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/7\">",
"      Gonzales R, Bartlett JG, Besser RE, et al. Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background. Ann Intern Med 2001; 134:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/8\">",
"      Steinman MA, Gonzales R, Linder JA, Landefeld CS. Changing use of antibiotics in community-based outpatient practice, 1991-1999. Ann Intern Med 2003; 138:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/9\">",
"      McCaig LF, Besser RE, Hughes JM. Antimicrobial drug prescription in ambulatory care settings, United States, 1992-2000. Emerg Infect Dis 2003; 9:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/10\">",
"      Falsey AR, Erdman D, Anderson LJ, Walsh EE. Human metapneumovirus infections in young and elderly adults. J Infect Dis 2003; 187:785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/11\">",
"      Boldy DA, Skidmore SJ, Ayres JG. Acute bronchitis in the community: clinical features, infective factors, changes in pulmonary function and bronchial reactivity to histamine. Respir Med 1990; 84:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/12\">",
"      Jonsson JS, Sigurdsson JA, Kristinsson KG, et al. Acute bronchitis in adults. How close do we come to its aetiology in general practice? Scand J Prim Health Care 1997; 15:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/13\">",
"      MacKay DN. Treatment of acute bronchitis in adults without underlying lung disease. J Gen Intern Med 1996; 11:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/14\">",
"      Denny FW, Clyde WA Jr, Glezen WP. Mycoplasma pneumoniae disease: clinical spectrum, pathophysiology, epidemiology, and control. J Infect Dis 1971; 123:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/15\">",
"      Wadowsky RM, Castilla EA, Laus S, et al. Evaluation of Chlamydia pneumoniae and Mycoplasma pneumoniae as etiologic agents of persistent cough in adolescents and adults. J Clin Microbiol 2002; 40:637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/16\">",
"      Foy HM, Kenny GE, Cooney MK, Allan ID. Long-term epidemiology of infections with Mycoplasma pneumoniae. J Infect Dis 1979; 139:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/17\">",
"      Johnson S. Possibly autoantibody complications in Mycoplasma pneumoniae infection. Clin Infect Dis 2006; 43:1246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/18\">",
"      Powell DA, Hu PC, Wilson M, et al. Attachment of Mycoplasma pneumoniae to respiratory epithelium. Infect Immun 1976; 13:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/19\">",
"      Grayston JT, Kuo CC, Wang SP, Altman J. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med 1986; 315:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/20\">",
"      Grayston JT, Diwan VK, Cooney M, Wang SP. Community- and hospital-acquired pneumonia associated with Chlamydia TWAR infection demonstrated serologically. Arch Intern Med 1989; 149:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/21\">",
"      Ward JI, Cherry JD, Chang SJ, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 2005; 353:1555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/22\">",
"      Cornia PB, Hersh AL, Lipsky BA, et al. Does this coughing adolescent or adult patient have pertussis? JAMA 2010; 304:890.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/23\">",
"      Nennig ME, Shinefield HR, Edwards KM, et al. Prevalence and incidence of adult pertussis in an urban population. JAMA 1996; 275:1672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/24\">",
"      Wenzel RP, Fowler AA 3rd. Clinical practice. Acute bronchitis. N Engl J Med 2006; 355:2125.",
"     </a>",
"    </li>",
"    <li>",
"     Dingle JH, Badger GF, Jordan WS Jr. Illness in the home: A study of 25,000 illnesses in a group of Cleveland families, The Press of Western Reserve University, Cleveland 1964. p.68.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/26\">",
"      Williamson HA Jr. Pulmonary function tests in acute bronchitis: evidence for reversible airway obstruction. J Fam Pract 1987; 25:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/27\">",
"      M&uuml;ller B, Harbarth S, Stolz D, et al. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis 2007; 7:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/28\">",
"      Metlay JP, Schulz R, Li YH, et al. Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med 1997; 157:1453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/29\">",
"      Gonzales R, Sande M. What will it take to stop physicians from prescribing antibiotics in acute bronchitis? Lancet 1995; 345:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/30\">",
"      Hoppe JE. Methods for isolation of Bordetella pertussis from patients with whooping cough. Eur J Clin Microbiol Infect Dis 1988; 7:616.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/31\">",
"      Sotir MJ, Cappozzo DL, Warshauer DM, et al. Evaluation of polymerase chain reaction and culture for diagnosis of pertussis in the control of a county-wide outbreak focused among adolescents and adults. Clin Infect Dis 2007; 44:1216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/32\">",
"      Koidl C, Bozic M, Burmeister A, et al. Detection and differentiation of Bordetella spp. by real-time PCR. J Clin Microbiol 2007; 45:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/33\">",
"      Faix DJ, Sherman SS, Waterman SH. Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 361:728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/34\">",
"      Centers for Disease Control and Prevention (CDC). Evaluation of rapid influenza diagnostic tests for influenza A (H3N2)v virus and updated case count--United States, 2012. MMWR Morb Mortal Wkly Rep 2012; 61:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/35\">",
"      Hurt AC, Alexander R, Hibbert J, et al. Performance of six influenza rapid tests in detecting human influenza in clinical specimens. J Clin Virol 2007; 39:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/36\">",
"      Harper SA, Bradley JS, Englund JA, et al. Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009; 48:1003.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/37\">",
"      Klausner JD, Passaro D, Rosenberg J, et al. Enhanced control of an outbreak of Mycoplasma pneumoniae pneumonia with azithromycin prophylaxis. J Infect Dis 1998; 177:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/38\">",
"      Klement E, Talkington DF, Wasserzug O, et al. Identification of risk factors for infection in an outbreak of Mycoplasma pneumoniae respiratory tract disease. Clin Infect Dis 2006; 43:1239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/39\">",
"      Uldum SA, Jensen JS, S&oslash;nderg&aring;rd-Andersen J, Lind K. Enzyme immunoassay for detection of immunoglobulin M (IgM) and IgG antibodies to Mycoplasma pneumoniae. J Clin Microbiol 1992; 30:1198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/40\">",
"      Shuvy M, Rav-Acha M, Izhar U, et al. Massive empyema caused by Mycoplasma pneumoniae in an adult: a case report. BMC Infect Dis 2006; 6:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/41\">",
"      Biberfeld G, Biberfeld P, Wigzell H. Antibodies of surface antigens of lymphocytes and lymphoblastoid cells in cold-agglutinin-positive sera from patients with Mycoplasma pneumoniae infection. Scand J Immunol 1976; 5:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/42\">",
"      Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 2000; 31:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/43\">",
"      Kumar S, Hammerschlag MR. Acute respiratory infection due to Chlamydia pneumoniae: current status of diagnostic methods. Clin Infect Dis 2007; 44:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/44\">",
"      Tuuminen T, Palom&auml;ki P, Paavonen J. The use of serologic tests for the diagnosis of chlamydial infections. J Microbiol Methods 2000; 42:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/45\">",
"      Murdoch DR. Molecular genetic methods in the diagnosis of lower respiratory tract infections. APMIS 2004; 112:713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/46\">",
"      Schuetz P, Christ-Crain M, Thomann R, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 2009; 302:1059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/47\">",
"      Briel M, Schuetz P, Mueller B, et al. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med 2008; 168:2000.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/48\">",
"      Burkhardt O, Ewig S, Haagen U, et al. Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection. Eur Respir J 2010; 36:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/49\">",
"      Schuetz P, Chiappa V, Briel M, Greenwald JL. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med 2011; 171:1322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/50\">",
"      Schuetz P, M&uuml;ller B, Christ-Crain M, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev 2012; 9:CD007498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/51\">",
"      Prieto B, Alvarez FV. Lack of transferability of results between procalcitonin assays. Clin Chem 2009; 55:2226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/52\">",
"      Gilbert DN. Procalcitonin as a biomarker in respiratory tract infection. Clin Infect Dis 2011; 52 Suppl 4:S346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/53\">",
"      Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23:932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/54\">",
"      Metlay JP, Kapoor WN, Fine MJ. Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination. JAMA 1997; 278:1440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/55\">",
"      J&oacute;nsson JS, G&iacute;slason T, G&iacute;slason D, Sigurdsson JA. Acute bronchitis and clinical outcome three years later: prospective cohort study. BMJ 1998; 317:1433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/56\">",
"      Hallett JS, Jacobs RL. Recurrent acute bronchitis: the association with undiagnosed bronchial asthma. Ann Allergy 1985; 55:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/57\">",
"      Bolser DC. Cough suppressant and pharmacologic protussive therapy: ACCP evidence-based clinical practice guidelines. Chest 2006; 129:238S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/58\">",
"      Smucny JJ, Flynn CA, Becker LA, Glazier RH. Are beta2-agonists effective treatment for acute bronchitis or acute cough in patients without underlying pulmonary disease? A systematic review. J Fam Pract 2001; 50:945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/59\">",
"      Braman SS. Chronic cough due to acute bronchitis: ACCP evidence-based clinical practice guidelines. Chest 2006; 129:95S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/60\">",
"      Becker LA, Hom J, Villasis-Keever M, van der Wouden JC. Beta2-agonists for acute bronchitis. Cochrane Database Syst Rev 2011; :CD001726.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/61\">",
"      Smith SM, Schroeder K, Fahey T. Over-the-counter (OTC) medications for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev 2012; 8:CD001831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/62\">",
"      Jiang L, Li K, Wu T. Chinese medicinal herbs for acute bronchitis. Cochrane Database Syst Rev 2012; 2:CD004560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/63\">",
"      Little P, Rumsby K, Kelly J, et al. Information leaflet and antibiotic prescribing strategies for acute lower respiratory tract infection: a randomized controlled trial. JAMA 2005; 293:3029.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/64\">",
"      Smith SM, Fahey T, Smucny J, et al. Antibiotics for acute bronchitis. Cochrane Database Syst Rev 2012; CD000245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/65\">",
"      Shehab N, Patel PR, Srinivasan A, Budnitz DS. Emergency department visits for antibiotic-associated adverse events. Clin Infect Dis 2008; 47:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/66\">",
"      Little P, Stuart B, Moore M, et al. Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. Lancet Infect Dis 2013; 13:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/67\">",
"      Petersen I, Johnson AM, Islam A, et al. Protective effect of antibiotics against serious complications of common respiratory tract infections: retrospective cohort study with the UK General Practice Research Database. BMJ 2007; 335:982.",
"     </a>",
"    </li>",
"    <li>",
"     file://publications.nice.org.uk/respiratory-tract-infections-antibiotic-prescribing-cg69/guidance (Accessed on February 20, 2013).",
"    </li>",
"    <li>",
"     National Quality Forum (NQF). Avoidance of Antibiotic Treatment in Adults with Acute Bronchitis. Available at: file://www.qualityforum.org/MeasureDetails.aspx?actid=0&amp;SubmissionId=1216#p=5&amp;s=n&amp;so=a (Accessed on July 31, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/70\">",
"      Roth S, Gonzales R, Harding-Anderer T, et al. Unintended consequences of a quality measure for acute bronchitis. Am J Manag Care 2012; 18:e217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/71\">",
"      Gonzales R, Anderer T, McCulloch CE, et al. A cluster randomized trial of decision support strategies for reducing antibiotic use in acute bronchitis. JAMA Intern Med 2013; 173:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/72\">",
"      Linder JA. Antibiotic Prescribing for Acute Respiratory Infections-Success That's Way Off the Mark: Comment on \"A Cluster Randomized Trial of Decision Support Strategies for Reducing Antibiotic Use in Acute Bronchitis\". JAMA Intern Med 2013; 173:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/73\">",
"      Bergquist SO, Bernander S, Dahnsj&ouml; H, Sundel&ouml;f B. Erythromycin in the treatment of pertussis: a study of bacteriologic and clinical effects. Pediatr Infect Dis J 1987; 6:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/38/29289/abstract/74\">",
"      Treanor JJ, Hayden FG, Vrooman PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA 2000; 283:1016.",
"     </a>",
"    </li>",
"    <li>",
"     Bradley JS, Englund JA, File TM, et al. Influenza H1N1: Frontline questions and expert opinion answers. Available at: www.idsociety.org/Content/aspx?id=15743 (Accessed on January 13, 2009).",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6870 Version 20.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.76.133-420B8D9EB9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_38_29289=[""].join("\n");
var outline_f28_38_29289=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Influenza",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Other pathogens",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Mycoplasma pneumoniae",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Chlamydophila pneumoniae",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Pertussis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Chest x-ray",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Microbiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Procalcitonin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14751396\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14751404\">",
"      Chronic bronchitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14751411\">",
"      Pneumonia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14751418\">",
"      Postnasal drip syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14751425\">",
"      Gastroesophageal reflux",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14751432\">",
"      Asthma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Symptomatic",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Lack of efficacy of routine antibiotic therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Mycoplasma pneumoniae or Chlamydophila pneumoniae",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Pertussis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Influenza",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/55/23418?source=related_link\">",
"      Acquired long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/14/30954?source=related_link\">",
"      Chronic obstructive pulmonary disease: Definition, clinical manifestations, diagnosis, and staging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/37/13911?source=related_link\">",
"      Clinical manifestations and diagnosis of Bordetella pertussis infections in adolescents and adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/1/18456?source=related_link\">",
"      Clinical manifestations of seasonal influenza in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/1/19482?source=related_link\">",
"      Diagnosis of asthma in adolescents and adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/25/5528?source=related_link\">",
"      Diagnosis of seasonal influenza in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/26/26026?source=related_link\">",
"      Diagnostic approach to community-acquired pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/18/5418?source=related_link\">",
"      Evaluation of subacute and chronic cough in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/43/7866?source=related_link\">",
"      Management of infection in acute exacerbations of chronic obstructive pulmonary disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/27/20918?source=related_link\">",
"      Microbiology, epidemiology, and pathogenesis of Bordetella pertussis infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/5/3162?source=related_link\">",
"      Mycoplasma pneumoniae infection in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?23/28/24002?source=related_link\">",
"      Patient information: Acute bronchitis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?8/57/9106?source=related_link\">",
"      Patient information: Acute bronchitis in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?42/0/43011?source=related_link\">",
"      Patient information: Cough in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?21/43/22195?source=related_link\">",
"      Patient information: Coughing up blood (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?12/12/12483?source=related_link\">",
"      Patient information: What you should know about antibiotics (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/6/7270?source=related_link\">",
"      Pneumonia caused by Chlamydophila (Chlamydia) pneumoniae in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/13/44249?source=related_link\">",
"      Prevention of seasonal influenza in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/52/30537?source=related_link\">",
"      The common cold in adults: Treatment and prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/22/39271?source=related_link\">",
"      Treatment and prevention of Bordetella pertussis infection in adolescents and adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/46/22250?source=related_link\">",
"      Treatment of seasonal influenza in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/16/27913?source=related_link\">",
"      Treatment of subacute and chronic cough in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_38_29290="Lichenoid drug eruption 1";
var content_f28_38_29290=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F83767%7EDERM%2F83768%7EDERM%2F83769&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F83767%7EDERM%2F83768%7EDERM%2F83769&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Lichenoid drug eruption (drug-induced lichen planus)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In this patient with a lichenoid drug eruption, flat erythematous papules are typically distributed on the trunk and upper extremities. Grouped and confluent lesions also can be seen.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Lichenoid drug eruption (drug-induced lichen planus)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 329px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Flat erythematous/violaceous papules on the shoulder and upper arm of a patient with lichenoid drug eruption.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Lichenoid drug eruption involving the dorsum of the hand",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In contrast to lichen planus, the lesions of lichenoid drug eruption are distributed on the extensor aspects of the extremities. In this patient, confluent violaceous papules are located on the dorsal aspect of the hand.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_38_29290=[""].join("\n");
var outline_f28_38_29290=null;
var title_f28_38_29291="First events MI angina";
var content_f28_38_29291=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F82589&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F82589&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Proportion of first coronary events as myocardial infarction and angina pectoris Framingham study subjects ages 35 to 94",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"1\" rowspan=\"2\">",
"        Age",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\" rowspan=\"1\">",
"        Percent",
"as myocardial infarction",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\" rowspan=\"1\">",
"        Percent",
"as angina",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Men",
"       </td>",
"       <td class=\"subtitle2\">",
"        Women",
"       </td>",
"       <td class=\"subtitle2\">",
"        Men",
"       </td>",
"       <td class=\"subtitle2\">",
"        Women",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        35 to 54",
"       </td>",
"       <td>",
"        52.1",
"       </td>",
"       <td>",
"        31.9",
"       </td>",
"       <td>",
"        32.2",
"       </td>",
"       <td>",
"        57.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        55 to 64",
"       </td>",
"       <td>",
"        46.1",
"       </td>",
"       <td>",
"        27.5",
"       </td>",
"       <td>",
"        39.7",
"       </td>",
"       <td>",
"        59.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        65 to 74",
"       </td>",
"       <td>",
"        56.6",
"       </td>",
"       <td>",
"        36.8",
"       </td>",
"       <td>",
"        28.9",
"       </td>",
"       <td>",
"        49.8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        75 to 94",
"       </td>",
"       <td>",
"        60.2",
"       </td>",
"       <td>",
"        57.0",
"       </td>",
"       <td>",
"        21.1",
"       </td>",
"       <td>",
"        29.1",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    44-year follow-up of cohort and 20-year follow-up of offspring.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_38_29291=[""].join("\n");
var outline_f28_38_29291=null;
var title_f28_38_29292="Selection for bullectomy";
var content_f28_38_29292=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F68646&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F68646&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Patient selection for resection of giant bullae: More favorable and less favorable characteristics",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Parameter",
"       </td>",
"       <td class=\"subtitle1\">",
"        Favorable",
"       </td>",
"       <td class=\"subtitle1\">",
"        Less favorable",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        <strong>",
"         Clinical",
"        </strong>",
"       </td>",
"       <td>",
"        Age &le;50 years",
"       </td>",
"       <td>",
"        Age &gt;50 years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Progressive dyspnea despite maximal medical therapy",
"       </td>",
"       <td>",
"        Comorbid illness (eg, coronary heart disease, heart failure)*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ex-smoker",
"       </td>",
"       <td>",
"        Current smoker",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"6\">",
"        <strong>",
"         Physiological",
"        </strong>",
"       </td>",
"       <td>",
"        FEV1 &ge;40 percent predicted",
"       </td>",
"       <td>",
"        FEV1 &lt;40 percent predicted",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hyperinflation (eg, TLC &gt;100 percent predicted, RV &gt;150 percent predicted)",
"       </td>",
"       <td>",
"        Absence of hyperinflation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"4\">",
"        &nbsp;",
"       </td>",
"       <td>",
"        DLCO &lt;40 percent predicted",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        PaCO2 &gt;45 mmHg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pulmonary hypertension (PA systolic &gt;45 mmHg, PA mean &gt;35 mmHg)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Unable to participate in pulmonary rehabilitation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"4\">",
"        <strong>",
"         Imaging",
"        </strong>",
"       </td>",
"       <td>",
"        CXR: bulla &ge;30 percent of hemithorax in a symptomatic patient",
"       </td>",
"       <td>",
"        CXR: poorly defined bulla(e)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        HRCT: Large and localized bulla with vascular crowding and normal, compressed parenchyma around bulla",
"       </td>",
"       <td>",
"        Homogeneous, diffuse emphysema without a single large bulla",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Angiography: vascular crowding with preserved distal vascular branching&bull;",
"       </td>",
"       <td>",
"        Angiography: vague bullae, disrupted vasculature elsewhere in lung&bull;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Isotope scan: well-localized matching defect with normal uptake and washout for the rest of the lung&bull;",
"       </td>",
"       <td>",
"        Isotope scan: absence of target zones, poor washout in rest of the lung&bull;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     FVC: forced vital capacity; FEV1: forced expiratory volume in one second; TLC: total lung capacity; RV: residual volume; CXR: chest radiograph; HRCT: high resolution computed tomography.",
"     <br>",
"      * Comorbid illnesses may be considered relative contraindications depending on degree of severity.",
"      <br>",
"       &bull; Angiography and isotope scanning are rarely performed, having been replaced by HRCT scanning.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Data from: www.thoracic.org/COPD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_38_29292=[""].join("\n");
var outline_f28_38_29292=null;
var title_f28_38_29293="Smoking acutely raises BP";
var content_f28_38_29293=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F58131&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F58131&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    First cigarette raises blood pressure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 255px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Change in systolic blood pressure over 15 minutes after smoking the first cigarette of the day (blue squares) or during sham smoking (red circles) in 10 normotensive smokers. Smoking was associated with a 15 to 20 mmHg rise in systolic pressure that began to dissipate at 15 minutes.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Gropelli, A, Giorgi, DM, Omboni, S, et al, J Hypertens 1992; 10:495.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_38_29293=[""].join("\n");
var outline_f28_38_29293=null;
var title_f28_38_29294="Risk of dementia by ethnicity";
var content_f28_38_29294=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F55394&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F55394&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 584px\">",
"   <div class=\"ttl\">",
"    Risk of dementia by ethnicity and family history",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 564px; height: 354px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The data illustrates the cumulative risk of dementia in first- degree biological relatives of Alzheimer disease probands, stratified by relatives' sex and ethnicity. First-degree relatives of African Americans with Alzheimer disease had a higher cumulative risk of dementia than relatives of whites.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Green, RC, Cupples, LA, Go, R, et al. JAMA 2002; 287:329",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_38_29294=[""].join("\n");
var outline_f28_38_29294=null;
var title_f28_38_29295="Abnormal mammogram";
var content_f28_38_29295=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F59883&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F59883&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 490px\">",
"   <div class=\"ttl\">",
"    Abnormal mammogram",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 470px; height: 380px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This is an abnormal mammogram showing a mass, caused by breast cancer.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; Yale University, 2006. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_38_29295=[""].join("\n");
var outline_f28_38_29295=null;
